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Abstract
Huijbers, P.M.C. (2016). Transmission of antibiotic resistance from animals to humans: Broilers 
as a reservoir of ESBL-producing bacteria. PhD thesis, Wageningen University, Wageningen, 
the Netherlands.
Antibiotic resistance in animals becomes a public health issue when there is transmission 
of antibiotic resistant bacteria, or their resistance genes, from animals to humans. β-lactam 
antibiotics are critically important for the treatment of human bacterial infections. Resistance 
to this class of antibiotics, mediated by extended-spectrum β-lactamases (ESBL) has 
emerged. Broilers might contribute to transmission to humans due to the high prevalence of 
ESBL-producing Enterobacteriaceae among their intestinal biome, compared to other livestock 
species, companion animals, and wildlife. Transmission to humans might occur via the food 
chain, by direct contact or via the environment. The aim was to investigate transmission of 
antibiotic resistant bacteria between animals and humans, and more specifically transmission 
of ESBL-producing E. coli between broilers, and between broilers and humans in varying 
degrees of contact with these animals. Systematically collected and categorised evidence 
from literature showed that clinically relevant antibiotic resistant bacteria were present in the 
natural environment, that is in soil, water, air and wildlife. It was therefore hypothesised that 
humans in areas with high broiler densities might have an increased risk for carriage of ESBL-
producing Enterobacteriaceae. This hypothesis was rejected, as the observed risk was lower 
for these individuals. The situation might be different for individuals living on broiler farms 
as ESBL-producing E. coli were detected on all investigated farms. Among broilers, the within 
farm prevalence approached 100%, and there was no difference between conventional and 
organic farms at five weeks, i.e. just before slaughter on conventional farms. On organic farms, 
the prevalence decreased to 80.0% at 70 days, i.e. slaughter age. Not only transmission to 
humans via the farm environment, but close physical contact with broilers might, therefore, 
lead to increased risk for carriage. Prevalence among farmers, their family members and 
employees on both conventional (19.1%) and organic (18.5%) broiler farms was higher 
compared to humans in the general population (5.1%). Moreover, people in close contact 
with live broilers showed the highest risk (27.1 vs. 14.3%). Evidence for clonal transmission 
of ESBL-producing E. coli between humans and broilers was found on conventional farms, 
and horizontal gene transfer was suspected on both conventional and organic farms. Even 
without selection pressure from antibiotics ESBL-producing E. coli were able to transmit and 
persist in an organic broiler flock, which shows that broilers form a reservoir of antibiotic 
resistance genes. This leads to an increased risk of carriage of humans on farms through 
direct contact with broilers and possibly via the direct farm environment. As only a very small 
percentage of the general population is exposed to live broilers, direct contact with broilers 
does not appear to be important for carriage in the general human population.
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Introduction
The emergence of antibiotic resistant bacteria in both humans and animals requires urgent 
attention. Antibiotic resistance in animals becomes a public health issue when there is 
transmission of antibiotic resistant bacteria, or their resistance genes, from animals to humans. 
Infections caused by antibiotic resistant bacteria are difficult to treat, and are associated 
with excess mortality, prolonged hospital stays, and increased costs [1]. Antibiotic resistance 
genes are not restricted to pathogens, however. They are widely distributed among human 
and animal commensal bacteria, and bacteria in the natural environment [2,3]. Limiting the 
spread of antibiotic resistance genes is of utmost importance, and requires an approach that 
takes into account transmission between humans, between animals, between animals and 
humans, and the possible role of the environment in all these transmissions.
This chapter begins by examining the origin, evolution and transmission of antibiotic 
resistant bacteria. β-lactam antibiotics are critically important for the treatment of human 
bacterial infections [4], and resistance to this class of antibiotics has emerged in Gram-
negative bacteria. The chapter, therefore, proceeds with an introduction to β-lactamase 
mediated resistance, and the occurrence and transmission of β-lactamase-producing 
Enterobacteriaceae in humans, animals and the environment. Finally, the scope and outline 
of this thesis are given.
Origin, evolution and transmission of antibiotic resistant bacteria
Origin
Antibiotic resistance is a naturally occurring phenomenon, widespread in the environment that 
predates the modern selective pressure of clinical antibiotic use [5]. Metagenomic analyses of 
DNA from 30,000-year-old permafrost sediments from Alaska yielded a diverse collection of 
genes encoding resistance to β-lactam, tetracycline and glycopeptide antibiotics [5], providing 
evidence for this concept. The apparently ancient and ubiquitous character of antibiotic 
resistance genes in the natural environment raises questions about their function in nature. 
Finding an answer to this question begins with the definition of an antibiotic, which is “a chemical 
substance, produced by micro-organisms, which has the capacity to inhibit the growth of and 
even to destroy bacteria and other micro-organisms” [6]. Evidence is accumulating, however, 
that antibiotics and antibiotic resistance might have other functions besides bacterial inhibition 
and protection. At low (i.e. sub-inhibitory) concentrations, antibiotics affect the transcription of 
many cellular functions [7,8]. This effect on transcription is also seen for synthetic antibiotics, 
suggesting that their modes of action are analogues to those of antibiotics that occur in the 
natural environment [9]. It has subsequently been hypothesised that antibiotics may act as 
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signalling molecules in the natural environment [9,10]. The question then follows whether 
antibiotic resistance is a self-protection process, a mechanism to modulate the signalling 
activity of antibiotics, or perhaps it has another function that remains to be elucidated [10]. 
Evolution
Since antibiotic resistance genes seem to have their origins in environmental bacteria, changes 
affecting microbiota in the environment may have an impact on antibiotic resistance. These 
changes could be brought about by the release of antibiotics used for prophylaxis and curative 
treatment in human and veterinary medicine, and for growth promotion in animal husbandry, but 
also the release of human and animal related microbiota containing resistance genes [11]. The 
evolution of genes encoding β-lactamases can be used to illustrate this. It has been suggested 
that plasmid-encoded β-lactamases have their origin in penicillin-binding proteins, which are 
enzymes involved in cross-linking peptidoglycan to form bacterial cell walls, and are the target 
for β-lactam antibiotics [12,13]. It is also speculated that these genes encoding β-lactamases 
originate from soil-dwelling actinomycetes such as Streptomyces, and have spread to other 
Gram-positive bacteria, and then to Gram-negative bacteria through horizontal gene transfer 
[14]. Selection pressure from antibiotics used in human and veterinary medicine might have 
influenced the spread of these β-lactamases, and might also have led to the accumulation 
of mutations, resulting, for example, in genes that encode β-lactamases with an extended 
spectrum in Gram-negative Enterobacteriaceae ([15]; see section 2).
Transmission
Transmission can involve transfer of whole bacteria from one host to the other i.e. clonal 
transfer, or transfer of resistance genes, located on mobile genetic elements, between 
bacterial species i.e. horizontal gene transfer, including both pathogenic and non-pathogenic 
strains. These processes are influenced by antibiotic use in human and veterinary medicine 
[16]. Antibiotic resistant bacteria are excreted by humans and animals via e.g. faeces, leading 
to contamination of the environment (Figure 1). In the environment, antibiotic resistant 
bacteria of human and animal origin come into contact with environmental bacteria, 
potentially resulting in the exchange of resistance genes. 
Humans and animals may be exposed to antibiotic resistant bacteria by direct physical 
contact or indirect contact via the environment, that is fomites and the natural environment 
(Figure 1). Exposure to these bacteria could lead to infection, carriage or disease in both 
humans and animals. Infection is defined as the acquisition of an antibiotic resistant bacterium 
by a host. Carriage, or colonisation, is defined as an outcome of infection whereby an antibiotic 
resistant bacterium is recovered from a non-sterile site (e.g. intestine) at which no damage is 
clinically apparent. Disease is defined as a state of infection where host damage occurs as a 
result of host-microbe interaction and is sufficient to disturb host homeostasis [17].
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
General Introduction
13
4 
 
1.1.3 Transmission 
Transmission can involve transfer of whole bacteria from one host to the other i.e. clonal transfer, or 
transfer of resistance genes, located on mobile genetic elements, between bacterial species i.e. 
horizontal gene transfer, including both pathogenic and non-pathogenic strains. These processes are 
influenced by antibiotic use in human and veterinary medicine [16]. Antibiotic resistant bacteria are 
excreted by humans and animals via e.g. faeces, leading to contamination of the environment (Figure 
1.1). In the environment, antibiotic resistant bacteria of human and animal origin come into contact 
with environmental bacteria, potentially resulting in the exchange of resistance genes.  
 
 
Figure 1.1 Schematic representation of transmission of antibiotic resistant bacteria between humans, 
animals and the environment. Antibiotics (+AB) are used for treatment and prophylaxis in human and 
veterinary medicine, and these antibiotics are disseminated to the environment e.g. via faeces.  
 
Humans and animals may be exposed to antibiotic resistant bacteria by direct physical contact or 
indirect contact via the environment, that is fomites and the natural environment (Figure 1.1). 
Exposure to these bacteria could lead to infection, carriage or disease in both humans and animals. 
Infection is defined as the acquisition of an antibiotic resistant bacterium by a host. Carriage, or 
colonisation, is defined as an outcome of infection whereby an antibiotic resistant bacterium is recovered 
from a non-sterile site (e.g. intestine) at which no damage is clinically apparent. Disease is defined as a 
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Figure 1. Schematic representation of transmission of antibiotic resistant bacteria between humans, 
animals and the environ ent. Antibiotics (+AB) are used for treatment and prophylaxis in human and 
veterinary medicine, and these antibiotics are disseminated to the environment e.g. via faeces. 
β-lactamase-producing Enterobacteriaceae
Resistance to β-lactam antibiotics has emerged in Gram-negative Enterobacteriaceae, 
which is mainly due to the production of β-lactamases, especially the extended-spectrum 
β-lactamases (hereafter referred to as ESBLs), but also AmpC β-lactamases [2]. The 
mechanism by which β-lactam ses confer resistance is by ntibiotic m dification; they are 
able to hydrolyse the characteristic β-lactam ring, there y inactivating the antibiotic [18]. 
ESBLs cause resistance to various types of newer beta-lactam antibiotics, including penicillins, 
third-generation cephalosporins (cefotaxime, ceftriaxone, ceftazidime) and monobactams 
(aztreonam), but not cephamycins (cefoxitin, cefotetan), and carbapenems (imipenem, 
meropenem, ertapenem) (reviewed by [19]). AmpC β-lactamases have a broader spectrum 
of resistance. In addition to penicillins, third-generation cephalosporins and monobactams, 
they also confer resistance to cephamycins, and are not inhibited by clavulanic acid (reviewed 
by [20]).
In Enterobacteriaceae, ESBLs are generally encoded by plasmid-located genes. The most 
common ESBL-gene families are bla
TEM
, bla
SHV
, bla
CTX-M
, and bla
OXA
 (www.lahey.org/studies). bla
TEM
 
and bla
SHV
 are derived from bla
TEM-1
, bla
TEM-2 
and bla
SHV-1
, which lack an extended-spectrum, and 
differ in as few as one amino acid from their progenitors, leading to a changed substrate profile. 
Certain bla
CTX-M
 types seem to have emerged from environmental bacteria of the Kluyvera spp. 
[21]. bla
TEM
, bla
SHV
 and bla
CTX-M
 have been found most commonly in Escherichia coli and Klebsiella 
pneumoniae, but also in other members of the Enterobacteriaceae such as Citrobacter spp., 
Proteus spp., Salmonella spp., Morganella morganii and Enterobacter spp. bla
OXA
 have mainly 
been found in Pseudomonas aeruginosa (reviewed by [22]). 
AmpC-enzymes are encoded by both chromosomal and plasmid-located genes in 
Enterobacteriaceae. In species such as Enterobacter spp. and Citrobacter spp., AmpC enzymes 
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are inducible upon exposure to β-lactam antibiotics and can be expressed at high levels by 
mutation. Overexpression confers resistance to broad-spectrum cephalosporins including 
cefotaxime and ceftazidime. In bacterial species lacking or poorly expressing chromosomal 
AmpC-genes such as K. pneumonia and E. coli, transmissible plasmids have acquired genes 
for AmpC-enzymes. AmpC-genes include blaCMY, blaACT, blaDHA, blaFOX and blaMIR. Some of these 
varieties are determined by chromosomal genes, and represent possible progenitors for the 
plasmid-determined enzymes (reviewed by [20]). 
β-lactamase genes are associated with transposable elements, which facilitate their 
movement between chromosome and plasmid, and between plasmids within a bacterial 
cell. For movement of genes between bacterial cells a conjugative element (i.e. plasmid or 
conjugative transposon) or bacteriophage is required (reviewed by [16]). It is speculated that 
mobile genetic elements and bacteriophages have contributed to the successful selection and 
dispersion of β-lactamase genes within and between bacterial species [23,24].
Occurrence and transmission of β-lactamase-producing Enterobacteriaceae
Occurrence and risk factors in humans and animals
In Europe from 2010 to 2013, a 9.5% to 12.6% significant increase in resistance to third-
generation cephalosporins in E. coli, which is an indicator for ESBL-production, was observed 
in invasive human isolates (blood and cerebrospinal fluid). In the Netherlands, the percentage 
of third-generation cephalosporin resistant E. coli (3GCREC) was 5.1% out of 3387 invasive 
E. coli isolates in 2010 and 5.8% out of 4740 in 2013, with 88.3% of 3GCREC isolates being 
ESBL-positive in 2013. In comparison, the lowest and highest percentages of 3GCREC 
in 2013 were found in Iceland (5.0% out of 121; 73.6% ESBL) and Bulgaria (39.6% out of 
187; 90.9% ESBL), respectively [25]. Risk factors associated with hospital-acquired infections 
with ESBL-producing Enterobacteriaceae include female gender, previous antibiotic therapy, 
use of a nasogastric tube, use of invasive procedures (i.e. arterial or urinary catheters), and 
a longer period of hospitalisation [26-28]. Information about prevalence of ESBL-producing 
Enterobacteriaceae carriage in the general population is limited to specific studies, as no 
systematic (international) surveillance network has been set up to monitor ESBL-producing 
Enterobacteriaceae in the community. In the Netherlands, the prevalence of ESBL- and AmpC-
carriage among individuals registered at five general practitioners in the area of Amsterdam 
(n=550) was 9.5% and 1.3%, respectively [29]. Risk factors for community-acquired infections 
with ESBL-producing Enterobacteriaceae include recent antibiotic-use, residence in a long term 
care facility, recent hospitalisation, age ≥65 years, and male gender [30]. Travel abroad has 
been reported as a risk factor in multiple studies [31-33].
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ESBL-producing Enterobacteriaceae are also reported in livestock, companion animals, 
and wildlife. In the European programme for monitoring antimicrobial resistance, cefotaxime-
resistance (i.e. indicator for ESBL) was shown among E. coli isolates randomly selected from 
broilers at the slaughterhouse (6.6%), from pigs (1.3%), and from cattle (i.e. veal calves, beef 
cattle, dairy cows; 1.2%; [34]). In the Dutch monitoring programme, these percentages were 
2.9% resistance among broilers, 2.0% in white veal calves, 0.5% in pigs and 0.4% among dairy 
cows. No positive isolates were recovered from rosé veal calves (0.0%; [35]). When selective 
enrichment was applied, prevalences of 66.0% in broilers, 17.9% in white veal calves, 12.3% 
in pigs, 11.3% in rosé veal calves, and 6.0% in dairy cows were found [35]. Unlike in livestock, 
prevalences of ESBL-producing Enterobacteriaceae in companion animals, such as dogs, 
cats and horses, are only available from specific studies. Without selective enrichment, 
between 2.6% (1/39) and 6.9% (14/204) of dogs, and between 0.0% (0/36) and 3.3% (2/61) 
of cats were ESBL-positive [36,37]. With selective enrichment, and taking into account that 
samples originated from non-diarrheic and diarrheic animals, 45.0% (9/20) of non-diarrheic 
dogs, 55.0% (11/20) of diarrheic dogs, 0.0% (0/20) of non-diarrheic cats, and 25.0% (5/20) 
of diarrheic cats were ESBL-positive [38]. Doljeska et al. [39] isolated E. coli after selective 
enrichment from horses at a riding centre and an equine clinic, and found 11.4% (5/44) ESBL-
positive horses at a riding centre and 34.2% (13/38) at an equine clinic. The first study on 
ESBL-producing bacteria in wildlife dates from 2006, where 16% (9/56) of animals sampled 
from national parks were found to be colonised by ESBL-producing E. coli after selective 
enrichment. Positive isolates were recovered from birds of prey (n=5), deer (n=2), fox (n=1) 
and owl (n=1; [40]). Since then, studies have focussed mainly on wild birds, wild boar and 
rodents (reviewed by [41]). When focussing on those studies where selective enrichment 
was used, the prevalence of carriage ranged from 0.5% (2/396) to 26.9% (32/119) in wild 
birds [42,43], 1.7% (5/293) to 10.4% (8/77) in wild boar [44,45], and 4.2% (19/456) to 14.2% 
(8/56) in rodents [46,47]. Studies looking at risk factors for infection with or carriage of ESBL-
producing bacteria in animals are few and limited to the veterinary hospital setting. A study in 
dogs from a veterinary teaching hospital in Australia showed that hospitalisation, treatment 
with a fluoroquinolone, and diagnostic imaging within 42 days prior to admission increased the 
risk of carriage of multi-drug resistant E. coli at admission [48]. In a study at the same veterinary 
hospital, it was also shown that hospitalisation for >6 days, treatment with cephalosporins prior 
to admission, treatment with cephalosporins for >1 day, and treatment with metronidazole 
while hospitalised were associated with increased risk of rectal carriage of multi-drug resistant 
E. coli during hospitalisation [49].
Transmission between humans, animals and the environment
It is clear from the previous section that β-lactamase-producing Enterobacteriaceae are 
widely distributed among human and animal populations, and that there are a number of risk 
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factors associated with infection or carriage. Understanding more about transmission within, 
and between human and animal populations is an important starting point for intervention. 
When spatiotemporally-related isolates from two individuals are the same with respect to 
bacterial species, plasmid type, and/or ESBL-gene this is an indication that transmission 
has occurred. Using this measurement it can be said that transmission of ESBL-producing 
Enterobacteriaceae has been shown between humans in hospitals [50,51], and between 
humans in households [52,53]. Furthermore, E. coli strain sharing has been shown between 
pets, and between humans and pets (i.e. dog, cat) within the same household [54], which 
suggests that strains of ESBL-producing Enterobacteriaceae might also be shared. Studies 
looking at transmission of β-lactamase-producing Enterobacteriaceae between humans and 
animals on livestock farms are scarce and limited to pig farms, but results suggest that working 
with positive pigs is associated with an increased risk of carriage [55-57]. There do not seem 
to be any studies looking at on-farm transmission of ESBL-producing bacteria between animals. 
Transmission between livestock is plausible, as animals are usually housed together in groups 
where frequent contact with other group members, as well as with the shared environment 
(e.g. faecal matter), occurs. Further research is needed to determine, and preferably quantify, 
transmission rates and routes between livestock, between humans and livestock on farms, 
and between humans living in proximity to the farm environment.
Aim and outline of the thesis
Poultry, in particular broilers, might play a role in the transmission of resistance genes to 
humans due to the high prevalence of ESBL-producing Enterobacteriaceae among their 
intestinal biome [58], compared to other livestock species, companion animals, and wildlife 
[34-36,41]. Poultry meat has been identified as a possible source for human disease [59], and 
transmission to humans via the food chain is hypothesised [60], as a high degree of genetic 
similarity among ESBL-E. coli isolates from chicken meat and humans based on the mobile 
genetic elements, virulence genes, and genomic backbone was shown [61]. This is only one 
possible route, however, by which ESBL-producing Enterobacteriaceae might be exchanged 
between humans and animals. Transmission by close physical contact and via the environment 
should also be considered as broiler farms, their immediate surroundings, but also the 
wider natural environment could be contaminated with ESBL-producing Enterobacteriaceae, 
potentially leading to transmission at sites relevant for human exposure. The aim of this thesis 
is, therefore, to investigate transmission of antibiotic resistant bacteria between animals and 
humans, and more specifically the transmission of ESBL-producing E. coli between broilers, 
and between broilers and humans in varying degrees of contact with broilers. In order to gain 
insight into transmission routes, studies were conducted answering key questions on (1) 
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the role of the natural environment in the transmission of clinically relevant antimicrobial 
resistant (AMR) bacteria to humans; (2) prevalence of, and risk factors for, carriage of ESBL-
producing Enterobacteriaceae in the general human population living in areas with high and low 
broiler densities, and humans on conventional and organic broiler farms; and (3) prevalence of 
carriage, and transmission dynamics among broilers on a broiler farm under field conditions.
Clinically relevant AMR bacteria, present among the intestinal biome of humans and animals, 
might be disseminated to the natural environment i.e. soil, water, and air/dust, via human and 
animal faeces i.e. wastewater and manure. Relevant literature was therefore systematically 
collected and categorised to elucidate the role of the natural environment in the transmission 
of these bacteria to humans (Chapter 2). The occurrence of clinically relevant AMR bacteria 
in the environment leads to the hypothesis that individuals in areas with high broiler 
densities might have an increased risk for carriage. The prevalence of, and risk factors for 
carriage of ESBL-producing Enterobacteriaceae are therefore determined for humans living 
in municipalities with either a high or low broiler density (Chapter 3). Not only transmission 
via the environment, but close physical contact with broilers might lead to increased risk for 
carriage in humans. The prevalence of ESBL/AmpC-producing E. coli carriage among farmers, 
their family members and employees on a conventional broiler farm are therefore estimated. 
Furthermore, risk factors for carriage, with an emphasis on contact with live broilers are 
identified and quantified. To gain further insight into transmission routes, isolates from 
humans and broilers within farms are compared with respect to molecular characteristics 
(Chapter 4). Due to differences in management practices between conventional and organic 
farms, especially antibiotic use, the prevalence of ESBL/AmpC-producing E. coli carriage 
among broilers, and humans living and/or working on organic broiler farms are estimated, 
and compared to results from the conventional farms. In addition, molecular typing results 
of isolates from humans and broilers are presented (Chapter 5). More information about 
transmission of ESBL-producing E. coli between broilers could provide valuable insights 
into the extensive dissemination of these bacteria among animals, resulting in a starting 
point for on-farm intervention. Transmission rates and routes of ESBL-producing E. coli, and 
specific phylogenetic groups, are therefore quantified in an organic broiler flock where no 
antibiotics were used (Chapter 6). This thesis concludes with a discussion of the contribution 
of ESBL-producing E. coli from broilers to human carriage, and the relative contribution of 
other sources and pathways in carriage of humans in the general population. Furthermore, 
recommendations for future research and main conclusions from this thesis are given 
(Chapter 7).
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Abstract
To establish a possible role for the natural environment in the transmission of clinically 
relevant AMR bacteria to humans, a literature review was conducted to systematically 
collect and categorize evidence for human exposure to extended-spectrum β-lactamase-
producing Enterobacteriaceae, methicillin-resistant Staphylococcus aureus, and 
vancomycin-resistant Enterococcus spp. in the environment. In total, 239 datasets 
adhered to inclusion criteria. AMR bacteria were detected at exposure-relevant sites 
(35/38), including recreational areas, drinking water, ambient air, and shellfish, and in 
fresh produce (8/16). More datasets were available for environmental compartments 
(139/157), including wildlife, water, soil, and air/dust. Quantitative data from exposure-
relevant sites (6/35) and environmental compartments (11/139) were scarce. AMR 
bacteria were detected in the contamination sources (66/66) wastewater and manure, 
and molecular data supporting their transmission from wastewater to the environment 
(1/66) were found. The abundance of AMR bacteria at exposure-relevant sites suggests 
risk for human exposure. Of publications pertaining to both environmental and human 
isolates, however, only one compared isolates from samples that had a clear spatial and 
temporal relationship, and no direct evidence was found for transmission to humans 
through the environment. To what extent the environment, compared to the clinical 
and veterinary domains, contributes to human exposure needs to be quantified. AMR 
bacteria in the environment, including sites relevant for human exposure, originate from 
contamination sources. Intervention strategies targeted at these sources could therefore 
limit emission of AMR bacteria to the environment.
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Introduction
The occurrence and spread of antimicrobial resistant (AMR) bacteria are pressing public 
health problems worldwide. Recently, in its first global report on surveillance of antimicrobial 
resistance, the World Health Organization (WHO) reported very high rates of resistance in 
bacteria (e.g., Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus) that cause 
common healthcare-associated and community-acquired infections in people in all WHO 
regions [1]. Infections caused by AMR bacteria are associated with excess mortality, prolonged 
hospital stays, and increased costs [2]. In order to formulate effective intervention strategies 
to combat intractable infections caused by AMR bacteria, it is important to discern which 
fraction of the total disease burden and costs are attributable to different sources, including 
animal reservoirs and vehicles such as foods, or the environment [3]. 
Enteric bacteria are introduced into the environment with human and animal feces, 
and people may be exposed to these bacteria through, e.g., recreation in contaminated 
surface water, consumption of contaminated drinking water, fresh produce, or (shell)
fish, and inhalation of bioaerosols. Previous studies indicate that the risk of contracting 
Salmonella spp. or Campylobacter spp. in recreational waters is higher than or equal to the 
risk of contracting the organisms through chicken consumption [4-6]. In the United States of 
America, 9% of all outbreaks with the pathogenic E. coli O157 are waterborne [7]. Based on 
global WHO risk assessments, it was estimated that there are over 120 million cases annually 
of gastrointestinal disease from exposure to coastal waters via recreation or by eating raw 
or lightly cooked shellfish [8]. Multiple studies have described outbreaks of infections with 
Enterobacteriaceae associated with consumption of fresh produce [9]. Examples include the 
2011 outbreak of E. coli O104:H4 associated with sprouts in Europe and Northern America 
[10], and the 2006 outbreak of E. coli O157:H7 associated with spinach in the United States 
[11]. 
The natural environment has been identified as a pathway by which transmission of AMR 
bacteria to humans might occur [12]. The extent to which this occurs remains unknown, 
however. It is important to establish the relative role of the environment in the transmission 
of AMR bacteria to humans, compared with the spread of AMR bacteria through contact 
with animal carriers, consumption of food of animal origin, (international) travel, and their 
spread in healthcare and community settings. The aim of the current study was to establish 
a possible role for the natural environment, defined as soil, water, air/dust, and wildlife, in 
the transmission of clinically relevant AMR bacteria to humans by systematically reviewing 
the peer-reviewed literature. For this purpose three AMR bacteria were selected: extended-
spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-Ent), methicillin-resistant 
S. aureus (MRSA), and vancomycin-resistant Enterococcus spp. (VRE). Additionally, the 
contribution of fecal contamination sources (human wastewater and animal manure) to the 
burden of the AMR bacteria in the environment was explored. 
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Methods
Search strategy
Two databases (Medline and Scopus) were searched on April 10th, 2014, to identify 
publications describing one or more of three AMR bacteria in relation to the environment. 
The bacterial species were selected to represent Gram-negative and Gram-positive species, 
and species of fecal and non-fecal origin. Moreover, each of the bacterial species colonizes 
both animals and humans, has a clinically relevant type of resistance, and is sufficiently 
prevalent in humans and/or animals that its presence in the environment may be anticipated. 
Accordingly, ESBL-Ent (i.e., E. coli, Enterobacter spp., K. pneumoniae), MRSA and VRE were 
selected, and carbapenemase-producing Enterobacteriaceae were not selected. 
For the purpose of the present review, environment was defined as natural environment 
(or ‘outdoor’ environment). Consequently, indoor environments such as hospitals or livestock 
housing were excluded. Four environmental compartments were distinguished: soil, water, 
air/dust, and wildlife (Figure 1). Wildlife was categorized as an environmental compartment 
because these animals are not treated with antibiotics, and their carriage of AMR bacteria is 
most likely explained by uptake from the natural environment during foraging and drinking. 
Wildlife can therefore be considered as an extension of the specified environmental 
compartments, as well as a vehicle for multiplication and spread of these bacteria. Within 
the environmental compartments, sites relevant for human exposure were defined and 
included in the search strategy: recreational areas (i.e., beach sand and recreational water), 
irrigation water, drinking water, urban water (e.g., fountains), shellfish, and ambient air. Fresh 
produce, i.e., food of plant origin such as vegetables and fruits, may be contaminated with 
AMR bacteria during growth in contaminated soil and/or irrigation with contaminated water. 
Consequently this was also included as a ‘site’ relevant for human exposure. Finally, the main 
sources of fecal contamination of the environment, wastewater and manure, were included 
in the search strategy. For the purpose of the current study, manure was defined as animal 
feces that is intentionally (e.g., for use as fertilizer) or unintentionally (e.g., droppings of free-
range animals) introduced into the natural environment, or that is stored, presumably for use 
as fertilizer. Consequently, only measurements of AMR bacteria in animal feces introduced in 
natural environments (e.g., not fecal swabs or droppings sampled in stables) were included.
Combinations of key search terms for AMR bacteria and defined environmental 
compartments, contamination sources, and exposure-relevant sites were used to interrogate 
the online databases (Table 1). Specifically, the titles, abstracts, and key words of publications 
included in the online databases were screened for these key search terms.
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Table 1. Combinations of key search terms used for the identification of literature on AMR bacteria from 
environmental compartments, contamination sources, and exposure-relevant sites.
Key subjects Medline search terms
Bacteria (enterobacter* or escherichia coli? or e coli? or klebsiella? or enterococc* or 
staphylococcus aureus or s aureus).af
AND
Resistance types (extended spectrum beta lactamase? or esbl? or (methicillin adj2 resistan*) or 
mrsa? or (vancomycin adj2 resistan*) or vre?).af.
AND
Environmental 
compartments
(water* or freshwater? or seawater or aquatic or coastal or beach* or lake? or 
river? or soil? or land? or pasture? or sediment? or air or airborne or dust or 
wildlife or wild animal? or bird? or mammal? or rodent?).mp.
OR
Contamination 
sources
(manure or dropping? or slurry or sludge or lagoon? or compost or fertili?er? or 
sewage or effluent? or wastewater?).mp
OR
Exposure-relevant 
sitesa
(crop? or vegetable? or fresh produce or sprout? or shellfish or fish).mp
Key subjects Scopus search terms
Bacteria (TITLE-ABS-KEY(enterobacter* OR escherichia-coli OR e-coli OR klebsiella OR 
enterococc* OR staphylococcus-aureus OR s-aureus))
AND
Resistance types ((TITLE-ABS-KEY(extended-spectrum-beta-lactamase OR esbl OR mrsa OR vre) 
OR TITLE-ABS-KEY(vancomycin W/1 resistan*) OR TITLE-ABS-KEY(methicillin W/1 
resistan*)))
AND
Environmental 
compartments
(TITLE-ABS-KEY(*water OR water* OR aquatic OR coastal OR beach OR lake OR 
river OR soil OR land OR pasture OR sediment OR air OR airborne OR dust OR 
wildlife OR wild-animal OR bird OR mammal OR rodent))
OR
Contamination 
sources
(TITLE-ABS-KEY(manure OR dropping OR slurry OR sludge OR lagoon OR compost 
OR fertili?er OR sewage OR effluent))
OR
Exposure-relevant 
sitesa
(TITLE-ABS-KEY(crop OR vegetable OR fresh-produce OR sprout OR shellfish OR 
fish))
a The exposure-relevant sites recreational water, drinking water, urban water, irrigation water, and ambient air are 
captured by search terms included under environmental compartments.
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Figure 1. Schematic diagram of environmental compartments, contamination sources, exposure-
relevant sites, and processes affecting survival and spread of bacteria. 
Selection criteria
Two reviewers independently screened titles and abstracts, resulting from the automated 
database search, for exclusion criteria. Publications were excluded if they were in a language 
other than English, Dutch, or German, contained non-original research (e.g., reviews), or 
did not investigate the specified compartments or AMR bacteria (Figure 2). Publications 
solely describing resistance genes (i.e., genes encoding ESBL or resistance to methicillin or 
vancomycin), independently of bacterial hosts, were excluded. In case of conflict of opinion 
about inclusion of an article based on title or abstract, this was discussed by both reviewers 
until consensus was reached. Full texts were retrieved for included publications, and for 
publications where the decision for inclusion or exclusion could not be based on the contents 
of title and abstract, or where abstracts were not available. Full texts were further assessed 
for compliance with the inclusion and exclusion criteria (Figure 2A).
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Included publications
n=2676
Included publications
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Included publications
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Included publications
n=241
Included datasets
n=312
Included datasets
n=248
Included datasets
n=239
Medline
n=902
Scopus
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Step 2: Screen full-text articles
- Retracted article (n=1)
- No PDF available (n=2)
- No culture method used (n=1)
- Sample description incomplete (n=1)
Step 1: Assessment according to 
exclusion criteria
n=1566
Duplicate removal
n=864
Step 3: Assessment according to 
quality criteria
n=64
Step 4: Screen datasets
- Environmental compartment 
unspecified (n=9)
A
B
Figure 2. Flowchart of the (A) publication and (B) dataset selection process.
Data extraction
Study characteristics and data from included publications were extracted and exported to a 
database using a custom-made form. Full details of the extraction fields are available in Table 
S1 (Supporting Information). In case multiple publications described the same or overlapping 
sets of samples or isolates, these publications were considered as one data source, i.e., 
one publication. Publications were categorized on the basis of the type of investigated 
compartment (contamination sources, environmental compartments, exposure-relevant 
sites) and the type of AMR bacteria. Individual publications could be included within more 
than one category.
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To ensure the quality of the dataset, the method used to isolate AMR bacteria was 
assessed. First, it was determined whether selective culture methods were used to detect 
the AMR bacteria. Selective culture was defined as culture (pre-enrichment or direct plating) 
in the presence of relevant antibiotics: third-generation cephalosporin-supplemented 
medium or commercial screening medium for the isolation of ESBL-Ent; methicillin-, 
oxacillin-, or cefoxitin-supplemented medium or commercial screening medium for MRSA; 
and vancomycin-supplemented medium for VRE. The rationale for this assessment is the lack 
of sensitivity of non-selective culturing methods for the detection of AMR bacteria, and the 
resulting unreliability for drawing conclusions on the basis of lack of detection when non-
selective culturing was used. Second, it was determined whether the antibiotic resistance 
was confirmed using phenotypic and/or molecular methods. Phenotypic confirmation tests 
deemed valid included growth of isolates on media containing concentrations equal to or 
above clinical breakpoints, established minimal inhibitory concentrations (MICs) equal to or 
above clinical breakpoints, and, in the case of disc diffusion assays, inhibition zones smaller 
than clinical breakpoints as described in the Clinical and Laboratory Standards Institute (CLSI) 
guidelines [13]. VanB-carrying VRE variants with MICs below the current CLSI breakpoint 
concentration (32 µg/mL) have been described [14]; therefore growth at concentrations 
>16 µg/mL was also considered a valid phenotypic confirmation. Polymerase chain reactions 
(PCRs) detecting mecA and vanA or vanB genes were considered valid molecular tests for 
MRSA and VRE, respectively. For ESBL-Ent, PCRs detecting CTX-M genes, PCRs detecting TEM, 
SHV, and OXA genes in combination with sequencing to establish subtypes, or PCRs detecting 
other ESBL genes were considered valid molecular confirmation tests. Sequencing of TEM, 
SHV, and OXA genes is required since non-ESBL-encoding alleles exist of these genes. Studies 
in which AMR bacteria were investigated but not detected using only non-selective culture 
methods, or where resistance of isolates was not confirmed appropriately, were excluded 
from analysis.
For each publication, it was assessed whether AMR bacteria were enumerated, and 
whether environmental isolates were compared with isolates from fecal contamination 
sources or with human isolates for phenotypic or genetic relatedness. From the perspective 
of the current review, i.e., study of documentation on transmission from the environment to 
humans and on emission from contamination sources to the environment, only comparisons 
between isolates from samples with a spatiotemporal relationship were considered relevant. 
Tests frequently used for establishing relatedness of isolates included pulsed-field gel 
electrophoresis (PFGE), multilocus sequence typing (MLST), antibiotic resistance profiling, 
Staphylococcus protein A gene (spa)-typing (specifically for MRSA), and PhenePlate (PhP) 
biochemical fingerprinting (specifically for VRE). Additional tests included those identifying 
resistance genes and their genetic environment, e.g., identification of ESBL-genotype and 
plasmid characterization for ESBL-Ent, and staphylococcal cassette chromosome SCCmec-
typing for MRSA.
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Results 
General
The selection process yielded 241 publications that met the inclusion criteria (Figure 2A), 
and from these publications data were extracted. Fifteen publications described the same or 
overlapping samples or isolates, and these were combined to represent seven publications. 
Some publications described multiple AMR bacteria, environmental compartments, 
contamination sources, and/or exposure-relevant sites. For further study, data from 
included publications were divided into datasets, with each dataset describing one type of 
AMR bacteria (i.e., ESBL-Ent, MRSA, VRE) in combination with one type of environmental 
compartment (i.e., soil, water, air/dust, wildlife), contamination source (i.e., wastewater, 
manure), or fresh produce. The 241 included publications resulted in 312 datasets (Figure 
2B). After applying the defined quality criteria, 64 datasets were excluded. For 9 datasets, 
the results could not be interpreted due to lack of specification in which of the studied 
compartment(s) AMR bacteria were found. These had not been not excluded earlier in the 
selection process because the publications also contained other, valid datasets. This left 239 
datasets for further study. Details on publications describing these datasets are available 
in Table S2 (Supporting Information). The majority of datasets described wildlife (n=71), 
wastewater (mostly municipal or urban sewage) (n=60), and water (n=56), followed by soil 
(n=25), fresh produce (n=16), manure (n=6), and air/dust (n=5). ESBL-Ent (n=102) and VRE 
(n=88) were described more often compared to MRSA (n=49).
All continents were represented; however more than half of the datasets described 
isolates collected in Europe (n=139), followed by North America (n=39), Asia (n=38), Africa 
(n=9), South America (n=8), Oceania (n=3), and the Antarctic (n=2). One dataset contained 
isolates that were collected from both Europe and Asia.
Exposure-relevant sites and fresh produce
Of 157 datasets concerning environmental compartments (Table 2), 24% (38/157) included 
sites that are relevant for human exposure (Table 3). Of these, almost two-thirds were 
about recreational water (n=15) or beach sand (n=12). The remaining datasets were about 
drinking water (n=5), ambient air (n=3), shellfish (n=2), and irrigation water (n=1). No 
datasets pertaining to urban water (e.g., fountains) were identified. Furthermore, 16 datasets 
concerned fresh produce such as vegetables, fruits, sprouts, and herbs (Table 3). Overall, 
AMR bacteria were detected in 92% (35/38) of datasets about exposure-relevant sites, and in 
50% (8/16) of datasets about fresh produce.
Only six datasets concerning exposure-relevant sites included quantitative data on the 
AMR bacteria (Table 4). Five datasets concerned concentrations in recreational areas, ranging 
from 100.1-103 CFU/100mL [15-18]. One dataset provided information on concentrations in 
blue mussels, which was <10 CFU/g [19].
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Table 3. Detection of AMR bacteria at exposure-relevant sites and in fresh produce.
Exposure-relevant 
site
AMR 
bacteriaa
Countries investigated
Detectionb
n/N %
Beach sand ESBL-Ent Portugal 1/1 100
MRSA United States 8/8 100
VRE Malaysia, United States 3/3 100
Sub total 12/12 100
Recreational water ESBL-Ent Algeria, Netherlands 2/2 100
MRSA United States 9/10 90
VRE Malaysia, United States 3/3 100
Sub total 14/15 93
Drinking water ESBL-Ent Bangladesh, Democratic Republic of Congo, 
Nicaragua
3/3 100
MRSA - - -
VRE Germany, South Africa 1/2 50
Sub total 4/5 80
Ambient air ESBL-Ent Poland 2/2 100
MRSA Germany 1/1 100
VRE - - -
Sub total 3/3 100
Shellfish ESBL-Ent - - -
MRSA - - -
VRE Denmark, United Kingdom 2/2 100
Sub total 2/2 100
Irrigation water ESBL-Ent Netherlands 0/1 0
MRSA - - -
VRE - - -
Sub total 0/1 0
Total 35/38 92
Fresh producec ESBL-Ent Japan, Netherlands, Portugal, Saudi Arabia, Spain 4/7 57
MRSA Iran, South Korea 2/2 100
VRE
Denmark, Germany, Italy, Portugal, South Africa, 
Spain, Sweden, Turkey, United Kingdom
2/7 29
Total 8/16 50
a Abbreviations used: AMR bacteria, antimicrobial resistant bacteria; ESBL-Ent, extended-spectrum β-lactamase-
producing Enterobacteriaceae; MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant 
Enterococcus spp. b n/N, number of datasets where at least one positive sample was detected divided by the total 
number of datasets; %, percentage of datasets where AMR bacteria were detected. c AMR bacteria were detected in 
vegetables, fruits, (imported) herbs, sprouts, mixed salad, and pre-packaged fruit juice. They were not detected in 
other vegetables, lettuce from a farm, mixed salad, sprouts, and crops from a farm. 
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Genetic relatedness between environmental and human isolates
Of all publications where AMR bacteria were detected in environmental samples, 12 included 
information on the relationship between human and environmental isolates by PFGE, PhP 
biochemical fingerprinting, MLST, spa-typing, or SCCmec-typing (ESBL-Ent, n=4; MRSA, n=6; 
VRE, n=2). Together these publications contained six datasets on wildlife, six on surface water, 
and four on soil. Two of the publications on soil and surface water concerned exposure-
relevant sites (i.e., recreational waters and beach sand). Of the publications pertaining to 
environmental and human isolates, however, only one compared isolates from samples 
that had a clear spatial and temporal relationship [20]. Human nasal cultures, beach sand 
samples, and marine water samples were collected on the same day and stranded pilot 
whale (Globicephala macrorhynchus) samples were collected within two months at a marine 
mammal conservancy in the United States. MRSA isolates from whales, human volunteers 
attending these animals, and the beach sand and marine water associated with the marine 
mammal conservancy showed a high degree of genetic relatedness (≥95% similar PFGE 
patterns and same SCCmec-type) [20].
Environmental compartments
AMR bacteria were detected in at least one of the samples in 89% (139/157) of the datasets 
concerning environmental compartments (Table 2). The majority of these datasets were 
about ESBL-Ent (n=67), followed by VRE (n=47) and MRSA (n=43). High prevalences, defined 
as the percentage of datasets with at least one positive sample for the AMR bacteria, were 
observed in all environmental compartments and ranged from 85-100% (Table 2). All air/dust 
datasets concerned AMR hotspots (i.e., wastewater treatment plants and livestock farms). 
In the case of soil, the majority of datasets were obtained at recreational beaches and from 
agriculturally related soils. By contrast, datasets concerning wildlife and water were obtained 
from a variety of species and locations, not necessarily related to AMR hotspots. 
Bacterial concentrations were described in 8% (11/139) of datasets where AMR bacteria 
were detected: three soil datasets from Germany, Denmark, and United States; five water 
datasets from the Netherlands, United States, and Denmark; two air datasets from Germany; 
and one wildlife dataset from Denmark (Table 4).
In three publications, birds and mammals were investigated in conjunction with at 
least one other environmental compartment, at the same time and geographic location, 
to establish the relation between isolates from different compartments [20-22]. Doljeská 
et al. [21] showed that ESBL-Ent were present in pond water and in black-headed gulls 
(Larus ridibundus) nesting on the same pond. However, based on AMR profiles, ESBL genes, 
and macro-restriction profiles, isolates from wildlife and surface water were not related. 
Hernandez et al. [22] isolated ESBL-Ent from surface water but not from penguin (Pygoscelis 
papua) feces. Hower et al. [20] found MRSA isolates with 99% similar PFGE profiles and the 
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same SCCmec- and spa-type in short-finned pilot whales (G. macrorhynchus), water, and 
beach sand.
Table 4. Concentrations of AMR bacteria in environmental compartments, including exposure-relevant 
sites.
Environmental 
compartment
AMR
bacteria
Type (source) Concentrationd Country Reference
Soil MRSA Agricultural
a (around 
turkey and broiler farm)
2.3x103-2.7x105 CFU/
pair bootswabs Germany [55]
Sand (beach)b,c 2.0-66.2 MPN/100mL United States [17]
VRE
Agriculturala (research 
station)
ND, <10 CFU/ge Denmark [19]
Non-agriculturala 
(research station)
ND, <10 CFU/ge
Water ESBL-Ent Fresh/marine (river, lake, 
North Sea)b
0.15-15 CFU/100mL Netherlands [15]
Fresh (not under 
influence of WWTP)
10 CFU/100mL
Fresh (river at discharge 
WWTP)
102-103 CFU/100mL
MRSA Marine (Pacific Ocean)b,c 2.0-66.2 MPN/100mL United States [17]
Marine (Pacific Ocean)b 0.65 CFU/100mL United States [16]
Marine (Atlantic Ocean, 
bather related)b
<2-780 CFU/100mL United States [18]
Marine (Atlantic Ocean, 
ambient)b
<2-260 CFU/100mL
VRE Marine (at outlet WWTP) ≤10-2 CFU/mL Denmark [19]
Air/dust MRSA 50m outside stable 
(turkey farm)b
7-93 CFU/m3 Germany [55]
150m outside stable 
(turkey farm)b
11-23 CFU/m3
Directly outside stable 
(pig farm)
3.2x101- 4.0x101 CFU/m3 Germany [56]
Wildlife VRE Shellfish (at outlet 
WWTP)b
<10 CFU/g Denmark [19]
a ‘agricultural’, soil exposed to animal manure; ‘non-agricultural’, soil not exposed to animal manure. b Exposure-
relevant site. c Marine water, freshwater, and sand samples from two marine beaches were pooled to give this result. 
d Abbreviations used: CFU, colony-forming units; MPN, most probable number; ND, not detected. e VRE were not 
detected by direct plating on Slanetz-Bartley agar with vancomycin.
Contamination sources
AMR bacteria were detected in at least one of the samples in all (60/60) datasets concerning 
wastewater (Table 5). The majority of these datasets concerned VRE (n=33), followed by 
ESBL-Ent (n=23) and MRSA (n=4). Three types of wastewater could be distinguished: (1) 
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community wastewater, or water derived from sewer systems and wastewater treatment 
plants (WWTP); (2) hospital wastewater; and (3) industrial wastewater, or water derived from 
slaughterhouses, factories, and farms. AMR bacteria were detected in at least one of the 
samples in all (6/6) datasets concerning manure. These datasets most often concerned ESBL-
Ent (n=5), followed by VRE (n=1). No datasets on MRSA in manure were identified in the 
current review (Table 5).
Table 5. Detection of AMR bacteria in datasets describing contamination sources.
Contamination 
source
AMR 
bacteriaa
Geographic regions 
investigated
Detectionb
Description of samples
n/N %
Wastewater ESBL-Ent Africa, Europe, S. 
America, Oceania
23/23 100
Untreated, secondary effluent, sludge, 
other
MRSA
Europe, N. America, 
Oceania
4/4 100
Untreated, secondary effluent, tertiary 
effluent, sludge, other
VRE
Asia, Europe, N. 
America
33/33 100
Untreated, secondary effluent, tertiary 
effluent, sludge, other, unspecified
Sub total 60/60 100
Manure ESBL-Ent Europe, Asia 5/5 100 Broiler, laying hen, pig, duck, dairy cow
MRSA - - - -
VRE Europe 1/1 100 Pig
Sub total 6/6 100
Total 66/66 100
a Abbreviations used: AMR bacteria, antimicrobial resistant bacteria; ESBL-Ent, extended-spectrum β-lactamase-
producing Enterobacteriaceae; MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant 
Enterococcus spp. b n/N, number of datasets where at least one positive sample was detected divided by the total 
number of datasets; %, percentage of datasets where AMR bacteria were detected. 
Eighteen percent (12/66) of datasets about contamination sources included quantitative 
data: 11 of the wastewater datasets and one of the manure datasets (Table 6). The effect 
of wastewater treatment on concentrations of ESBL-Ent and VRE was investigated in seven 
publications originating from Algeria [23], Spain [24], Denmark [19,25], United States [26,27], 
and Portugal [28]. The majority of these publications described only mechanical (e.g., 
sedimentation) and biological (e.g., activated sludge) treatment of wastewater. A reduction 
of 1-4 log
10
-units was observed during secondary treatment. In three publications [26-28], 
concentrations of VRE in tertiary effluent were additionally described. Tertiary treatment 
in these publications entailed UV treatment, chlorination, lagooning and sand filtration, 
respectively. A further reduction of 2-3 log
10
-units was observed relative to secondary treated 
effluents. UV treatment, chlorination and lagooning brought VRE concentrations below the 
detection limit, but VRE could still be detected after sand filtration [26-28]. No information 
was available on the effect of manure treatment on AMR bacterial concentrations.
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Three publications about wastewater included bacterial concentrations in community 
wastewater receiving wastewater from AMR hotspots as well as hotspot wastewater, i.e., from 
a hospital [28], and drug production plants [19,25]. Concentrations of AMR bacteria were 
highest in AMR hotspot wastewater, followed by WWTP influent and WWTP effluent. When 
investigated [19,25], WWTP influents or sewage not containing AMR hotspot wastewater 
had lower concentrations of AMR bacteria compared to the counterparts receiving hotspot 
wastewater (Table 6).
Table 6. Concentrations of AMR bacteria in contamination sources.
Contamination 
source
AMR 
bacteria
Type (source)a Concentrationb Country Reference
Wastewater ESBL-Ent Influent (WWTP) 4.6x103-1.6x105 CFU/100mL Algeria [23]
Effluent (WWTP) 5.1x102-1.3x103 CFU/100mL
Rinse water 
(poultry farm)
3.9x106-5.8x107 CFU/L Netherlands [57]
Effluent (WWTP) 102-103 CFU/100mL Netherlands [15]
Hospital 104-105 CFU/mL Poland [58]
VRE Influent (WWTP) 2-140 CFU/100mL
United 
Kingdom
[59]
Influent (WWTP) 103-104 CFU/100ml Spain [24]
Effluent (WWTP) 10-102 CFU/100mL
Factory 0.9x105-5.1x106 CFU/mL Denmark [25]
Influent (WWTP, 
inlet 1c)
1.5x102-5.8x103 CFU/mL
Influent (WWTP, 
inlet 2d)
6.9x101-6.4x102 CFU/mL
Sludge (WWTP) 4.2x102-6.1x104 CFU/mL
Effluent (WWTP) 3.6x10-1-2.8x100 CFU/mL
Sludge (Factory) 109 CFU/mL Denmark [19]
Effluent (Factory) 103 CFU/mL
Sewaged (sewer 
upstream)
<10-103 CFU/mL
Sewagec (sewer 
downstream)
102-104 CFU/mL
Influent (WWTPd, 
inlet 1c)
103-104 CFU/mL
Influent (WWTPd, 
inlet 2d)
102-104 CFU/mL
Influent (WWTPc) 103 CFU/mL
Sludge (WWTPd) 103-104 CFU/mL
Sludge (WWTPc) 103 CFU/mL
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Contamination 
source
AMR 
bacteria
Type (source)a Concentrationb Country Reference
Effluent (WWTPd) 10-1-100 CFU/mL
Effluent (WWTPc) 10-1 CFU/mL
Influent (WWTP) 2.5x103-8.6x104 CFU/100mL United States [27]
Secondary 
effluent (WWTP)
9.6x101-1.0x103 CFU/100mL
Tertiary effluent 
(WWTP)
ND-3.3 CFU/100mLe
Other (WWTP) ND-1.9x105 CFU/100mL
Influent (WWTP)
ND (winter), 104-105 
CFU/100mL (spring, 
summer)
United States [26]
Secondary 
effluent (WWTP)
ND (winter), 400-5200 
CFU/100mL (spring, 
summer)
Tertiary effluent 
(WWTP)
ND
Hospital 1.6x101-2.2x103 CFU/mL Portugal [28]
Influentc (WWTP) 6.7x100 -4.1x10
2 CFU/mL
Effluent (WWTP) ~100 CFU/mL
Manure ESBL-Ent Dung heap 
(poultry farm)
≥0.1 CFU/g Netherlands [57]
Storage tank 
(poultry farm)
<0.1 CFU/g
Free-range area 
(poultry farm)
3.1x103-9.3x103 CFU/g
a WWTP, wastewater treatment plant. b CFU, colony-forming units; ND, not detected. c Receiving and d not receiving 
wastewater from the specified hotspot (e.g., hospital or factory wastewater). e Only detected when chlorination was 
not operational.
Relation between isolates from environmental compartments and contamination sources
Twenty publications included datasets describing both wastewater and environmental 
compartments. In only nine of these, however, was it specified that the investigated 
wastewater and environmental compartments were geographically connected and sampled 
at the same time [15,19,24,29-34]. All of these publications investigated surface water in 
conjunction with wastewater and were performed in multiple European countries. Two of 
the datasets additionally included air at a Polish WWTP in which ESBL-Ent were detected, and 
another included Danish wildlife (mussels) in which VRE were detected [19,30,31]. In eight 
of nine publications describing surface water receiving wastewater from WWTP (all except 
ref 31), ESBL-Ent and VRE were detected in both wastewater and surface water. In three of 
Table 6. Continued
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these eight publications, the relation between isolates from wastewater and environmental 
isolates was not investigated [24,32,34]. In three other publications, isolates were compared 
with respect to PFGE profiles or ESBL genotype [19,30,31]. Isolates from wastewater and 
surface water had different PFGE profiles in the Danish study [19], while similar ESBL 
genotypes were seen in wastewater, river water, and air at the Polish WWTP [30,31]. In the 
two remaining studies, isolates were compared with respect to multiple characteristics. 
Novais et al. [33] showed that isolates from wastewater and surface water had different PFGE 
profiles, while resistance genes, virulence traits, and AMR profiles were similar, suggesting 
horizontal gene transfer. Blaak et al. [15] conducted multiple analyses on spatiotemporally 
related ESBL-Ent isolates obtained from Dutch wastewater and downstream surface water 
(including recreational water), and demonstrated identical isolates with respect to sequence 
type, phylogenetic group, AMR profile, and ESBL genotype. A contribution of WWTP/sewage 
to the presence of AMR bacteria in surface water is further supported by quantitative data 
from two studies: Blaak et al. [15] showed similar ESBL-Ent concentrations in surface water at 
WWTP effluent discharge points and in effluents (102-103 CFU/100mL), and Gómez et al. [24] 
demonstrated that VRE concentrations were higher closer to the WWTP (104 CFU/100mL), 
compared to upstream or further downstream (102-102.5 CFU/100mL).
In five publications, manure was investigated in relation to environmental compartments 
[35-39]. In two of these direct deposition of feces in the environment was investigated. 
Hasan et al. [37] detected ESBL-E. coli in wild birds inhabiting the same lakeshore as poultry 
and ducks from surrounding households. Isolates were spatially related, but their temporal 
relationship was unclear [37]. Ma et al. [38] detected ESBL-E. coli in water from ponds on a 
duck farm. Isolates from the ponds and ducks were spatiotemporally related and had similar 
PFGE profiles, phylogenetic groups, and/or ESBL-genes [38]. The three remaining publications 
concerned livestock manure in conjunction with application to agricultural land. Friese et al. 
[35] detected ESBL-E. coli in samples taken from previously fertilized fields (within the last 6 
weeks) around (unspecified distance) pig and broiler houses, and in slurry samples. It was 
not indicated, however whether pig slurry from the farms was used to fertilize the fields 
[35]. Hartmann et al. [36] detected ESBL-E. coli in cultivated soil amended one year before 
with liquid cow manure from one farm and in pasture soil on another farm. No information 
was provided, however, on the spatiotemporal relationship between these isolates and those 
from fresh and composted manure [36]. Manero et al. [39] investigated whether VRE was 
present in crops receiving pig slurry and soils receiving or not receiving pig slurry, but VRE 
were not detected.
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Discussion
Transmission of clinically relevant AMR bacteria to humans by exposure to the natural 
environment, e.g., recreational water and beach sands, drinking water, ambient air, and 
shellfish, is plausible. Quantitative data available in a small proportion of the included 
datasets describing environmental compartments support this. There were no publications, 
however, providing direct evidence for transmission of AMR bacteria to humans resulting 
from exposure to the environment. In the current review, the highest level of evidence for 
transmission was considered when genetic relatedness was shown between bacterial strains 
through molecular typing of spatiotemporally related human and environmental isolates 
collected at exposure-relevant sites. Although a number of studies performed molecular 
typing of human and environmental isolates, only one obtained this level of evidence [20]. In 
this study, the direction of transmission could not be determined (environment transmitting 
AMR bacteria to humans or vice versa), however, nor could transmission via a common source 
be excluded. Tools to further investigate transmission of clinically relevant AMR bacteria to 
humans by exposure to the natural environment include risk assessments, microbial source 
tracking, and epidemiological studies. Ideally, these tools should be combined to place 
environmental exposure in context with exposures in the clinical and veterinary/agricultural 
domains. Attribution of different sources and pathways that play a role in the transmission of 
AMR bacteria to humans can help to identify and prioritize intervention strategies.
Using Quantitative Microbial Risk Assessment (QMRA), the risk of human exposure to AMR 
bacteria in the environment can be quantified [40]. This approach requires knowledge on the 
concentrations of clinically relevant AMR bacteria at exposure-relevant sites. Furthermore, it 
requires dose estimates following human consumption of fresh produce or shellfish, ingestion 
of surface water, and inhalation of bioaerosols, together with the frequency and duration of 
these events. Although scarce, datasets including quantitative data from exposure-relevant 
sites were identified in the current review. Where AMR bacteria were not enumerated at 
exposure-relevant sites, additional aspects to be considered for risk assessment include 
survival in, and transport of, AMR bacteria to sites of exposure, and changes in bacterial 
concentration between the measured site (i.e., environmental compartment, contamination 
source) and site of exposure. Horizontal gene transfer rates between clinically relevant AMR 
bacteria and environmental bacteria must also be addressed for more accurate estimates of 
exposure [41]. Another aspect to be considered for risk assessment is in vivo fitness of AMR 
bacteria in the human host following ingestion; however, quantitative data are lacking. 
Microbial source tracking might be used to gain further understanding of how clinically 
relevant AMR bacteria emitted from contamination sources are transmitted to humans via the 
environment [42]. This method involves phenotypic and genotypic characterization of AMR 
bacterial isolates of human, animal, and environmental origin for the purpose of identifying 
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differences between groups of bacteria that can be used to ascertain the source from which 
they were derived [3]. Phenotypic characterization methods include serotyping and antibiotic 
susceptibility profiling [3]. Among genotypic methods, pulsed-field gel electrophoresis 
(PFGE) is considered the ‘gold standard’, but microarrays, multilocus sequence typing (MLST), 
multilocus variable-number tandem repeat analysis (MLVA), and whole genome sequencing 
(WGS) are becoming widespread [43]. The current systematic review did not include articles 
that investigated the prevalence of antibiotic resistance genes without relating them to a 
specific bacterial species. This was based on the assumption of a more direct risk associated 
with exposure to AMR bacteria that are capable of colonizing or infecting humans. However, 
taking into account the spread of whole bacteria alone might underestimate transmission of 
AMR, as horizontal gene transfer also plays an important role in the dissemination of antibiotic 
resistance [44]. Compared to culture-dependent techniques, metagenomic approaches and 
next-generation sequencing could provide more insight into the prevalence and diversity 
of antibiotic resistance determinants in the environment, while quantitative PCR might be 
helpful in collecting information about their distribution [45]. Microbial source tracking 
to investigate transmission of AMR bacteria to humans at exposure-relevant sites should 
preferably take into account transfer of both bacteria and their resistance determinants. 
Epidemiological approaches can be used to identify possible exposure routes responsible 
for carriage of, or infection with, AMR bacteria. For example, Frank et al. [46] describe an 
outbreak of an infection with Shiga-toxin-producing E. coli O104:H4 harboring an ESBL gene 
(CTX-M-15) in Germany, where sprouts were identified as the most likely vehicle of infection 
[47]. In a study population comprising 100 cases and 190 controls, Søraas et al. [48] showed 
that recreational freshwater swimming was an independent risk factor for ESBL-positive 
urinary tract infections in people in Norway, along with travel to Asia, the Middle East, or 
Africa during the past six weeks to 24 months, recent use of fluoroquinolones and β-lactams, 
and diabetes mellitus. In a cross-sectional study by Huijbers et al. [49], however, swimming 
in a river, lake, or pond was not identified as a risk factor for ESBL-Ent carriage in 1025 Dutch 
adults. Furthermore, Rosenberg Goldstein et al. [50] found no significant difference in the 
odds of methicillin-susceptible S. aureus (MSSA), multidrug resistant MSSA, and vancomycin-
susceptible enterococci colonization among spray irrigation workers using reclaimed water 
(n=19) and controls not routinely exposed to reclaimed water (n=24). Also, none of the 
sampled individuals were positive for MRSA or VRE [50]. These particular studies were not 
included in the current review, as they did not actually investigate the presence of ESBL-Ent, 
MRSA, and/or VRE in the environment. This might have led to the exclusion of studies that 
support the role of the environment in transmission of clinically relevant AMR bacteria. A 
search for epidemiological studies reporting a relation between environmental exposure and 
infection with AMR bacteria showed that these were scarce, however (data not shown). It 
might also be possible to consider data on susceptible variants of selected bacterial species 
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and assume that a proportion of these infections were caused by resistant variants. This 
approach does not take into account that the survival and spread of AMR bacteria might 
be different compared to those of susceptible strains both in the environment and upon 
entering the human body. Furthermore, for the purpose of risk assessment and attribution 
of different transmission routes, which provide targets for interventions, information about 
prevalence, concentration, and types of AMR bacteria in the environment is imperative.
Quantitative and molecular data provide evidence for dissemination of AMR bacteria 
from contamination sources to the environment, including to exposure-relevant sites. AMR 
bacteria were detected in all publications investigating wastewater. Moreover, where AMR 
bacteria were enumerated, high concentrations were observed, also in wastewater that is 
discharged onto surface water. This, together with molecular typing results, demonstrates 
the contribution of sewage and WWTP effluent to the presence of AMR bacteria in surface 
water. AMR bacteria were also detected in the six publications concerning manure in 
relation to the environment. There are currently no studies investigating the prevalence 
and concentration of AMR bacteria in manure or slurry prior to soil application. There are 
also no studies demonstrating the effect of manure or slurry application on the prevalence 
and concentration of AMR bacteria in soil and on fresh produce. Studies investigating the 
effect of manure application on resistance genes in soil have been conducted, however. For 
example, Fahrenfeld et al. [51] showed significant increases in soil gene copy numbers of 
antibiotic resistance genes (sul1, sul2, and ermF) after manure application, and dissipation 
of these genes to background levels within 2 months. The role of manure application on 
environmental contamination with clinically relevant AMR bacteria needs to be addressed 
further and placed into perspective relative to environmental contamination from human 
sources. An aspect not addressed by this review, but also important to consider here, is the 
dissemination of antibiotic residues to the environment through wastewater and manure 
[40]. For example, half-lives of five days for β-lactams to 100 days for tetracyclines and 
sulfonamides have been reported in manure [52], suggesting that when applied to land they 
might act as selective agents to help propagate AMR bacteria or resistance genes.
It is clear that, in order to estimate exposures and risks associated with environmental 
pathways of AMR bacteria further investigation is necessary. Management options exist, 
however, that can work synergistically with existing policies and goals, and could be put into 
effect immediately [53]. Dissemination via wastewater to exposure-relevant sites is suspected; 
therefore, an effective target for intervention could be at wastewater collection points and 
wastewater treatment plants. It has been shown that concentrations of AMR bacteria were 
reduced by advanced wastewater treatment processes such as ozone, UV, ultrafiltration, and 
chlorination [26,27]. In addition, membrane bioreactor processes have been shown to be 
very effective in reducing bacterial numbers by over 6 log
10 
[54], and might prove useful in 
diminishing AMR bacteria. Another intervention measure could be treatment of manure; 
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however, data on AMR bacteria in manure are scarce, and there are no studies investigating 
the effect of manure treatment on concentrations of AMR bacteria in the environment. The 
efficiency of reducing AMR bacteria by composting and other digestion processes should be 
evaluated.
In conclusion, the abundance of AMR bacteria at exposure-relevant sites suggests that 
risk of human exposure to AMR bacteria in the environment is plausible. To what extent the 
environment contributes to human exposure, also compared to the clinical and veterinary/
agricultural domains, needs to be quantified. Important knowledge gaps have been identified 
that should be addressed in future studies. AMR bacteria in the environment, including sites 
relevant for human exposure, originate from wastewater and probably manure. Intervention 
strategies targeted at these sources could therefore limit emission of AMR bacteria to the 
environment.
Acknowledgements
This work was financially supported by the Netherlands Organization for Health Research and 
Development (ZonMw) and the Dutch Ministry of Health, Welfare and Sport (VWS). We thank 
drs. A.M.P. Kersten for her valuable assistance with the literature search and Prof. dr. J.W.M. 
van der Meer and Prof. dr. T.J.M. Verheij for their helpful suggestions on the manuscript.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Chapter 2
42
References
1. World Health Organization (WHO). 2014. 
Antimicrobial resistance: global report on 
surveillance; World Health Organization: Geneva, 
Switzerland. http://www.who.int/drugresistance/
documents/surveillancereport/en/ (accessed 3 
September 2015). 
2. de Kraker, M.E.A., Davey, P.G., Grundmann, H. 
2011. Mortality and hospital stay associated with 
resistant Staphylococcus aureus and Escherichia 
coli bacteraemia: Estimating the burden of 
antimicrobial resistance in Europe. PLoS Medicine. 
8:e1001104. 
3. Pires, S.M., Evers, E.G., van Pelt, W., et al. 
2009. Attributing the human disease burden 
of foodborne infections to specific sources. 
Foodborne Pathogens and Disease. 6:417-424.
4. Domingues A.R., Pires, S.M., Halasa, T., et al. 2012. 
Source attribution of human campylobacteriosis 
using a meta-analysis of case-control studies of 
sporadic infections. Epidemiology and Infection. 
140:970-981.
5. Domingues, A.R., Pires, S.M., Halasa, T., et al. 
2012. Source attribution of human salmonellosis 
using a meta-analysis of case-control studies of 
sporadic infections. Epidemiology and Infection. 
140:959-969.
6. Evers, E.G., van der Vels-Klerx, H.J., Nauta, M.J., 
et al. 2008. Campylobacter source attribution by 
exposure assessment. International Journal of Risk 
Assessment and Management. 8:174-189.
7. Rangel, J.M., Sparling, P.H., Crowe, C., et al. 
2005. Epidemiology of Escherichia coli O157:H7 
outbreaks, United States, 1982-2002. Emerging 
Infectious Diseases. 11:603-609.
8. Shuval, H. 2003. Estimating the global burden of 
thalassogenic diseases: human infectious diseases 
caused by wastewater pollution of the marine 
environment. Journal of Water and Health. 1:53-
64.
9. Franz, E., van Bruggen, A.H. 2008. Ecology of E. coli 
O157:H7 and Salmonella enterica in the primary 
vegetable production chain. Critical Reviews in 
Microbiology. 34:143-161.
10. Centres for Disease Control and Prevention (CDC). 
2013. Outbreak of Escherichia coli O104:H4 
infections associated with sprout consumption 
- Europe and North America, May-July 2011. 
Morbidity and Mortality Weekly Report. 62:1029-
1031.
11. Centers for Disease Control and Prevention (CDC). 
2006. Ongoing multistate outbreak of Escherichia 
 coli serotype O157:H7 infections associated with 
consumption of fresh spinach - United States, 
September 2006. Morbidity and Mortality Weekly 
Report. 55:1-2.
12. Davies, J., Davies, J. 2010. Origins and evolution of 
antibiotic resistance. Microbiology and Molecular 
Biology Reviews. 74:417-433.
13. Clinical Laboratory Standards Institute (CLSI). 
2010. Performance standards for antimicrobial 
susceptibility testing; 20th Informational 
Supplement M100-20; Clinical Laboratory 
Standards Institute: Wayne, PA.
14. Centres for Disease Control and Prevention (CDC). 
2010. Vancomycin-resistant Enterococci (VRE) and 
the clinical laboratory; Centres for Disease Control 
and Prevention: Atlanta, GA. http://www.cdc.
gov/HAI/settings/lab/VREClinical-Laboratory.html 
(accessed 3 September 2015).
15. Blaak, H., de Kruijf, P., Hamidjaja, R.A., et al. 2014. 
Prevalence and characteristics of ESBL-producing 
E. coli in Dutch recreational waters influenced 
by wastewater treatment plants. Veterinary 
Microbiology. 171:448-459.
16. Goodwin, K.D., McNay, M., Cao, Y., et al. 2012. 
A multi-beach study of Staphylococcus aureus, 
MRSA, and Enterococci in seawater and beach 
sand. Water Research. 46:4195-4207.
17. Levin-Edens, E., Soge, O.O., No, D., et al. 2012. 
Methicillin-resistant Staphylococcus aureus from 
Northwest marine and freshwater recreational 
beaches. FEMS Microbiology Ecology. 79:412-420.
18. Plano, L.R.W., Shibata, T., Garza, A.C., et al. 
2013. Human-associated methicillin-resistant 
Staphylococcus aureus from a subtropical 
recreational marine beach. Microbial Ecology. 
65:1039-1051.
19. Guardabassi, L., Dalsgaard, A. 2004. Occurrence, 
structure, and mobility of Tn1546-like elements 
in environmental isolates of vancomycin-resistant 
Enterococci. Applied Environmental Microbiology. 
70:984-990.
20. Hower, S., Phillips, M.C., Brodsky, M., et al. 
2013. Clonally related methicillin-resistant 
Staphylococcus aureus isolated from short-finned 
pilot whales (Globicephala macrorhynchus), 
human volunteers, and a bayfront cetacean 
rehabilitation facility. Microbial Ecology. 65:1024-
1038.
21. Doljeská, M., Bieroŝová, B., Kohoutová, L., et al. 
Antibiotic-resistant Salmonella and Escherichia 
coli isolates with integrons and extended-
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Role of the environment in the transmission of antimicrobial resistance to humans
43
spectrum beta-lactamases in surface water and 
sympatric black-headed gulls. Journal of Applied 
Microbiology. 106:1941-1950.
22. Hernández, J., Stedt, J., Bonnedahl, J., et al. 
2012. Human-associated extended-spectrum 
β-lacatamase in the Antarctic. Applied 
Environmental Microbiology. 78:2056-2058.
23. Alouache, S., Estepa, V., Messai, Y., et al. 2014. 
Characterization of ESBLs and associated 
quinolone resistance in Escherichia coli and 
Klebsiella pneumoniae isolates from an urban 
wastewater treatment plant in Algeria. Microbial 
Drug Resistance. 20:30-38.
24. Gómez, M., Díaz, M.T., Araujo, M., et al. 2010. 
Waste water treatment plants as redistributors of 
resistance genes in bacteria. WIT Transactions on 
Ecology and the Environment. 135:83-94.
25. Guardabassi, L., Brønnum, P.T., Danø, R., et al. 
2002. Dissemination of vancomycin-resistant 
Enterococci harboring vanA through disposal 
of waste derived from industrial production of 
vancomycin. Microbial Drug Resistance. 8:401-
406.
26. Nagulapally, S.R., Ahmad, A., Henry, A., et al. 
2009. Occurrence of ciprofloxacin-, trimethoprim-
sulfamethoxazole-, and vancomycin-resistant 
bacteria in a municipal wastewater treatment 
plant. Water Environment Research. 81:82-90.
27. Rosenberg Goldstein, R.E., Micallef, S.A., Gibbs, 
S.G., et al. 2014. Detection of vancomycin-
resistant Enterococci (VRE) at four U.S. wastewater 
treatment plants that provide effluent for reuse. 
Science of the Total Environment. 466-467:404-
411.
28. Varela, A.R., Ferro, G., Vredenburg, J., et al. 
2013. Vancomycin resistant Enterococci: from 
the hospital effluent to the urban wastewater 
treatment plant. Science of the Total Environment. 
450-451:155-161.
29. Blanch, A.R., Caplin, J.L., Iversen, A., et al. 2003. 
Comparison of enterococcal populations related 
to urban and hospital wastewater in various 
climatic and geographic European regions. Journal 
of Applied Microbiology. 94:994-1002.
30. Korzeniewska, E., Korzeniewska, A., Harnisz, 
M. 2013. Antibiotic resistant Escherichia coli 
in hospital and municipal sewage and their 
emission to the environment. Ecotoxicology and 
Environmental Safety. 91:96-102.
31. Korzeniewska, E., Harnisz, M. 2013. Extended-
spectrum beta-lactamase (ESBL)-positive 
Enterobacteriaceae in municipal sewage and 
their emission to the environment. Journal of 
Environmental Management. 128:904-911.
32. Kühn, I., Iversen, A., Finn, M., et al. 2005. 
Occurrence and relatedness of vancomycin-
resistant Enterococci in animals, humans, and 
the environment in different European regions. 
Applied Environmental Microbiology. 71:5383-
5390.
33. Novais, C., Coque, T.M., Ferreira, H., et al. 2005. 
Environmental contamination with vancomycin-
resistant Enterococci from hospital sewage in 
Portugal. Applied Environmental Microbiology. 
71:3364-3368.
34. Schwartz, T., Kohnen, W., Jansen, B., et al. 2003. 
Detection of antibiotic-resistant bacteria and their 
resistance genes in wastewater, surface water, 
and drinking water biofilms. FEMS Microbiology 
Ecology. 43:325-335.
35. Friese, A., Schulz, J., Laube, H., et al. 2013. Faecal 
occurrence and emissions of livestock-associated 
methicillin-resistant Staphylococcus aureus (LA-
MRSA) and ESBL/AmpC-producing E. coli from 
animal farms in Germany. Berliner und Münchener 
Tierärztliche Wochenschrift. 126:175-180.
36. Hartmann, A., Locatelli, A., Amoureux, L., et al. 
2012. Occurrence of CTX-M producing Escherichia 
coli in soils, cattle, and farm environment in France 
(Burgundy region). Frontiers in Microbiology. 
3:e83.
37. Hasan, B., Sandegren, L., Melhus, Å., et al. 2012. 
Antimicrobial drug-resistant Escherichia coli in 
wild birds and free-range poultry, Bangladesh. 
Emerging Infectious Diseases. 18:2055-2058.
38. Ma, J., Liu, J.H., Lv, L., et al. 2012. Characterization 
of extended-spectrum β-lactamase genes found 
among Escherichia coli isolates from duck and 
environmental samples obtained on a duck farm. 
Applied Environmental Microbiology. 78:3668-
3673.
39. Manero, A., Vilanova, X., Cerdà-Cuéllar, M., et al. 
2006. Vancomycin- and erythromycin-resistant 
Enterococci in a pig farm and its environment. 
Environmental Microbiology. 8:667-674.
40. Ashbolt, N.J., Amézquita, A., Backhaus, T., et al. 
2014. Human health risk assessment (HHRA) 
for environmental development and transfer 
of antibiotic resistance. Environmental Health 
Perspectives. 121:993-1001.
41. Hunter, P.R., Wilkinson, D.C., Catling, L.A., et 
al. 2008. Meta-analysis of experimental data 
concerning antimicrobial resistance gene transfer 
rates during conjugation. Applied Environmental 
Microbiology. 74:6085-6090.
42. Harwood, V.J., Staley, C., Badgley, B.D., et al. 2014. 
Microbial source tracking markers for detection 
of fecal contamination in environmental waters: 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Chapter 2
44
relationships between pathogens and human 
health outcomes. FEMS Microbiology Reviews. 
38:1-40.
43. Sabat, A.J., Budimir, A., Nashev, D., et al. 
2013. Overview of molecular typing methods 
for outbreak detection and epidemiological 
surveillance. Euro Surveillance. 18:20380.
44. Dröge, M., Pühler, A., Selbitschka, W. 1999. 
Horizontal gene transfer among bacteria in 
terrestrial and aquatic habitats as assessed by 
microcosm studies. Biology and Fertility of Soils. 
29:221-245.
45. Monier, J.M., Demanèche, S., Delmont, T.O., et 
al. 2011. Metagenomic exploration of antibiotic 
resistance in soil. Current Opinion in Microbiology. 
14:229-235.
46. Frank, C., Werber, D., Cramer, J.P., et al. 2011. 
Epidemic profile of Shiga-toxin-producing 
Escherichia coli O104:H4 outbreak in Germany. 
New England Journal of Medicine. 365:1771-1780.
47. Buchholz, U., Bernard, H., Werber, D., et al. 2011. 
German outbreak of Escherichia coli O104:H4 
associated with sprouts. New England Journal of 
Medicine. 365:1763-1770.
48. Søraas, A., Sundsfjord, A., Sandven, I., et al. 
2013. Risk factors for community-acquired 
urinary tract infections caused by ESBL-producing 
Enterobacteriaceae - A case-control study in a low 
prevalence country. PloS One. 8:e69581.
49. Huijbers, P.M.C., de Kraker, M., Graat, E.A.M., 
et al. 2013. Prevalence of extended-spectrum 
β-lactamase-producing Enterobacteriaceae in 
humans living in municipalities with high and low 
broiler density. Clinical Microbiology and Infection. 
19:E256-E259.
50. Rosenberg Goldstein, R.E., Micallef, S.A., Gibbs, 
S.G., et al. 2014. Occupational exposure to 
Staphylococcus aureus and Enterococcus spp. 
among spray irrigation worker using reclaimed 
water. International Journal of Environmental 
Research and Public Health. 11:4340-4355.
51. Fahrenfeld, N., Knowlton, K., Krometis, L.A., et al. 
2014. Effect of manure application on abundance 
of antibiotic resistance genes and their attenuation 
rates in soil: Field-scale mass balance approach. 
Environmental Science and Technology. 48:2643-
2650.
52. Chee-Sanford, J.C., Mackie, R.I., Koike, S., et al. 
2009. Fate and transport of antibiotic residues 
and antibiotic resistance genes following 
land application of manure waste. Journal of 
Environmental Quality. 38:1086-1108. 
53. Pruden, A., Joakim Larsson, D.G., Amézquita, A., 
et al. 2013. Management options for reducing 
the release of antibiotics and antibiotic resistance 
genes to the environment. Environmental Health 
Perspectives.121:878-885.
54. Krüger, U. 2000. Membrane-supported biological 
wastewater treatment. Schriftenreihe des Vereins 
für Wasser-, Boden-, und Lufthygiene. 105:319-
324.
55. Friese, A., Schulz, J., Zimmermann, K., et al. 
2013. Occurrence of livestock-associated 
methicillin-resistant Staphylococcus aureus in 
turkey and broiler barns and contamination of 
air and soil surfaces in their vicinity. Applied and 
Environmental Microbiology. 79:2759-2766.
56. Clauss, M.; Schulz, J.; Stratmann-Selke, J. 2013. 
Reduction of livestock-associated methicillin-
resistant Staphylococcus aureus (LA-MRSA) in 
the exhaust air of two piggeries by a bio-trickling 
filter and a biological three-step air cleaning 
system. Berliner und Münchener Tierärztliche 
Wochenschrift. 126:137-142.
57. Blaak, H., Hamidjaja, R.A., van Hoek, A.H.A.M., 
et al. 2014. Detection of extended-spectrum 
beta-lactamase (ESBL)-producing Escherichia coli 
on flies at poultry farms. Applied Environmental 
Microbiology. 80:239-246.
58. Korzeniewska, E., Harnisz, M. 2013. Beta-
lactamase-producing Enterobacteriaceae in 
hospital effluents. Journal of Environmental 
Management. 123:1-7.
59. Bates, J., Jordens, J.Z., Griffiths, D.T. 1994. 
Farm animals given as a putative reservoir for 
vancomycin-resistant enterococcal infection in 
man. Journal of Antimicrobial Chemotherapy. 
34:507-514.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Role of the environment in the transmission of antimicrobial resistance to humans
45
Supplementary Table S1. Data extraction form.
column id explanation code
refid name referee
ph=patricia huijbers; hb=hetty 
blaak
articleid
last name of first author, year of publication, addition if 
multiple pub one year
nameyyyyabc
title title article free text (export from EndNote)
author authors of article free text (export from EndNote)
journal journal title free text (export from EndNote)
pubyear year of publication free text (export from EndNote)
vol journal volume free text (export from EndNote)
pubtype type of publication free text (export from EndNote)
country country from which samples were collected free text
year year that samples were collected yyyy
amr AMR bacteria identified 1=esbl; 2= mrsa; 3=vre
bacteria specific bacterial genus/species identified if AMR=1 1=E. coli; 2=K. pneumoniae; 
3=Enterobacter spp.
compart which type(s) of compartment(s) were investigated
1=source; 2=environment; 
3=exposure
multiplecompart AMR bacteria identified in more than one compartment 1=yes; 0=no
environment which environmental compartment(s) were investigated
1=soil; 2=water; 3=air/dust; 
4=wildlife
environmentx short description of environmental compartment free text
source which source compartment(s) were investigated 1=manure; 2=wastewater; 
3=other; 4=none
sourcex short description of source compartment free text
exposure exposure compartment(s) that were investigated
1=fresh produce/crops; 
2=fish/shellfish; 3=drinking 
water; 4=irrigation water; 
5=recreational water; 
6=beach sand; 7=urban water; 
8=ambient air; 9=none
exposurex short description of exposure compartment free text
presence presence of AMR bacteria in compartment(s) 1=yes; 0=no; 2=unclear
presencex compartment(s) where AMR bacteria are present free text
enrichment selective enrichment during isolation process 1=yes; 0=no
isolation culture of bacteria during isolation process
1=nonselective; 2=selective; 
3= both
resistance method used to determine resistance mechanism 1=phenotypic; 2=molecular; 
3=both; 4=none
gene resistance gene(s) identified 1=yes; 0=no
genex name(s) of resistance gene(s) free text
quantify concentration of AMR bacteria determined 1=yes; 0=no
human human isolates investigated 1=yes; 0=no
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R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
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Abstract 
Prevalence of, and risk factors for, carriage of extended-spectrum β-lactamase (ESBL) 
-producing Enterobacteriaceae were determined for 1025 Dutch adults in municipalities 
with either high or low broiler densities. Overall prevalence of ESBL-carriage was 5.1%. 
The hypothesis that individuals in areas with high broiler densities are at greater risk for 
ESBL-carriage was rejected, as the risk was lower (OR=0.45; P=0.009) for these individuals. 
Owning a horse increased the risk (OR=4.69; P≤0.0001), but horse owners often owned 
multiple species of companion animals. Routes of transmission from animals to humans 
in the community, and the role of poultry in this process, remain to be elucidated.
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Extended-spectrum β-lactamase (ESBL) -mediated resistance presents a threat for treatment 
of bacterial infections [1]. ESBL-producing Enterobacteriaceae have been detected in patients 
[2, 3], individuals from the community [4, 5], meat [3, 6], livestock [7, 8], and companion 
animals [9]. Transmission between humans and animals [10, 11] might occur through the 
food chain [2, 3], contact with livestock [12], or the environment [8]. An ESBL-prevalence of 
4.9% has been found in Dutch hospitalised patients in the province with the highest number 
of broiler chickens [3], however little information is available about the prevalence of ESBL 
carriage in the Dutch community. ESBL-producing bacteria are present on all Dutch broiler 
farms, and 33% of farmers were ESBL carriers [12]. Individuals in areas with high broiler 
densities might therefore have an increased risk for ESBL carriage. The aim of this cross-
sectional study was to determine prevalence of, and identify risk factors for, carriage of ESBL-
producing Enterobacteriaceae in individuals living in municipalities with either high or low 
broiler densities.
A random sample of adults (≥ 18 years), stratified according to age and gender (Table 
1), was taken from eight Dutch municipalities across four provinces. Per province, the 
municipality with the highest number of commercial broilers per km2 and a municipality 
with a similar number of inhabitants, but with no commercial broilers, were selected. It was 
calculated that a sample size of 1800 individuals in both areas was required [13] based on 
an ESBL prevalence of 4.9% [3] in areas with high broiler densities, to show a difference 
of 3% (one-tailed, alpha-error=0.05, beta-error=0.20, assumed response=25%). In total 
3949 individuals were asked to return a rectal swab, and a questionnaire on demographics, 
contact with animals, lifestyle, medical history, eating habits and travel. For each respondent, 
distance to the nearest broiler farm was obtained using geographic data. Exclusion criteria were 
living or working on a commercial broiler farm, and moving outside the study area. The study 
was approved by the Medical Ethics Committee of University Medical Centre Utrecht, the 
Netherlands (protocol number 11-277).
Rectal swabs were analysed within 3 days of collection, and not frozen before processing. 
Isolation of Enterobacteriaceae occurred by selective pre-enrichment with(out) 1 mg/L 
cefotaxime (Sigma, St. Louis, MO, USA), followed by screening on MacConkey agar no. 3 
(Oxoid, Basingstoke, UK) supplemented with 1 mg/L cefotaxime. All oxidase-negative bacteria 
(BBL Dryslide Oxidase; Becton Dickinson, Franklin Lakes, NJ, USA) were tested phenotypically 
for ESBL-production by a combination disc-diffusion test using cefotaxime and ceftazidime, 
with and without clavulanic acid, according to CLSI guidelines [14]. A cefoxitin disc was used 
to detect combined ESBL/AmpC phenotypes. Individuals were classified as ESBL-positive 
when at least one isolate was identified phenotypically as an ESBL-producing gram-negative 
bacterium (BBL Crystal E/NF test; Becton Dickinson). Prevalences and their exact 95% CI were 
calculated based on the binomial distribution. Univariable and multivariable logistic regression 
analyses were performed for the variables in Table 2 to assess the relation between ESBL 
carriage and possible risk factors, according to the method of Hosmer and Lemeshow [15]. 
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Table 1. Distribution of respondents over age and gender in areas with high and low broiler density
Age class
High broiler density Low broiler density
No. of men
(% of total)
No. of women
(% of total)
Total
No. of men
(% of total)
No. of women
(% of total)
Total
18-40 years 36 (7) 72 (13) 108 (20) 32 (7) 68 (14) 100 (20)
41-65 years 122 (23) 187 (35) 309 (58) 114 (23) 155 (31) 269 (55)
≥66 years 65 (12) 51 (10) 116 (22) 66 (13) 57 (12) 123 (25)
Total 223 (42) 310 (58) 533 (100) 212 (43) 280 (57) 492 (100)
In total, 1033 (26.2%) individuals agreed to participate, of which 1025 individuals were 
eligible. Overall, prevalence of ESBL carriage was higher in areas with low broiler densities 
(6.7%; 33/492; exact 95% CI 4.7-9.3%) than in areas with high broiler densities (3.6%; 19/533; 
exact 95% CI 2.2-5.5%), and this difference was also present when combining test probabilities 
across provinces (P<0.01; χ2=20.6 with 8 df). The hypothesis that individuals in municipalities 
with high broiler densities would be at greater risk for ESBL carriage was therefore rejected. 
Mean distance to the nearest broiler farm was smaller for individuals in municipalities with 
high broiler densities (2.2 km; SD 1.4, range 0.2-7.3), compared with low broiler densities 
(6.2 km; SD 2.9, range 0.9-11.8; P≤0.0001). It could be argued whether this is a distance of 
biological relevance. Moreover, the overall high broiler density in the Netherlands (1301 
broilers/km2), and mobility of individuals between municipalities and provinces, may have 
disturbed a possible relationship between broiler density and ESBL carriage, leading to the 
rejection of our hypothesis.
Sixteen variables could be included in the multivariable analysis (Table 2). Distance to 
closest broiler farm was also associated with probability of a person being ESBL-positive 
(P=0.04), but was not included in multivariable analysis as this variable was co-linear with 
broiler density. Risk factors for ESBL carriage in the community suggested in the literature, 
such as consumption of poultry meat, travelling abroad, recent hospitalisation and recent 
antibiotic use [2, 16, 17] were not confirmed in this study. The observed prevalence of ESBL 
carriage and the similarity in answers to the questionnaire, which resulted in categories with 
<10% of available data, make it difficult to draw statistically valid conclusions on these risk 
factors. Two variables remained in the final model showing no lack of fit (P=0.96): broiler 
density and owning/contact with a horse. Confounding was not present, and interaction was 
not significant (P=0.67). High broiler density decreased the risk for ESBL carriage (3.6% vs. 
6.7%; OR=0.45; P=0.009). Owning/contact with a horse increased the risk (15.6% vs. 4.4%; 
OR=4.69; P≤0.0001). This might not be solely attributable to owning or having contact with a 
horse, as prevalence increased from 4% in individuals without companion animals to almost 
12% in individuals who owned more than four different species of companion animals (Table 
2). 
After response analysis with respect to age, sex, province and broiler density (Table 1), it 
was assumed that a representative sample of Dutch adults was obtained. The observed overall 
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prevalence of 5.1% (52/1025; exact 95% CI 3.8-6.6%) therefore indicates the prevalence in 
the community, and is comparable with other countries [4, 5, 18, 19]. Contact with multiple 
species of companion animals might play a role in transmission, but further research on 
the mutual exchange of ESBL-producing Enterobacteriaceae between companion animals 
and their owners is needed. Other routes of transmission from animals to humans in the 
community, and the role of poultry in this process remain to be elucidated.
Table 2. Frequency (n and %), prevalence (%), and overall P-values in univariable logistic regression of 
possible risk factors (n=1025). Overall prevalence was 5.1%
Variable Category
  Frequency   Prev.  
  %
Overall 
P-valuea
  n           %
Research question
Broiler density Low   492 48.0   6.7 0.02
High   533 52.0   3.6
Distance to nearest broiler farm 
(per km; continuous)b
ESBL-negatives        4.1 ± 3.0 km 0.04
ESBL-positives        5.0 ± 3.2 km
General characteristics
Province Noord-Brabant   280 27.3   3.6 0.05
Gelderland   219 21.4   3.7
Overijssel   268 26.2   4.5
Friesland   258 25.2   8.5
Sex Male   435 42.4   5.3 0.79
Female   590 57.6   4.9
Age (per year; continuous variable)b ESBL-negatives      53.6 ± 15.6 years 0.58
ESBL-positives      52.4 ± 14.1 years
Country of birth Abroad     27 2.7   0.0 0.27
The Netherlands   991 97.3   5.3
Contact with animals
Owning/contact with companion animal No   496 48.5   4.0 0.14
Yes   527 51.5   6.1
Cat No   860 84.1   4.5 0.08
Yes   163 15.9   8.0
Dog No   721 70.5   4.4 0.16
Yes   302 29.5   6.6
Rodent No   879 85.9   4.9 0.50
Yes   144 14.1   6.3
Bird No   940 91.9   5.1 0.91
Yes     83 8.1   4.8
Hobby chicken No   928 90.7   4.7 0.15
Yes     95 9.3   8.4
Hobby sheep/goat No   991 96.9   4.8 0.10
Yes     32 3.1 12.5
Horse No   959 93.7   4.4 0.001
Yes     64 6.3 15.6
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Variable Category
  Frequency   Prev.  
  %
Overall 
P-valuea
  n           %
No. of companion animals species 0   496 48.5   4.0 0.31
1   300 29.4   5.3
2   131 12.8   5.3
3     52 5.1   7.7
≥4     43 4.2 11.6
Companion animal received antibiotics No   945 93.5   4.6 0.13
Yes     66 6.5   9.1
Living on a livestock farmd No   980 96.3   4.8 0.16
Yes     38 3.7 10.5
Working on a livestock farmd No   945 93.2   4.9 0.74
Yes     69 6.8   5.8
Visiting a livestock farme No   719 70.5   5.3 0.67
Yes   301 29.5   4.7
Lifestyle
No. of individuals in residence ≤2   630 61.5   4.3 0.15
≥2   395 38.5   6.3
Working in health care No   853 83.4   5.5 0.14
Yes   170 16.6   2.9
Having a vegetable garden No   851 83.4   5.2 0.81
Yes   169 16.6   4.7
Swimming in a river, lake of pond No   940 92.1   5.0 0.65
Yes     81 7.9   6.2
Medical history (during last 6 months)
Visiting general practitioner No   456 44.9   6.6 0.06
Yes   560 55.1   3.9
Cases of urinary tract infection No   954 93.6   5.0 0.70
Yes     65 6.4   6.2
Hospital admission No   941 92.1   5.0 0.65
Yes     81 7.9   6.2
Visiting polyclinic No   666 65.5   5.6 0.37
Yes   351 34.5   4.3
Eating habits
Eating meatc No     13 1.3   0.0 0.39
Yes 1011 98.7   5.1
Eating chicken meat No     56 5.5   3.6 0.58
Yes   967 94.5   5.2
Eating meat purchased from farm No   974 95.0   4.8 0.16
Yes     51 5.0   9.8
Eating vegetables from garden No   811 79.1   5.6 0.16
Yes   214 20.9   3.3
Travel
Travelling abroad Inside Europe   995 93.4   4.8 0.18
Outside Europe     68 6.7   8.8
a Variables with P-value in bold (P<0.25) were included in the multivariable modelling procedure.
b Linearity of the logits was assessed before inclusion as continuous explanatory variables.
c Exact logistic regression. 
d Living/working on livestock farms include farms with laying hens, veal calves, dairy cattle, breeding 
pigs, finishing pigs, sheep/goats; people living/working on broiler farms were excluded.
e Visiting livestock farms include broiler farms, in addition to the farms mentioned in footnote d.
Table 2. Continued
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Synopsis
Objectives: Estimate the prevalence of extended-spectrum β-lactamase (ESBL)- and 
AmpC β-lactamase-producing Escherichia coli carriage among broiler farmers, their 
family members and employees; identify and quantify risk factors for carriage, with an 
emphasis on contact with live broilers; and compare isolates from humans and broilers 
within farms with respect to molecular characteristics to gain insight into transmission 
routes.
Methods: A cross-sectional prevalence study was conducted on 50 randomly selected 
Dutch broiler farms. Cloacal swabs were taken from 20 randomly chosen broilers. Faecal 
swabs were returned by 141 individuals living and/or working on 47 farms. ESBL/AmpC-
producing E. coli were isolated and, for selected isolates phylogenetic groups, plasmids 
and sequence types were determined. Questionnaires were used for risk factor analysis.
Results: All sampled farms were positive, with 96.4% positive pooled broiler samples. 
The human prevalence was 19.1%, with 14.3% and 27.1% among individuals having a 
low and high degree of contact with live broilers, respectively. Five pairs of human-broiler 
isolates had identical genes, plasmid families and E. coli sequence types, showing clonal 
transmission. Furthermore, similar ESBL/AmpC-genes on the same plasmid families in 
different E. coli sequence types in humans and broilers hinted at horizontal gene transfer.
Conclusions: Prevalence among people on broiler farms was higher than in previous 
studies involving patients and the general population. Furthermore, an increased risk 
of carriage was shown among individuals having a high degree of contact with live 
broilers. The (relative) contribution of transmission routes that might play a role in the 
dissemination of ESBL/AmpC-encoding resistance genes to humans on broiler farms 
should be pursued in future studies.
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Introduction
Extended-spectrum β-lactamase (ESBL)- and AmpC β-lactamase-producing Enterobacteriaceae 
are frequently reported in broilers [1,2]. This raises public-health concerns as the intestinal 
microbiome of these animals might form a reservoir for ESBL/AmpC-encoding resistance 
genes, capable of being transmitted to humans [3,4]. Transmission via the food chain has 
been suggested [5,6], but transmission resulting from close contact between humans and 
animals on livestock farms is also plausible [2]. Contact with live broilers has already been 
identified as a risk factor for methicillin-resistant Staphylococcus aureus (MRSA) carriage 
among humans [7,8].
In the Netherlands, the prevalence of carriage of ESBL/AmpC-producing Escherichia coli 
(hereafter referred to ESBL/AmpC carriage) among broiler farmers was 33.3% (6/18), and 
β-lactamase genes located on identical plasmid families were detected in isolates both from 
farmers and their animals [2]. Furthermore, the prevalence among farmers was higher than 
that found among patients (4.9%) [5], and among humans not living on farms (5.1%) [9] in the 
Netherlands. This suggests that contact with broilers, and/or the farm environment, could be 
a risk factor for ESBL/AmpC carriage among humans.
Risk factors for ESBL/AmpC carriage among people living and/or working on broiler 
farms have not yet been reported. The objectives were therefore to estimate the prevalence 
among broiler farmers, their family members and employees, and to identify and quantify 
risk factors for carriage, with an emphasis on contact with live broilers. To gain an insight into 
transmission routes between broilers and humans, E. coli isolates from humans and broilers 
from the same farm were compared with respect to ESBL/AmpC genes, plasmid families and 
sequence types (STs).
Methods
From 5 July 2010 to 11 April 2011, a cross-sectional study of MRSA and ESBL/AmpC-producing 
bacteria was conducted on 50 Dutch broiler farms with 228 individuals living or working on 
these farms. Study populations were defined and sampled according to Geenen et al. [8]. 
Participating farms had an average of three broiler houses (range 1-6; broilers of one age and 
using an all-in-all-out system), with a median number of broilers per farm of 78000 (range 
14400–200000). The age of broilers at sampling was 21-49 days, with an average of 31 days. 
In order to accurately estimate prevalence of ESBL/AmpC carriage among humans, given a 
prevalence of 33% among broiler farmers, a 95% confidence level and 10% accepted error, at 
least 85 individuals needed to be sampled. 
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Each farm was sampled by taking cloacal swabs from 20 broilers in total, the broilers being 
divided over all the broiler houses present on the farm. This sample size enables the detection 
of a positive farm at the 95% confidence level with a within-farm prevalence of at least 14%. 
The study was performed according to Dutch law on studies with animals. Farmers, family 
members and employees who voluntarily participated in the study returned an informed 
consent form, a faecal swab and a questionnaire on their lifestyle and health characteristics. 
For children aged <18 years parental consent was requested. Farmers also completed a 
questionnaire on the farm (management) characteristics. The median time between the 
sampling of broilers and the arrival of human samples was 1 day (range 0-28 days).
Broiler samples were pooled into 10 pools of 2 swabs each; human samples were 
examined individually. Bacteria were isolated by selective enrichment (Luria-Bertani broth 
with 1 mg/L cefotaxime) and cultured on selective plates for 18h at 37˚C (MacConkey agar 
no. 3 with 1 mg/L of cefotaxime). E. coli-like, indole-positive isolates (5 isolates per human 
sample and 10 isolates per broiler farm) were tested phenotypically for ESBL production by 
combination disc diffusion test according to CLSI guidelines [10]. A cefoxitin disc was used to 
detect the AmpC phenotypes. 
E. coli phylogenetic groups were determined for a minimum of one (range 1-3) isolate per 
person testing positive as reported by Clermont et al. [11] and Escobar-Páramo et al. [12]. 
E. coli was confirmed in isolates that were negative for all three amplicons as described by 
Frahm and Obst [13]. Subsequently, phylogenetic groups were determined for a minimum 
of one (range 1-9) positive broiler isolate from each farm with human ESBL/AmpC carriage. 
More than one isolate per human or broiler was included if there were differences in the disc 
diffusion test, indicative of the presence of different ESBL/AmpC genes.
β-Lactamase genes were identified by PCR and sequencing in line with Dierikx et al. [14]. 
If broiler and human isolates showed similar E. coli phylogenetic groups and/or ESBL/AmpC 
genes within the same farm, multilocus sequence typing (MLST) of E. coli was performed 
as described by Wirth et al. [15]. Plasmid characterisation was performed for a selection 
of isolates representing the diversity of ESBL/AmpC genes in humans and broilers, and on 
isolate pairs with the same E. coli ST and ESBL/AmpC gene by transformation and PCR-based 
replicon typing as described by Hordijk et al. [16] and Carattoli et al. [17].
Prevalences and their exact 95% CIs were calculated based on the binomial probability 
function. Risk factor analysis could not be conducted at the farm level as all the farms were 
classified as positive (i.e. bacteria were phenotypically characterised as ESBL/AmpC-producing 
E. coli in at least one broiler sample). To assess the relationship between ESBL/AmpC carriage 
among humans and possible risk factors, univariable and multivariable logistic regression 
analyses were performed for the variables in Table 1 as reported by Hosmer and Lemeshow 
[18]. As observations on the same farm might not have been independent, a random effect 
of farms was included using an exchangeable covariance structure.
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Results and discussion
This study investigates ESBL/AmpC carriage among not only farmers, but also all individuals 
living and/or working on broiler farms and is the first study reporting risk factors for carriage. 
Faecal swabs and informed consent forms were provided by 141/228 individuals from 47 
farms (a response rate of 61.8%). An average of 3 individuals per farm (range 1-9) was 
included, with an average age of 36.6 years (SD 19.1, range 1-80). Similar to the results of 
Dierikx et al. [2], ESBL/AmpC-producing E. coli were present in broilers on all 50 farms, with 
a pooled sample prevalence of 96.4% (482/500; 95% CI 94.4-97.9%). In total, 27 humans 
originating from 21 farms tested positive (19.1%; 95% CI 13.0-26.6%). The prevalence in 
farmers (25.5%; exact 95% CI 13.9-40.4%) and employees (37.5%; exact 95% CI 8.5-75.5%) 
was similar to that of Dierikx et al. (33.3%) [2]. The prevalence in partners (11.4%; exact 95% 
CI 3.2-26.7%) and family members (15.7%; exact 95% CI 7.0-28.6%) was lower than in farmers 
and employees, but still higher in comparison with patients and the general population [5,9]. 
It was hypothesised that a high degree of contact with live broilers could be a risk factor 
for human ESBL/AmpC carriage on broiler farms. Information about the number of hours 
per week present in the broiler house and the number of hours per week having physical 
contact with live broilers was completed by about half of the participants (by 81 and 77 
individuals, respectively). Analysis of variance of these variables showed that farmers (2.8 
h and 1.8 h) and employees (1.8 h and 0.6 h) had a significantly higher degree of contact 
(P<0.0001) compared with partners (0.7 h and 0.5 h) and other family members (0.3 h and 
0.1 h). In addition individuals reporting performance of activities in the broiler house (i.e. 
weighing, vaccination, blood sampling and/or health checks) were more often (χ2 P<0.0001) 
farmers and employees (98.1%) than partners and family members (33.8%). Based on this 
information a new variable (‘contact with broilers’) was created, with farmers and employees 
in one category and partners and family members in the other. ESBL/AmpC carriage among 
humans related to possible risk factors are shown in Table 1. Sex, age, hours spent in the 
broiler house, performance of activities in the broiler house, and type of person correlated 
strongly (>0.5) with the ‘contact with broilers’ variable. To avoid multicollinearity only the 
latter variable was included in the multivariable model. Three out of the seven initially included 
variables (Table 1) remained in the final multivariable model, in which the random farm effect 
explained 8% of the non-explained variation. In this model, based on 118 individuals with a 
complete record, farmers and employees were at a higher risk of ESBL/AmpC carriage than 
partners and family members (27.1% versus 14.3%; OR=2.5; P=0.08). It seems that there is 
an increased risk of exposure to ESBL/AmpC-producing E. coli for humans on broiler farms 
and that this risk is larger for individuals in close contact with broilers. Two other factors 
associated with higher risk of ESBL/AmpC carriage in humans were having diabetes or a 
skin disease (41.2% versus 15.8%; OR=16.5; P=0.002) and sampling in July-December 2010 
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(33.3% versus 7.8% in January-May 2011; OR=13.0; P=0.002). Risk factors reported in the 
literature such as travel abroad [19] and antibiotic use [20] were not identified in the current 
study. The similarity of answers to the questionnaire, which resulted in categories with <10% 
of available data, makes it difficult, however, to draw statistically valid conclusions on these 
risk factors.
Table 1. Prevalence of ESBL/AmpC carriage (Prev) among people living and/or working on 47 Dutch 
broiler farms in relation to farm-related and individual characteristics (n=141),a the overall prevalence 
being 19.1%.
Variable Category        Frequencyb Prev. 
Overall 
P-valuec
      n  %  %
Research question
Contact with broilers Partners, family 86 61.0 14.0 0.05
Farmers, employees 55 39.0 27.3
General characteristics
Sampling period Jan-May 2011 73 51.8 9.6 0.002
Jul-Dec 2010 68 48.2 29.4
Region South 48 34.0 22.9 0.84
East 38 27.0 18.4
West 10 7.1 20.0
North 45 31.9 15.6
Farm characteristics
Presence in broiler house No 22 17.5 13.6 0.40
Yes 104 82.5 21.2
Hours spent in broiler house 0 22 27.2 13.6 0.02
≤ 2 32 39.5 9.4
> 2 27 33.3 37.0
Physical contact with broilers No 28 22.4 14.3 0.38
Yes 97 77.6 19.7
Hours in physical contact with broilers 0 28 36.4 14.3 0.79
≤ 1 30 39.0 20.0
> 1 19 24.7 21.1
Activities in the broiler housed No activity 50 39.7 14.0 0.17
≥ 1 activity 76 60.3 23.7
Contact with livestock on other farms No 98 77.2 22.5 0.13
Yes 29 22.8 10.3
Changing room in broiler house No 14 9.9 14.3 0.61
Yes 127 90.1 19.7
Shower present in broiler house No 78 55.3 24.4 0.08
Yes 63 44.7 12.7
Farm size ≤ 78000 broilers 63 46.7 15.9 0.46
>78000 broilers 72 53.3 20.8
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Variable Category        Frequencyb Prev. 
Overall 
P-valuec
      n  %  %
Individual characteristics
Type of person Partner 35 24.8 11.4 0.21
Family member 51 36.2 15.7
Farmer 47 33.3 25.5
Employee 8 5.7 37.5
Age 0-18 years 38 27.0 13.2 0.41
19-65 years 97 68.8 20.6
≥ 65 years 6 4.3 33.3
Sex Male 72 56.3 27.8 0.01
Female 56 43.8 8.9
Family members in residence ≤ 2 25 18.5 16.0 0.57
> 2 110 81.5 20.9
Visit to hospital or polyclinic in past year No 96 76.8 21.9 0.32
Yes 29 23.2 13.8
Antibiotic use during past 3 months No 115 92.7 20.9 0.45
Yes 9 7.3 11.1
Having diabetes or skin disease(s)e No 101 85.6 15.8 0.02
Yes 17 14.4 41.2
MRSA-positive in this study No 133 94.3 17.3 0.04
Yes 8 5.7 50.0
Shared use of towels No 48 39.7 14.6 0.23
Yes 73 60.3 23.3
Playing team sports No 83 66.4 18.1 0.45
Yes 42 33.6 23.8
Travel abroad during past year No 60 48.8 20.0 0.93
Yes 63 51.2 20.6
a In an ‘intercept only’ model (without explanatory variables) the random farm effect was not significant and 
explained only 1.9% of the non-explained variation.
b A number of questionnaires were not complete, resulting in variables with missing values.
c Variables with a P-value (based on the likelihood ratio test) in bold (P<0.25) were considered for multivariable 
modelling.
d Activities in the broiler house include weighing, vaccination, blood sampling and health checks.
e Skin diseases include psoriasis, eczema, impetigo, infected skin, infected wounds and boils.
The distribution of phylogenetic groups, ESBL/AmpC genes and plasmids for a selection 
of 43 human and 90 broiler E. coli isolates from 21 farms with humans testing positive is 
summarised in Table 2. The molecular characteristics of all the isolates are presented in Table 
S1. Phylogenetic groups A
0
, A
1
, B1
1
, and D
2 
predominated both in humans and in broilers. 
The most prevalent genes in isolates from humans as well as broilers were bla
CMY-2
, blaCTX-M-1 
and bla
SHV-12
, and the most recovered plasmid family was IncI1 (Table 2). The similarity of 
distribution of the phylogenetic groups, ESBL/AmpC genes and plasmid families in human 
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isolates compared with broiler isolates suggests an exposure to a local pool of resistance 
genes related to broilers and the farm environment. This is further supported by the fact 
that bla
CTX-M-15
, which is one of the most prevalent genes found in humans in the Netherlands 
[5,21], was not found in the present study. In addition, bla
SHV-12
 and bla
CMY-2 
predominated but 
are only found sporadically in isolates from patients [5,6] and the community [21]. 
Table 2. Distribution of phylogenetic groups, ESBL/AmpC genes and plasmids among E. coli isolates 
from broilers and humans, representing the 21 farms with human carriage.
Molecular characteristic
(PCR and sequencing)
Broiler Human Total
n % n % n %
Phylogenetic groups
D
2
29 32.2 8 18.6 37 27.8
A
0
19 21.1 10 23.2 29 21.8
B1
1
18 20.0 8 18.6 26 19.6
A
1
12 13.3 9 20.9 21 15.8
B2
3
8 8.9 2 4.7 10 7.5
D
1
4 4.5 4 9.3 8 6.0
B2
2
0 0.0 2 4.7 2 1.5
Total 90 100 43 100 133 100
ESBL/AmpC genesa
bla
CMY-2
34 38.7 14 32.6 48 36.6
bla
CTX-M-1
25 28.4 12 27.9 37 28.2
bla
SHV-12
15 17.1 10 23.3 25 19.1
bla
TEM-52
b 8 9.1 4 9.3 12 9.1
bla
CTX-M-2
2 2.3 1 2.3 3 2.3
AmpC promoter mutantsc 0 0.0 2 4.6 2 1.5
bla
CTX-M-1
, bla
CTX-M-9
1 1.1 0 0.0 1 0.8
bla
CTX-M-1
, bla
SHV-12
1 1.1 0 0.0 1 0.8
bla
CTX-M-14
1 1.1 0 0.0 1 0.8
bla
CTX-M-32
1 1.1 0 0.0 1 0.8
Totald 88 100 43 100 131 100
Plasmid, ESBL/AmpC gene combinations
IncI1, bla
CTX-M-1
16 37.2 8 30.8 24 34.8
IncK, bla
CMY-2
6 14.0 4 15.4 10 14.5
IncI1, bla
SHV-12
6 14.0 3 11.6 9 13.0
IncI1, bla
CMY-2
3 7.0 5 19.2 8 11.6
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Molecular characteristic
(PCR and sequencing)
Broiler Human Total
n % n % n %
IncX1, bla
TEM-52
2 4.7 2 7.7 4 5.8
IncX1, bla
SHV-12
2 4.7 0 0.0 2 2.9
IncN, bla
SHV-12
1 2.3 1 3.8 2 2.9
IncA/C, bla
CMY-2
1 2.3 0 0.0 1 1.4
IncB/O, bla
SHV-12
0 0.0 1 3.8 1 1.4
IncFIB, bla
CMY-2
1 2.3 0 0.0 1 1.4
IncFII, bla
SHV-12
1 2.3 0 0.0 1 1.4
IncHI2_IncP, bla
CTX-M-2
1 2.3 0 0.0 1 1.4
IncI1, bla
CTX-M-2
0 0.0 1 3.8 1 1.4
IncI1, bla
CTX-M-14
1 2.3 0 0.0 1 1.4
IncI1, bla
TEM-52
1 2.3 0 0.0 1 1.4
IncX1, bla
CTX-M-32
1 2.3 0 0.0 1 1.4
Untypable, bla
SHV-12
0 0.0 1 3.8 1 1.4
Totale 43 100 26 100 69 100
a A number of genes were found in combination with TEM-1b [CMY-2 (n=8), CTX-M-1 (n=10), CTX-M-2 (n=2), 
CTX-M-32 (n=1), SHV-12 (n=8), TEM-52 (n=5)]; see Table S1.
b One TEM-52 isolate was found with 1 mutation (C228T), and 11 TEM-52 isolates were found with 3 mutations 
(C18T, C228T and G396T) in this gene. All were synonymous mutations.
c One AmpC type 3 promoter mutant [mutations −42T−18A−1T(+23A+51T)+58T+81G] and one AmpC type 4 
promoter mutant (mutations +22T+26G+27T+32A+70T+81G) were found.
d In 2 isolates from broilers, only bla
TEM-1b
 was found. 
e Plasmids were not characterised for n=64 isolates.
MLST was performed for a selection of human and broiler isolates from 12 farms (Table 
3). On the other 9 farms with humans testing positive (Table S1), ESBL/AmpC genes and/or 
E. coli phylogenetic groups were not similar between humans and broilers so MLST was not 
performed. In five cases, broiler-human isolate pairs showed the same ESBL/AmpC gene, 
plasmid family and E. coli ST (Table 3). Given the epidemiological relatedness of isolates 
collected in this study, a clonal transfer of ESBL/AmpC-producing E. coli between broilers 
and humans is likely. The ST diversity observed in the current study and by Dierikx et al. [2] 
further suggests that finding these broiler-human isolate pairs is not a coincidence. Clonal 
transfer is only the starting point for transmission as horizontal gene transfer [3,4] may occur 
within bacterial populations e.g. between E. coli with different STs and between E. coli and 
other bacterial species. Focussing on clonal transfer alone will therefore underestimate the 
frequency of transfer. In the current study identical ESBL/AmpC genes located on the same 
plasmid family were found in different E. coli STs (Table 3; farms 10, 12 and 16), suggesting a 
horizontal transfer of plasmids via conjugation between different E. coli strains. 
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Table 3. E. coli STs in isolates from 12 farms where humans and broilers had similar ESBL/AmpC genes 
and phylogenetic groups within the same farm.
Farm Isolate Source
Phylogenetic 
group
E. coli 
ST
Clonal 
complex
β-Lactamase genes 
(PCR and sequencing)
a,b
Replicon type of 
plasmid with ESBL/
AmpC gene
04 HR1_1 Farmer D
2
648 bla
SHV-12
incB/O
C09_1 Broiler D
2
648 bla
SHV-12
incI1
07 HR1_1 Farmer D
2
117 bla
SHV-12
incI1
C02_1 Broiler D
2
117 bla
SHV-12
incFII
08 GR1_3 Family B1
1
351  bla
CMY-2
; bla
TEM-1b
incI1
C02_1 Broiler B1
1
351  bla
CMY-2
incI1
10 HR1_3 Farmer A
0
93 ST168 bla
SHV-12
; bla
TEM-1b
incN
GR2_1 Family A
0
399 ST399 bla
CTX-M-1
incI1
C02_1 Broiler A
0
189 ST165 bla
CTX-M-1
; bla
TEM-1b
incI1
12 HR1_1 Farmer B2
3
131 bla
CMY-2
incI1
HR1_3 Farmer B1
1
641 ST86 bla
CMY-2
HR1_5 Farmer D
2
NEWc bla
CTX-M-1
incI1
C01_2 Broiler D
2
1640 bla
CTX-M-1
; bla
TEM-1b
incI1
C08_1 Broiler B1
1
1146 bla
CMY-2
C09_2 Broiler D
2
1775 bla
CMY-2
; bla
TEM-1b
incI1
C10_1 Broiler B2
3
355 bla
CMY-2
15 HR1_3 Farmer D
2
117 bla
CMY-2
incI1
 GR1_4 Family D
2
117 bla
CMY-2
incI1
C03_1 Broiler D
2
57 ST35 bla
CMY-2
incK
16 HR1_3 Farmer A
1
48 ST10 bla
CTX-M-1
; bla
TEM-1b
incI1
C03_1 Broiler A
1
10 ST10 bla
CTX-M-1
incI1
20 GR2_1 Family A
1
10 ST10 bla
CTX-M-1
incI1
 C04_1 Broiler A
1
10 ST10 bla
CTX-M-1
incI1
25 GR2_4 Family A
0
1818  bla
TEM-52
d incX1
 C01_1 Broiler A
0
1818  bla
TEM-52
d incX1
GR2_1 Family A
0
373 ST168 bla
CMY-2
incK
 C03_1 Broiler A
0
373 ST168 bla
CMY-2
incK
C05_1 Broiler D
2
38 ST38 bla
CMY-2
; bla
TEM-1b
incK
27 HR1_1 Farmer A
1
88 ST23 bla
CTX-M-1
incI1
 HR1_5 Farmer A
1
88 ST23 bla
CTX-M-1
incI1
 C06_1 Broiler A
1
88 ST23 bla
CTX-M-1
incI1
C08_1 Broiler A
0
2223 bla
CTX-M-1
incI1
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Farm Isolate Source
Phylogenetic 
group
E. coli 
ST
Clonal 
complex
β-Lactamase genes 
(PCR and sequencing)
a,b
Replicon type of 
plasmid with ESBL/
AmpC gene
28 HR1_1 Farmer A
0
1324 bla
CTX-M-1
incI1
C09_1 Broiler A
0
641 ST86 bla
CTX-M-1
37 GR2_1 Family A
1
23 ST23 bla
SHV-12
; bla
TEM-1b
incI1
GR3_2 Family D
2
1163 bla
CMY-2
; bla
TEM-1b
incI1
C05_1 Broiler A
0
2509 bla
TEM-52
d; blaTEM-1b
 C07_1 Broiler D
2
57 ST350 bla
CMY-2
; bla
TEM-1b
incK
a Bold text indicates human-broiler or human-human isolate pairs from the same farm with the same ESBL/AmpC 
gene, plasmid family and E. coli ST.
b With the primers used in this study no distinction was made between TEM-1b and TEM-198; however for readability 
of the table, TEM-1b was inserted.
c MLST results: adk35, fumC3, gyrB234, icd342, mdh45, purA5, recA95.
d Isolates were found with 3 mutations (C18T, C228T and G396T). All were synonymous mutations. 
Transmission between humans and broilers has been shown but knowledge about the 
(relative) contribution of transmission routes that might play a role in the dissemination of 
ESBL/AmpC-encoding resistance genes is lacking. Direct contact between humans and live 
broilers seems to play a major role, given the highest prevalence in farmers and employees. It 
is important, however, also to consider transmission via the farm environment and between 
humans within the household, given the relatively high prevalence in family members. E. 
coli have a high survival rate in the environment, which might lead to the accumulation of 
these bacteria [22], both inside and outside the broiler house, and indirect transmission to 
individuals living on farms. Environmental samples were not collected in the current study. 
A high rate of intestinal colonisation with ESBL-producing organisms was shown for the 
household members of patients suffering from community acquired urinary tract infections, 
and up to 66.6% of isolates from case patients and their corresponding household members 
had indistinguishable pulsed-field gel electrophoresis patterns [23]. In the current study two 
isolates were found, one from a farmer and one from a family member, from the same farm 
with bla
CMY-2
, located on a plasmid from the incI1 family, in an E. coli with ST117, which might 
indicate human-to-human transmission. The family member reported no contact with live 
broilers, and rarely entered the broiler house. 
This study contributes to the growing body of evidence supporting the risk for humans 
working and/or living on broiler farms and the transmission of ESBL/AmpC-producing 
Enterobacteriaceae between broilers and humans. To further elucidate the role of broilers 
in ESBL/AmpC carriage among humans on broiler farms, future studies should attempt to 
quantify the transmission between broilers, and between humans and broilers, taking into 
account indirect (via the environment) and direct transmission routes, as well as clonal 
spread and horizontal gene transfer. 
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Supplementary Table. Characteristics of β-lactamase genes and plasmids present in E. coli isolates from 
broilers, farmers, family members and employees.
Farm Isolate Source Phylogenetic 
group
E. coli 
ST
Clonal 
complex
β-lactamase genes 
(PCR and sequencing)
a,b
Replicon type of 
plasmid with ESBL/
AmpC gene
04 HR1_1 Farmer D
2
648 bla
SHV-12
incB/O
C02_1 Broiler A
1
bla
TEM-52
incX1
C05_3 Broiler D
2
bla
CTX-M-1
; bla
TEM-1b
incI1
C06_1 Broiler D
2
bla
SHV-12
incI1
C09_1 Broiler D
2
648 bla
SHV-12
incI1
C10_1 Broiler D
2
bla
SHV-12
incI1
05 HR1_1 Farmer B1
1
bla
TEM-52
incX1
HR1_3 Farmer B1
1
bla
TEM-52
HR1_5 Farmer B1
1
bla
TEM-52
C01_1 Broiler B1
1
bla
TEM-1b
C04_2 Broiler A
0
bla
TEM-52
C05_1 Broiler A
0
bla
CMY-2
incFIB
C06_1 Broiler B1
1
bla
TEM-52
; blaTEM-1b
C07_1 Broiler A
1
bla
SHV-12
incI1
C10_2 Broiler A
0
bla
CTX-M-1
incI1
07 HR1_1 Farmer D
2
117 bla
SHV-12
incI1
C02_1 Broiler D
2
117 bla
SHV-12
incFII
C08_1 Broiler D
1
bla
TEM-52
; blaTEM-1b incI1
C08_2 Broiler A
0
bla
CTX-M-1
incI1
08 HR1_1 Farmer A
1
bla
CMY-2
incK
HR1_5 Farmer B2
3
bla
CTX-M-1
; bla
TEM-1b
incI1
GR1_3 Family B1
1
351 bla
CMY-2
; bla
TEM-1b
incI1
C02_1 Broiler B1
1
351 bla
CMY-2
incI1
C04_1 Broiler B1
1
bla
CTX-M-1
C05_1 Broiler A
0
bla
CMY-2
incA/C
C06_1 Broiler B1
1
bla
CTX-M-1
; bla
TEM-1b
incI1
C07_1 Broiler B1
1
bla
CTX-M-1
C09_1 Broiler D
2
bla
SHV-12
incI1
09 MR1_3 Employee B2
2
bla
CMY-2
incK
C02_1 Broiler D
2
bla
SHV-12
C04_1 Broiler B1
1
bla
CMY-2
C06_1 Broiler B2
3
bla
CTX-M-1
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Farm Isolate Source Phylogenetic 
group
E. coli 
ST
Clonal 
complex
β-lactamase genes 
(PCR and sequencing)
a,b
Replicon type of 
plasmid with ESBL/
AmpC gene
10 HR1_3 Farmer A
0
93 ST168 bla
SHV-12
; bla
TEM-1b
incN
HR1_5 Farmer A
0
bla
SHV-12
; bla
TEM-1b
GR2_1 Family A
0
399 ST399 bla
CTX-M-1
incI1
GR2_5 Family A
1
bla
CTX-M-1
C02_1 Broiler A
0
189 ST165 bla
CTX-M-1
; bla
TEM-1b
incI1
C03_1 Broiler D
1
bla
TEM-52
; blaTEM-1b
C06_1 Broiler D
2
bla
CTX-M-1
; bla
SHV-12
C07_1 Broiler B1
1
bla
CTX-M-14
incI1
C08_1 Broiler D
2
bla
SHV-12
; bla
TEM-1b
C08_2 Broiler B1
1
bla
SHV-12
11 MR1_4 Employee B1
1
bla
CTX-M-2
; bla
TEM-1b
incI1
C01_1 Broiler A
1
bla
CTX-M-1
C03_1 Broiler D
2
bla
SHV-12
; bla
TEM-1b
incI1
C03_2 Broiler A
0
bla
CTX-M-1
C08_1 Broiler A
1
bla
CTX-M-1
incI1
C10_1 Broiler A
1
bla
CTX-M-1
12 HR1_1 Farmer B2
3
131 bla
CMY-2
incI1
HR1_3 Farmer B1
1
641 ST86 bla
CMY-2
HR1_5 Farmer D
2
NEWc bla
CTX-M-1
incI1
C01_2 Broiler D
2
1640 bla
CTX-M-1
; bla
TEM-1b
incI1
C02_1 Broiler A
0
bla
CMY-2
incI1
C04_1 Broiler A
0
bla
TEM-1b
C06_1 Broiler B1
1
bla
CMY-2
C08_1 Broiler B1
1
1146 bla
CMY-2
C09_2 Broiler D
2
1775 bla
CMY-2
; bla
TEM-1b
incI1
C09_3 Broiler A
0
bla
CTX-M-1
C10_1 Broiler B2
3
355 bla
CMY-2
15 HR1_3 Farmer D
2
117 bla
CMY-2
incI1
GR1_4 Family D
2
117 bla
CMY-2
incI1
C02_2 Broiler D
2
bla
CMY-2
C03_1 Broiler D
2
57 ST35 bla
CMY-2
incK
C08_1 Broiler A
0
bla
CMY-2
16 HR1_1 Farmer A
1
bla
CTX-M-1
; bla
TEM-1b
HR1_3 Farmer A
1
48 ST10 bla
CTX-M-1
; bla
TEM-1b
incI1
HR1_5 Farmer A
1
bla
CTX-M-1
; bla
TEM-1b
C02_1 Broiler B1
1
bla
CTX-M-1
; bla
TEM-1b
incI1
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Farm Isolate Source Phylogenetic 
group
E. coli 
ST
Clonal 
complex
β-lactamase genes 
(PCR and sequencing)
a,b
Replicon type of 
plasmid with ESBL/
AmpC gene
10 HR1_3 Farmer A
0
93 ST168 bla
SHV-12
; bla
TEM-1b
incN
HR1_5 Farmer A
0
bla
SHV-12
; bla
TEM-1b
GR2_1 Family A
0
399 ST399 bla
CTX-M-1
incI1
GR2_5 Family A
1
bla
CTX-M-1
C02_1 Broiler A
0
189 ST165 bla
CTX-M-1
; bla
TEM-1b
incI1
C03_1 Broiler D
1
bla
TEM-52
; blaTEM-1b
C06_1 Broiler D
2
bla
CTX-M-1
; bla
SHV-12
C07_1 Broiler B1
1
bla
CTX-M-14
incI1
C08_1 Broiler D
2
bla
SHV-12
; bla
TEM-1b
C08_2 Broiler B1
1
bla
SHV-12
11 MR1_4 Employee B1
1
bla
CTX-M-2
; bla
TEM-1b
incI1
C01_1 Broiler A
1
bla
CTX-M-1
C03_1 Broiler D
2
bla
SHV-12
; bla
TEM-1b
incI1
C03_2 Broiler A
0
bla
CTX-M-1
C08_1 Broiler A
1
bla
CTX-M-1
incI1
C10_1 Broiler A
1
bla
CTX-M-1
12 HR1_1 Farmer B2
3
131 bla
CMY-2
incI1
HR1_3 Farmer B1
1
641 ST86 bla
CMY-2
HR1_5 Farmer D
2
NEWc bla
CTX-M-1
incI1
C01_2 Broiler D
2
1640 bla
CTX-M-1
; bla
TEM-1b
incI1
C02_1 Broiler A
0
bla
CMY-2
incI1
C04_1 Broiler A
0
bla
TEM-1b
C06_1 Broiler B1
1
bla
CMY-2
C08_1 Broiler B1
1
1146 bla
CMY-2
C09_2 Broiler D
2
1775 bla
CMY-2
; bla
TEM-1b
incI1
C09_3 Broiler A
0
bla
CTX-M-1
C10_1 Broiler B2
3
355 bla
CMY-2
15 HR1_3 Farmer D
2
117 bla
CMY-2
incI1
GR1_4 Family D
2
117 bla
CMY-2
incI1
C02_2 Broiler D
2
bla
CMY-2
C03_1 Broiler D
2
57 ST35 bla
CMY-2
incK
C08_1 Broiler A
0
bla
CMY-2
16 HR1_1 Farmer A
1
bla
CTX-M-1
; bla
TEM-1b
HR1_3 Farmer A
1
48 ST10 bla
CTX-M-1
; bla
TEM-1b
incI1
HR1_5 Farmer A
1
bla
CTX-M-1
; bla
TEM-1b
C02_1 Broiler B1
1
bla
CTX-M-1
; bla
TEM-1b
incI1
Farm Isolate Source Phylogenetic 
group
E. coli 
ST
Clonal 
complex
β-lactamase genes 
(PCR and sequencing)
a,b
Replicon type of 
plasmid with ESBL/
AmpC gene
C03_1 Broiler A
1
10 ST10 bla
CTX-M-1
incI1
C04_1 Broiler B1
1
bla
CTX-M-1
C05_1 Broiler A
0
bla
CMY-2
incK
C06_1 Broiler A
1
bla
CTX-M-2
; bla
TEM-1b
C07_1 Broiler A
1
bla
CTX-M-2
incHI2_incP
C07_2 Broiler B1
1
bla
CTX-M-1
; bla
CTX-M-9
C08_1 Broiler A
0
bla
CMY-2
17 GR2_1 Family A
0
bla
CMY-2
; bla
TEM-1b
GR3_1 Family D
1
bla
SHV-12
incI1
GR3_3 Family D
1
bla
SHV-12
C02_1 Broiler D
2
bla
CTX-M-32
; bla
TEM-1b
incX1
C03_1 Broiler D
2
bla
SHV-12
C05_1 Broiler D
2
bla
SHV-12
incX1
C06_1 Broiler D
2
bla
SHV-12
incX1
C07_1 Broiler D
1
bla
CMY-2
C08_1 Broiler D
2
bla
CMY-2
C09_1 Broiler D
2
bla
SHV-12
C10_1 Broiler B1
1
bla
CTX-M-1
incI1
18 GR1_1 Family D
1
bla
CMY-2
incK
C03_1 Broiler D
2
bla
CMY-2
C04_1 Broiler A
1
bla
CMY-2
C06_1 Broiler D
2
bla
CMY-2
incK
C10_1 Broiler D
2
bla
CMY-2
20 GR2_1 Family A
1
10 ST10 bla
CTX-M-1
incI1
C04_1 Broiler A
1
10 ST10 bla
CTX-M-1
incI1
C09_1 Broiler A
1
bla
SHV-12
incN
C10_1 Broiler B1
1
bla
CTX-M-1
incI1
22 GR1_1 Family B1
1
AmpC type 3 
promotor mutantd
C08_1 Broiler D
1
bla
CMY-2
25 GR2_1 Family A
0
373 ST168 bla
CMY-2
incK
GR2_4 Family A
0
1818 bla
TEM-52
incX1
GR2_5 Family D
2
bla
CMY-2
C01_1 Broiler A
0
1818 bla
TEM-52
incX1
C03_1 Broiler A
0
373 ST168 bla
CMY-2
incK
C05_1 Broiler D
2
38 ST38 bla
CMY-2
; bla
TEM-1b
incK
C06_1 Broiler B2
3
bla
CMY-2
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Farm Isolate Source Phylogenetic 
group
E. coli 
ST
Clonal 
complex
β-lactamase genes 
(PCR and sequencing)
a,b
Replicon type of 
plasmid with ESBL/
AmpC gene
27 HR1_1 Farmer A
1
88 ST23 bla
CTX-M-1
incI1
HR1_5 Farmer A
1
88 ST23 bla
CTX-M-1
incI1
C01_1 Broiler B1
1
bla
TEM-52
; blaTEM-1b
C06_1 Broiler A
1
88 ST23 bla
CTX-M-1
incI1
C08_1 Broiler A
0
2223 bla
CTX-M-1
incI1
28 HR1_1 Farmer A
0
1324 bla
CTX-M-1
incI1
HR1_4 Farmer A
0
bla
CTX-M-1
C03_1 Broiler B1
1
bla
CTX-M-1
; bla
TEM-1b
incI1
C09_1 Broiler A
0
641 ST86 bla
CTX-M-1
31 GR4_5 Family D
1
bla
CMY-2
; bla
TEM-1b
C03_1 Broiler B2
3
bla
CMY-2
C05_1 Broiler D
2
bla
CMY-2
C06_1 Broiler D
2
bla
CMY-2
C07_1 Broiler B2
3
bla
CMY-2
37 HR1_1 Farmer A
0
bla
SHV-12
; bla
TEM-1b
non-typable
HR1_5 Farmer A
0
bla
SHV-12
; bla
TEM-1b
GR2_1 Family A
1
23 ST23 bla
SHV-12
; bla
TEM-1b
incI1
GR2_3 Family B2
2
bla
SHV-12
; bla
TEM-1b
GR3_2 Family D
2
1163 bla
CMY-2
; bla
TEM-1b
incI1
C03_1 Broiler A
0
bla
CTX-M-1
incI1
C05_1 Broiler A
0
2509 bla
TEM-52
; blaTEM-1b
C07_1 Broiler D
2
57 ST350 bla
CMY-2
; bla
TEM-1b
incK
40 GR4_2 Family B1
1
bla
CMY-2
; bla
TEM-1b
C04_1 Broiler B2
3
bla
CMY-2
C06_1 Broiler B2
3
bla
CMY-2
C09_1 Broiler B2
3
bla
CMY-2
46 HR1_3 Farmer D
2
AmpC type 4 promotor 
mutante; bla
TEM-1b
C05_1 Broiler D
2
bla
CMY-2
C08_1 Broiler D
2
bla
CMY-2
a With the primers used in this study no distinction was made between TEM-1b and TEM-198, however for readability 
of the Table, TEM-1b was inserted.
b One TEM-52 isolate was found with 1 mutation (C228T) and 11 TEM-52 isolates were found with 3 mutations in this 
gene (C18T, C228T, G396T). All were synonymous mutations.
c MLST results: adk35, fumC3, gyrB234, icd342 mdh45, purA5, recA95.
d Positions of mutations in AmpC promoter region: −42T−18A−1T(+23A+51T)+58T+81G.
e Positions of mutations in AmpC promoter region: +22T+26G+27T+32A+70T+81G.
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Farm Isolate Source Phylogenetic 
group
E. coli 
ST
Clonal 
complex
β-lactamase genes 
(PCR and sequencing)
a,b
Replicon type of 
plasmid with ESBL/
AmpC gene
27 HR1_1 Farmer A
1
88 ST23 bla
CTX-M-1
incI1
HR1_5 Farmer A
1
88 ST23 bla
CTX-M-1
incI1
C01_1 Broiler B1
1
bla
TEM-52
; blaTEM-1b
C06_1 Broiler A
1
88 ST23 bla
CTX-M-1
incI1
C08_1 Broiler A
0
2223 bla
CTX-M-1
incI1
28 HR1_1 Farmer A
0
1324 bla
CTX-M-1
incI1
HR1_4 Farmer A
0
bla
CTX-M-1
C03_1 Broiler B1
1
bla
CTX-M-1
; bla
TEM-1b
incI1
C09_1 Broiler A
0
641 ST86 bla
CTX-M-1
31 GR4_5 Family D
1
bla
CMY-2
; bla
TEM-1b
C03_1 Broiler B2
3
bla
CMY-2
C05_1 Broiler D
2
bla
CMY-2
C06_1 Broiler D
2
bla
CMY-2
C07_1 Broiler B2
3
bla
CMY-2
37 HR1_1 Farmer A
0
bla
SHV-12
; bla
TEM-1b
non-typable
HR1_5 Farmer A
0
bla
SHV-12
; bla
TEM-1b
GR2_1 Family A
1
23 ST23 bla
SHV-12
; bla
TEM-1b
incI1
GR2_3 Family B2
2
bla
SHV-12
; bla
TEM-1b
GR3_2 Family D
2
1163 bla
CMY-2
; bla
TEM-1b
incI1
C03_1 Broiler A
0
bla
CTX-M-1
incI1
C05_1 Broiler A
0
2509 bla
TEM-52
; blaTEM-1b
C07_1 Broiler D
2
57 ST350 bla
CMY-2
; bla
TEM-1b
incK
40 GR4_2 Family B1
1
bla
CMY-2
; bla
TEM-1b
C04_1 Broiler B2
3
bla
CMY-2
C06_1 Broiler B2
3
bla
CMY-2
C09_1 Broiler B2
3
bla
CMY-2
46 HR1_3 Farmer D
2
AmpC type 4 promotor 
mutante; bla
TEM-1b
C05_1 Broiler D
2
bla
CMY-2
C08_1 Broiler D
2
bla
CMY-2
a With the primers used in this study no distinction was made between TEM-1b and TEM-198, however for readability 
of the Table, TEM-1b was inserted.
b One TEM-52 isolate was found with 1 mutation (C228T) and 11 TEM-52 isolates were found with 3 mutations in this 
gene (C18T, C228T, G396T). All were synonymous mutations.
c MLST results: adk35, fumC3, gyrB234, icd342 mdh45, purA5, recA95.
d Positions of mutations in AmpC promoter region: −42T−18A−1T(+23A+51T)+58T+81G.
e Positions of mutations in AmpC promoter region: +22T+26G+27T+32A+70T+81G.
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Abstract
The aim of this study was to estimate the prevalence of methicillin-resistant 
Staphylococcus aureus (MRSA) and extended-spectrum and AmpC β-lactamase (ESBL/
AmpC)-producing Escherichia coli among broilers, and humans living and/or working on 
organic broiler farms; further characterise isolates; and compare these results with those 
from conventional farms.
In the Netherlands, only 9 certified organic broiler farms were present. On 8 of these 
farms, 60 throat swabs and 20 cloacal swabs were taken per farm for MRSA and ESBL/
AmpC-E. coli detection, respectively, at an average age of both 34 (T1) and 68 (T2) days. 
Faecal swabs and questionnaires were returned by 27 out of 36 humans. For selected 
ESBL/AmpC-producing E. coli isolates, phylogenetic groups, β-lactamase genes, plasmid 
families and sequence types were determined.
MRSA was not detected in broiler and human samples. ESBL/AmpC-producing E. coli 
were isolated from broilers on 7/8 farms at T1 and on all farms at T2. Furthermore, 3 
farmers at T1, and 2 farmers and 1 family member at T2 were positive. Genes found in 
broilers and humans were almost exclusively bla
CTX-M-1
 and bla
CMY-2
. Given the high overall 
human ESBL/AmpC-prevalence (18.5%), which is similar to conventional farms, contact 
with live broilers is assumed a risk factor for carriage. Farm and sample-level prevalence 
at T1 are consistent with those from conventional farms. At T2, just before slaughter, 
sample-level prevalence of ESBL/AmpC-E.coli appears to have decreased (94.3 vs. 80%), 
which could have important consequences for contamination of retail meat.
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Introduction
Human infections with methicillin-resistant Staphylococcus aureus (MRSA), and extended-
spectrum and AmpC β-lactamase (ESBL/AmpC)-producing Escherichia coli have both 
been associated with reservoirs in livestock [1,2]. This raises a public health concern as 
transmission could occur between animals and humans. Livestock-associated (LA)-MRSA and 
ESBL/AmpC-producing E. coli have been found in broilers, and in individuals working and/or 
living on conventional Dutch broiler farms [3,4,5]. The prevalences of MRSA and ESBL/AmpC-
producing E. coli are higher in humans on these farms than in the community [4,5,6,7], and 
contact with live broilers has been identified as a risk factor for human carriage [5,8]. 
In comparison to conventional farms, organic broiler farms have lower flock densities, 
different breeds, restrictions in antimicrobial use, availability of outdoor areas and later 
slaughter age. These factors could lead to a lower prevalence of MRSA and ESBL/AmpC-
producing E. coli among broilers on organic compared to conventional farms and might also 
affect carriage of humans. There are currently no studies investigating carriage of MRSA and 
ESBL/AmpC-producing E. coli among humans and broilers on organic farms. The aim of this 
study was to estimate the prevalence of MRSA and ESBL/AmpC-producing E. coli among 
broilers and humans living and/or working on organic broiler farms; further characterise 
isolates from humans and broilers; and compare these results with those from conventional 
farms.
Material and methods
Study population 
From October 2011 to April 2012 a prevalence study for MRSA and ESBL/AmpC-producing E. 
coli was conducted on 8 out of 9 certified organic broiler farms in the Netherlands. Certified 
organic broiler farms are those that comply with legal regulations laid down by the European 
Commission. Chapter 2 of Commission Regulation No 889/2008 describes production rules 
for different livestock species, including broilers [9].  Participating farms had a median of 1.5 
broiler houses (range 1-22) and the median number of broilers per farm was 4500 (range 
4000-6900). The human study population consisted of broiler farmers, their family members 
working and/or living on the farm and employees working on the farm. 
Sample collection and questionnaires
Broiler samples were collected by one employee of the Animal Health Service according to 
Geenen et al. [4] for MRSA and according to Huijbers et al. [5] for ESBL/AmpC-producing E. 
coli at two different times (T1 and T2) during the production cycle. Broiler age was on average 
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34 (range 24-48) days at T1 and 68 (range 62-69) days at T2. T1 was chosen so that results 
could be compared to the studies on conventional farms where broilers were sampled at 
an average age of 31 days [4,5]. As organic broilers have a later slaughter age, T2 was also 
selected to assess the situation just before slaughter. A randomly chosen flock was sampled 
for MRSA by taking throat swabs from 60 broilers (pooled to five samples), and for ESBL/
AmpC-producing E. coli by taking cloacal swabs from 20 broilers (pooled to 10 samples). The 
study was performed according to Dutch law on studies with animals. In addition, for MRSA-
detection, five environmental wipes were taken from all broiler houses on the farm, and five 
environmental wipes were taken from the farm residence (i.e., favourite armchair, TV remote 
control, inside and outside door handles and the favourite pet).
Human samples were also collected at T1 and T2. People who voluntarily participated 
in the study took a nose swab for MRSA-detection and a faecal swab for detection of ESBL/
AmpC-producing E. coli, as described by Geenen et al. [4] and Huijbers et al. [5], respectively. 
All participants signed a written informed consent and for children aged <18 years parental 
consent was requested. In addition, a questionnaire about farm management was completed 
by farmers, and a separate questionnaire on lifestyle and health characteristics was completed 
by farmers, family members and employees.
Microbiological examination
MRSA was isolated by incubation in Mueller-Hinton enrichment broth with 6.5% NaCl, 
followed by selective enrichment (broiler and environmental samples) or plating on 
ChromID MRSA plates (human samples), and plating on Columbia agar with 5% sheep blood 
and Brilliance MRSA agar [4]. A farm was classified as MRSA-positive if at least one broiler 
sample or environmental wipe tested positive for MRSA at T1 or T2. ESBL/AmpC-producing 
Enterobacteriaceae were isolated by selective enrichment and culture on selective plates. 
ESBL/AmpC E. coli-like isolates were confirmed phenotypically by combination disc diffusion 
test, including a cefoxitin disc for the detection of AmpC phenotypes [5]. Further molecular 
characteristics, i.e., phylogenetic group and ESBL/AmpC-gene were determined for one or 
two human isolates and a minimum of four (range 4-9) broiler isolates per farm. On farms 
with positive humans, multilocus sequence typing (MLST) and PCR-based replicon typing 
were performed on a minimum of one human isolate and at least one broiler isolate if they 
showed the same phylogenetic group and ESBL/AmpC-gene [5]. MLST was also performed on 
isolates from broilers and humans showing the B2
3 
or D phylogenetic groups because virulent 
extra-intestinal strains of E. coli mainly belong to these groups [10]. A farm was classified as 
ESBL/AmpC-positive if at least one broiler sample tested positive for ESBL/AmpC-producing 
E. coli at T1 or T2. 
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Statistical analysis
Prevalences and their exact 95% confidence intervals (95% CI) were calculated based on 
the binomial distribution. In order to compare organic and conventional farms, data from 
Geenen et al. [4] and Huijbers et al. [5] with respect to the presence of MRSA or ESBL/AmpC-
producing E. coli on farms, among broiler samples and humans were merged with data from 
the current study. These studies were done by the same institute and were comparable in 
design. Exact logistic regression was used to investigate the association between type of farm 
(i.e., organic vs. conventional farms) and the presence of MRSA or ESBL/AmpC-producing E. 
coli. Multiple observations on the same farm might not be independent, so a random farm 
effect was included using an exchangeable covariance structure, and explained 36.5% and 
2.0% of all non-explained variation in the models for broilers and humans, respectively.
Results and discussion
Descriptive statistics
In total, 27 out of 36 individuals agreed to participate. These participants included 9 farmers, 
16 family members and two employees. Per farm, this ranged from two to seven individuals, 
with an average age of 40.6 years (range 4-76 years). 
MRSA-carriage among broilers and humans
MRSA was not detected in all 80 pooled throat swabs and 120 environmental wipes, so all 
farms were classified MRSA-negative. The prevalence of positive organic farms (0/8) was 
not statistically different (P=1.0) from conventional farms (4/50; [4]). On-farm antimicrobial 
treatment has been associated with antimicrobial resistance [11]. Since antimicrobial 
consumption is lower on organic farms, it was hypothesised that both prevalence of positive 
organic farms as well as within-flock prevalence would be lower. Due to the small number 
of organic broiler farms in the Netherlands this cannot be determined at the national level, 
however. MRSA was also not detected in 27 samples from humans (0%; 95% CI 0.0-12.8), 
and in 75 environmental wipes taken from the farm residence (0%; 95% CI 0.0-4.8). Since 
prevalences were not different from those from conventional farms, risk factors for carriage of 
MRSA among humans living and/or working on organic and conventional farms are assumed 
to be comparable.
ESBL/AmpC-carriage among broilers and humans
All farms were ESBL/AmpC-positive, although one farm only tested ESBL/AmpC-positive 
at T2 (Farm 8). Possibly, the number of ESBL/AmpC-producing E. coli was below detection 
limit, or the longer vacancy between production cycles compared to other farms (25 vs. 
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median 10 days) might have resulted in a delay in farm contamination. The prevalence of 
positive farms at T1 (7/8) was not significantly different (P=0.28) from conventional farms 
(50/50; [5]). This was not expected considering the lower consumption of antimicrobials on 
organic broiler farms. On positive farms, the prevalence of ESBL/AmpC-producing E. coli at 
the sample-level (66/70=94.3%) at T1 was not different from conventional farms (96.4%; 
P=0.57). To the authors’ knowledge there are no other studies comparing farm- and sample-
level prevalences of ESBL/AmpC-producing E. coli between organic and conventional broiler 
farms. Schwaiger et al. [12] showed lower resistance rates for several β-lactam antibiotics, 
including second generation cephalosporins, in E. coli isolates from organically reared laying 
hens compared to conventionally reared laying hens. It should be noted however, that all 
E. coli isolates were sensitive to cefepime, cefotaxime and ceftazidime and ceftiofur, and 
they were not tested for ESBL/AmpC-production. On positive organic farms the prevalence 
of ESBL/AmpC-producing E. coli at the sample-level decreases from 94.3% to 80.0% (64/80; 
95% CI 69.6-88.1) at T2 (P=0.08). It can be speculated that fewer positive animals enter the 
slaughterhouse, potentially leading to retail meat that is less contaminated. This is supported 
by Cohen-Stuart et al. [13] who found that the prevalence of ESBL-producing bacteria was 
lower among organic (84%) compared to conventional (100%) retail meat samples in the 
Netherlands, and that the median bacterial load on organic samples was lower than on 
conventional ones. The decrease might also hold true for broilers on conventional farms if 
they would have a longer production cycle, but at their usual slaughter age of 6 weeks, a very 
high percentage of positive broilers enter the slaughterhouse.
ESBL/AmpC-genes and phylogenetic groups were determined in 49 isolates from broilers 
(Table 1). The genes found in broilers were almost exclusively bla
CTX-M-1
 (n=31) and bla
CMY-2
 
(n=17). In addition, an isolate harbouring bla
TEM-52
 (n=1) was found. The genes bla
CTX-M-1
 and 
bla
CMY-2 
were also highly prevalent on conventional farms in the Netherlands [3,5]. Interestingly 
bla
SHV-12
, which was frequently identified in broilers on conventional farms, was not found 
in the present study [3,5]. This might be explained by the small number of organic farms, 
but could also be due to the different broiler breeds or hatcheries associated with organic 
compared to conventional broiler production. The latter two factors have previously been 
shown to influence the occurrence of antimicrobial resistance on conventional broiler farms 
[11]. The predominant phylogenetic group was B1
1 
(n=15), but B2
3
 (n=9), D
2
 (n=10), A
0
 (n=7), 
D
1
 (n=4) and A
1
 (n=4) were also found. On conventional farms there was a similar distribution 
of phylogenetic groups [5]. Plasmid families were determined for 3 broiler isolates, which 
showed bla
CMY-2
 located on IncI1, bla
CMY-2
 on IncK, and bla
CTX-M-1
 on IncI1. MLST of isolates 
from phylogenetic groups B2
3
 yielded two different sequence types: ST131 (n=5) and ST429 
(n=2). Group D
1
 isolates showed ST69 (n=2) and unknown sequence types (n=2), and group 
D
2
 showed ST93 (n=2), ST117 (n=2), ST648 (n=2), ST155 (n=1) and ST569 (n=1). E. coli with 
ST131, commonly harbouring bla
CTX-M-15
, has been recognised as a pandemic clone responsible 
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for extra-intestinal infections in humans [14]. In the current study, isolates with ST131 were 
found in broilers, but these harboured bla
CTX-M-1
 and blaCMY-2 instead of blaCTX-M-15. Reports of E. 
coli ST131 harbouring ESBL/AmpC-genes in animals are few [14], however two other studies 
have shown a single ST131 isolate harbouring bla
CTX-M-1
 in a wild seagull and a domestic pig 
[15,16]. This is a potentially worrisome development given the global success of ST131 [14]. 
This is the first study investigating carriage of ESBL/AmpC-producing E. coli among humans 
on organic broiler farms. Overall, 18.5% (95% CI 6.3-38.1) of humans living and/or working 
on four broiler farms were ESBL/AmpC-positive, which is higher than in the general Dutch 
population (5.1%; [7]). At T1, positive humans were present on 37.5% of farms, which is 
similar to the percentage on conventional farms (42.0%, P=1.0). The prevalence of positive 
humans at T1 (three humans from three different farms) on organic broiler farms (11.1%; 95% 
CI 2.4-29.2) was also comparable (P=0.22) to conventional broiler farms (19.1%, [5]). Given 
the similarities in prevalence, risk factors are assumed to be comparable to those found for 
conventional farms. There, an increased risk of carriage was shown among individuals having 
a high degree of contact with live broilers [5]. 
ESBL/AmpC-genes identified in humans were bla
CMY-2 
(n=3), bla
CTX-M-1
 (n=1), and promotor 
mutants (n=1). Similar to studies on conventional farms, bla
CTX-M-15, 
the most predominant 
gene found in humans in the Netherlands [12], was not found in humans on organic farms. It 
appears that the presence of ESBL/AmpC-producing E. coli in humans can be both persistent 
and intermittent, as only one farmer was positive at both T1 and T2. This individual had the 
same gene (bla
CMY-2
), located on the same plasmid family (IncI1), in an E. coli with the same ST 
(ST131) at both sampling times. Persistent carriage has been shown before in a longitudinal 
study among travellers who were positive for ESBL-producing Enterobacteriaceae up to 
6 months post-travel [18]. In contrast to Huijbers et al. [5], clonal transfer of ESBL/AmpC-
producing E. coli between humans and broilers was not shown. This might be related to the 
low number of organic broiler farms existing in the Netherlands, resulting in fewer isolates 
from broilers and humans and a decreased chance of observing clonal transfer. Dierikx et al. 
[3] also did not find evidence of clonal transfer on 26 conventional farms, however. Horizontal 
transfer was suspected as similar ESBL/AmpC-genes and plasmid families were found among 
broiler and human isolates in both the current study and the studies by Dierikx et al. [3] 
and Huijbers et al. [5]. On one farm, a farmer and a family member showed the same E. coli 
ST (ST95) with bla
CMY-2
 on an IncI1 plasmid at different sampling times. The family member 
reported no contact with live broilers and rarely entered the broiler house, therefore it can 
be speculated that transmission occurred between family members. However, transmission 
via the farm environment, which has been previously shown to be contaminated with ESBL/
AmpC-producing E. coli [19], should also be considered. MLST of isolates from phylogenetic 
groups B2
3
 yielded two different sequence types: ST131 (n=2) and ST95 (n=2). The isolates 
with ST131 harboured bla
CMY-2 
as shown in broilers, but these were not animals from the 
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same farm. Group D
2
 isolates showed ST117 (n=1). E. coli ST117, found both in broilers and 
humans in the current study, has been previously associated with hospitalised patients and 
retail chicken meat [17]. Unfortunately the authors do not specify whether this is meat 
originating from chickens raised on organic or conventional farms. Zoonotic potential has 
been suggested for E. coli with ST95, ST117 and ST131 as both avian pathogenic (APEC) and 
human extra-intestinal (ExPEC) E. coli strains have been shown to belong to these clonal 
groups [20,21]. Furthermore, similarity in virulence traits, and the ability of certain APEC 
and human ExPEC strains to cause disease in a murine and avian models, respectively, lend 
support to this hypothesis [21].
Table 1. Characteristics of β-lactamase genes and plasmid families present in E. coli isolates from 
broilers, farmers, family members and employees at sampling times T1 and T2.
Farm_
time
Source
Phylogenetic 
group
E. coli ST Clonal 
complex
β-lactamase genes 
(PCR and sequencing)
Replicon type of 
plasmid with ESBL/
AmpC-genef
1_T1 Farmer A
1
  Promotor mutanta  
Farmer B2
2
  Promotor mutanta  
Broiler B1
1
bla
CMY-2
Broiler B2
3
131 bla
CTX-M-1
Broiler B1
1
bla
CTX-M-1
Broiler B1
1
bla
CMY-2
1_T2 Broiler B1
1
bla
CTX-M-1
Broiler B1
1
bla
CTX-M-1
Broiler B1
1
bla
CMY-2
2_T1 Broiler D
2
117 bla
CMY-2
Broiler B2
3
131 bla
CTX-M-1
Broiler B1
1
bla
CTX-M-1
2_T2 Broiler B1
1
bla
CTX-M-1
Broiler D
2
117 bla
CMY-2
Broiler B2
3
131 bla
CTX-M-1
3_T1b Broiler D
2
bla
CTX-M-1
Broiler A
0
93 ST168 bla
CTX-M-1
Broiler D
2
93 ST168 bla
CTX-M-1
Broiler D
2
648 bla
CTX-M-1
Broiler D
2
bla
CTX-M-1
3_T2 Farmer D
2
117  bla
CTX-M-1
 NT
Farmer A
0
1818 bla
CTX-M-1
Broiler A
1
bla
CTX-M-1
Broiler D
2
93 ST168 bla
CTX-M-1
Broiler D
2
648 bla
CTX-M-1
incI1
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Farm_
time
Source
Phylogenetic 
group
E. coli ST Clonal 
complex
β-lactamase genes 
(PCR and sequencing)
Replicon type of 
plasmid with ESBL/
AmpC-genef
4_T1 Farmer B2
3
131  bla
CMY-2
incI1
Broiler B1
1
bla
CTX-M-1
Broiler A
0
bla
CMY-2
incI1
4_T2 Farmer B2
3
131  bla
CMY-2
incI1
Broiler A
0
bla
CMY-2
d 
Broiler A
0
bla
CMY-2
NT
Broiler A
0
bla
CMY-2
Broiler D
1
Unknownc1 bla
CMY-2
NT
5_T1 Broiler B1
1
bla
CTX-M-1
Broiler B1
1
bla
CTX-M-1
Broiler B2
3
429 bla
CMY-2
5_T2 Broiler B1
1
bla
CTX-M-1
Broiler B2
3
429 bla
CMY-2
6_T1 Farmer B2
3
95 ST95 bla
CMY-2
incK
Broiler A
1
bla
CTX-M-1
; bla
TEM-1b
e 
Broiler B1
1
bla
CTX-M-1
Broiler A
1
bla
CTX-M-1
6_T2 Family B2
3
95 ST95 bla
CMY-2
incK
Broiler B2
3
131 bla
CMY-2
Broiler B2
3
bla
CTX-M-1
Broiler A
1
bla
CTX-M-1
Broiler B2
3
131 bla
CMY-2
incK
Broiler A
0
bla
CTX-M-1
7_T1 Broiler B1
1
bla
CTX-M-1
Broiler A
0
bla
CTX-M-1
; bla
TEM-1b
e
Broiler B1
1
bla
CTX-M-1
7_T2 Broiler D
1
Unknownc2 bla
CTX-M-1
d
 1mm
Broiler D
2
155 bla
CTX-M-1
8_T2 Broiler B2
3
bla
TEM-52
d 1mm
Broiler D
2
569 bla
CMY-2
Broiler D
1
69 bla
CMY-2
Broiler D
1
69 bla
CMY-2
a Positions of mutations in AmpC promoter region: −42T−18A−1T+58T+81G.
b Farmer reported treatment of an unspecified bacterial infection with antibiotics during the production cycle.
c1 MLST results: adk6, fumC23, gyrB44, icd11, mdh361_1mm, purA239, recA7 (mm = mismatches). c2 MLST results: 
adk337_2mm, fumC100_5mm, gyrB266_2mm, icd158, mdh118, purA16_1mm, recA107. 
d One CMY-2 isolate has a non-synonymous mutation; A736T (S246C). In addition, one CTX-M-1 isolate was found 
with a mutation (C741T) and one TEM-52 isolate had a mutation (C228T). Both are synonymous mutations.
e With the primers used in this study no distinction was made between TEM-1b and TEM-198, however for readability 
of the Table, TEM-1b was inserted.
f NT = Plasmid typing was unsuccessful, no transformants were obtained.
Table 1. Continued
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Conclusion
MRSA was not detected in broilers or humans on Dutch organic broiler farms. In contrast, 
ESBL/AmpC-producing E. coli were detected in broilers on all farms, with a prevalence of 
≥80% at the sample-level and in 18.5% of humans. Given the higher prevalence of ESBL/
AmpC-producing E. coli among humans living and/or working on organic farms compared 
to the general Dutch population and similarity to the prevalence in humans on conventional 
farms, contact with live broilers could also be a risk factor for carriage on organic farms. 
Farm- and sample-level prevalence of MRSA and ESBL/AmpC-producing E. coli in broilers 
at T1 are consistent with those from conventional farms. Sample-level prevalence of ESBL/
AmpC-producing E. coli in broilers appears to have decreased at T2, however. Fewer positive 
animals entering the slaughterhouse might lead to retail meat that is less contaminated. 
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Abstract
Extended-spectrum and AmpC β-lactamase-producing Escherichia coli (ESBL/AmpC-EC) 
are found throughout the broiler production chain. Transmission of resistance between 
broilers and humans could occur at any point, representing a potential public health issue. 
Insight in farm transmission dynamics could provide a basis for control, leading to fewer 
contaminated broilers. The aim was to quantify transmission rates and routes of ESBL/
AmpC-EC, and specific phylogenetic groups, in an organic broiler flock without antibiotic 
use. In each of two consecutive production rounds, 80 randomly chosen broilers were 
followed individually. Cloacal swabs from these, 20 other randomly chosen broilers, and 
11 environmental samples were taken at several moments from arrival till slaughter age. 
ESBL/AmpC-EC were isolated by selective pre-enrichment, and ESBL/AmpC-genes, E. coli 
phylogenetic groups and sequence types were determined. Transmission parameters 
(β) were estimated using a Generalised Linear Model with a susceptible-infectious-
susceptible model. Effect of direct broiler contact as compared to contact through 
the environment and previous infection status (yes/ no) were included as explanatory 
variables. The reproduction ratio (R) was calculated by multiplying β with the length of 
the infectious period. On day 1, prevalence was 28.8% (95%CI 19.2-40.0%) and 0.0% 
(95%CI 0.0-4.5%) among individually followed broilers, in round 1 and 2 respectively. 
In round 2, the environment was positive before arrival of day-old chicks. After 3 days, 
almost 100% of broilers and environmental samples were positive in both rounds. Most 
samples were positive for CTX-M-1 group genes, and A1 and B1 were the predominant 
phylogenetic groups. From day 3 there was a shift towards more phylogenetic groups 
and sequence types. R was 1.70 (95%CI 0.55-5.25) for total ESBL/AmpC-EC. Risk for an 
individual to become infected was lower if it had been infected previously (β
previously infected 
=0.02 vs. β
not previously infected 
=3.41; P<0.0001). For phylogenetic groups separately, R was 
0.88 (95%CI 0.38-2.07), 0.51 (95%CI 0.27-0.98), 0.99 (95%CI 0.65-1.51) for A1, B1 and 
rest (i.e. A0, B2, D1, D2) groups, respectively. When broilers were not previously infected, 
the environment was relatively more important for transmission of the A1 group, while 
this was direct contact between broilers for the B1 group. Positive day-old chicks and 
the environment both play a role in introduction and transmission of ESBL/AmpC-EC in 
flocks. These results suggest that, even without selective pressure from antibiotics, total 
ESBL/AmpC-EC persistence, and resulting endemic situation, seem to be caused by shifts 
in infections by different phylogenetic groups. It implies that contaminated broilers enter 
the slaughterhouse.
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Introduction
High prevalences of extended-spectrum β-lactamase and AmpC β-lactamase-producing 
Escherichia coli (ESBL/AmpC-EC) are reported in broiler (great) grandparent stock [1-5], on 
broiler farms [1,6-8], at the slaughterhouse [9], and in retail meat [2,10]. It is hypothesised 
that particular ESBL/AmpC-EC clones, or plasmids carrying β-lactamase genes, are introduced 
through breeding stock, and transmit through the broiler production chain, also in the 
absence of known selective antibiotic pressure [2,3]. This could present a threat for public 
health, as transmission of ESBL/AmpC-EC might occur between broilers and humans at any 
point in the production chain. ESBL/AmpC-mediated resistance transmitted in that way could 
complicate treatment of human bacterial infections [11]. Quantification of transmission may 
be a first step in further understanding the apparent persistence of ESBL/AmpC-EC in the 
broiler production chain, even in absence of antibiotic use.
Transmission can be expressed quantitatively by the basic reproduction ratio (R
0
), which is 
defined as the expected number of secondary cases caused by one typical infected individual 
during its entire infectious period in a completely susceptible population [12]. If R
0 
is less 
than one, major outbreaks or persistence of the infectious agent in the population is never 
possible, whereas when R
0 
is larger than one major outbreaks may occur, possibly leading to 
persistence [13]. Longitudinal field studies have been used before to quantify transmission 
of antibiotic resistance, for example of methicillin-resistant Staphylococcus aureus (MRSA) in 
pigs [14]. Longitudinal studies have been conducted measuring ESBL/AmpC-EC prevalence 
[1,15], however no such study has been conducted on an organic broiler farm, and no attempt 
has been made to quantify transmission. ESBL/AmpC-EC have been isolated from broilers and 
the broiler house environment on conventional farms [1,15], suggesting that both direct and 
indirect routes might play a role in transmission. The aim of the current study was, therefore, 
to quantify transmission rates for different routes of ESBL/AmpC-EC transmission. Broilers, 
tagged to allow individual tracking, were followed from arrival till slaughter age, on an organic 
broiler farm. Positive tested samples were further characterised with respect to ESBL/AmpC-
genes and E. coli genotypes for subsequent calculation of transmission rates for total ESBL/
AmpC-EC, and specific phylogenetic groups separately.
Material and methods
Farm selection and sampling
From 11 June – 11 November 2013 a longitudinal study was conducted during two consecutive 
production rounds on an organic broiler farm, where a production round was defined as the 
period from arrival of day-old chicks until slaughter. The farm was selected out of a total of 9 
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organic broiler farms present in The Netherlands in 2013, according to the following criteria: 
more than one year organic production, no other livestock species present on the farm, and 
convenience of geographic location. On this farm there were two separate broiler houses 
with approximately 4800 individuals each. There were two age groups, but per house only 
broilers of the same age were present. No medication was used during either production 
round. From day 42 of age until slaughter age (approximately 70 days), broilers were allowed 
access to the outdoor pasture. Between rounds the broiler house was left empty for 7 days, 
during which time litter and faeces were removed mechanically, and it was cleaned with a 
high pressure water hose. 
Upon arrival in the broiler house (day 1) in each production round, 80 broilers were 
randomly selected and labelled for individual tracking by applying a tag to the neck skin 
with a textile gun and nylon thread (QuickTag Fine Gauge Mk3 Long Needle Gun, Roxan 
Developments Ltd., United Kingdom). The number of broilers used was based on an expected 
prevalence of 5.0% in day-old chicks, an estimate obtained by sampling day-old chicks from 
the same farm prior to starting the current study, 95% confidence, and 5% absolute precision. 
The sample size was corrected for an estimated 10% loss to follow-up. Cloacal swabs from 
broilers with tag, randomly selected broilers without tag, environmental wipes from feeding, 
drinking water, and heating systems, and air samples from the broiler house were taken 
between arrival on the farm (day 1) and slaughter age (day 70): 7 times in round 1 (day 1, 3, 4, 
7, 10, 42, and 70), and 4 times in round 2 (day 1, 2, 3, 70). The exception was day 70 in round 
2 where a random selection of 100 broilers was taken because tags were no longer visible 
for identification. An overview of the types and numbers of all collected samples is given in 
Tables 1 and 2. Due to the large difference in prevalence on day 1 in round 1 between the 80 
broilers with tag and 20 randomly chosen broilers without tag (28.8% vs. 5.0%), it was decided 
to investigate the effect of tagging in round 2. Cloacal swabs were taken from 80 randomly 
selected broilers before and after tagging. The same was done for 20 extra randomly chosen 
broilers using the textile gun without nylon threads. Due to the high prevalence of ESBL/
AmpC-EC on day 3 in round 1, it was decided to sample day 2 in round 2 (Table 2).
The current study was conducted in accordance with the Dutch Law on Animal Health 
and Welfare, and approved by the Animal Welfare Committee of Wageningen University 
(registration code 2012110.b).
Microbiological examination
Bacteria were isolated from cloacal swabs, human faecal swabs, and environmental wipes by 
selective enrichment (Luria-Bertani broth with 1 mg/L cefotaxime), and culture on selective 
plates for 18h at 37˚C (MacConkey agar no. 3 with 1 mg/L cefotaxime). For broiler faeces, the 
paper lining of the transport box, soil, feed and litter samples initial suspensions were made by 
making a 10-1 dilution in Luria-Bertani broth, and homogenising using a pulsifier for 1 minute. 
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Subsequently, 100µl of the suspension was streaked onto selective plates (MacConkey agar 
no. 3 with 1 mg/L cefotaxime), and cultured for 18h at 37˚C. Oxidase and indole tests were 
performed on isolates with an E. coli-like morphology. Isolates were suspected to be E. coli 
when the oxidase test was negative and the indole test was positive. After day 1 of round 
1 it appeared that indole negative isolates were also E. coli, therefore only oxidase positive 
isolates were excluded from that point onwards. E. coli-like isolates (range 1-4 isolates per 
sample) were then tested phenotypically for ESBL-production by combination disc-diffusion 
test according to CLSI guidelines [16]. A cefoxitin disc was used to detect AmpC phenotypes.
Subsequently, E. coli phylogenetic groups were determined for all isolates with an ESBL/
AmpC-phenotype according to Clermont et al. [17] and Escobar-Páramo et al. [18]. E. coli 
were confirmed in isolates that were negative for all three amplicons using matrix-assisted 
laser desorption ionisation-time of flight. β-Lactamase-genes were identified in all isolates 
with an ESBL/AmpC-phenotype by using group specific primers for the detection of TEM, 
SHV and OXA-1-like genes (Multiplex I); CTX-M group 1, group 2 and group 9 genes (Multiplex 
II); and CIT genes as specified by Dallenne et al. [19]. A selection of CTX-M group 1 positive 
isolates (n=29) was sequenced and bla
CTX-M-1
 was identified in these isolates. When isolates 
with an AmpC-phenotype were negative in the CIT and both multiplex PCRs these were 
excluded from analysis. Multilocus sequence typing (MLST) of E. coli was performed on a 
selection of isolates from round 1 and 2, according to Wirth et al. [20]. In round 1, MLST was 
performed on all day 1 isolates that did not originate from broiler cloacal swabs i.e. isolates 
from air inside the broiler house, broiler faeces, transport box paper lining, delivery van, 
and the sample collector (n=31), on a random selection of day 1 isolates from broilers with 
and without tag (45/72), and on a random selection of isolates (142/206) from 20 randomly 
selected broilers with tag. In round 2, MLST was performed on all day 1 isolates that did not 
originate from broiler cloacal swabs i.e. isolates from environmental wipes inside the broiler 
house, transport box paper lining, delivery van, and the sample collector (n=21), and on an 
isolate from the only positive broiler (without tag) on day 1 (n=1).
Quantification of transmission
A susceptible-infectious-susceptible (SIS-)model [14,21] was used to quantify transmission of 
total ESBL/AmpC-EC and for separate phylogenetic groups within the study population. In this 
model, the transmission rate parameter, β, is the average number of cases caused by a typical 
infected individual in a totally susceptible population per unit of time. 
For each sampling moment, a broiler was classified infected (I) if at least one isolate 
recovered from a cloacal swab was positive for E. coli and an ESBL/AmpC-gene, and susceptible 
(S) if the cloacal swab tested negative. Broilers were also classified as infected or susceptible 
for A1, B1 and rest (i.e. A0, B2
3
, D1, D2) phylogenetic groups separately. Missing values were 
animals that died or could not be traced due to invisible or missing neck tags. Based on 
this, three variables were determined for each time interval (Δt): the number broilers that 
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were classified as infected (I) (and the total number sampled) at the start of the interval, 
the number of tagged susceptible animals (S) at the start of the interval, and the number 
of new cases (C) among the tagged broilers, i.e. those that are susceptible at the beginning 
of the interval and are positive at the end of the interval. This was determined separately 
for individuals previously and not previously infected. Underlying assumptions were: (1) 
all broilers were in random contact, (2) all individuals were equally susceptible when not 
infected and (3) infected individuals were equally infectious over time.
The number of new cases can only be determined for the tagged animals but their infection 
can be caused by any of the animals in the flock or any part of the environment of the broiler 
house. Therefore, based on the method of Broens et al. [14], total infection pressure (IPtotal) 
was introduced, and calculated as the sum of the proportion of infected (tagged plus random) 
broilers (IPbroiler), and the proportion of all environmental samples that were positive (i.e. air 
samples and environmental wipes from feed, water and heating systems; IP
environment
). The 
number of new cases (C) per time interval (Δt) depends on β
environment
 and βbroiler, the number of 
susceptible individuals (S), and total infection pressure (IPtotal). Infected (I) individuals become 
susceptible again at recovery rate, α (Figure 1).
1 
 
 
 
 
 
 
Figure 1. SIS-model used to quantify ESBL/AmpC-EC transmission rates. β, transmission 
parameter; S, susceptible individuals; IPtotal, total infection pressure; I, infected individuals; α, 
recovery rate. 
Susceptible Infected 
       βbroiler*S*IPtotal 
α*I 
βenvironment*S*IPtotal 
Figure 1. SIS-model used to quantify ESBL/AmpC-EC transmission rates. β, transmission parameter; S, 
susceptible individuals; IPtotal, total infection pressure; I, infected individuals; α, recovery rate.
Similar to Broens et al. [14], the probability for each broiler to become infected during 
a time period Δt depends on β
environment
, βbroiler, IPtotal, and is equal to: 1 – e
–β*IPtotal*Δt. From 
this probability, it can be shown that the number of new cases (C) in a period Δt follows 
a binomial distribution with parameter 1 – e–β*IPtotal*Δt and binomial total S, the number of 
tagged susceptible individuals at the start of each time period (Δt). Consequently, the relation 
between the expected number of cases per unit of time (E(C)) and the transmission rate β, 
IPtotal, and the number of susceptibles is as follows [14,22]: 
E (C) = S * (1 – e–β*IPtotal*Δt) (1)
 
The data were analysed with SAS 9.2 [23] using a Generalised Linear Model with a 
complementary log-log link function, the term log (IPtotal * Δt) as offset variable, C as the 
number of new cases, and S as the number of trials in the binomial process. The relation 
between the expected (E) value of a number of new cases out of a number of susceptibles 
during a time period Δt is presented in the following basic statistical model:
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cloglog (E C/S) = log (β) + log (IPtotal * Δt) (2)
Exponentiation of the estimated parameter log(β), gives the transmission rate parameter β. 
The reproduction ratio, R, can then be calculated by multiplying β with the average length 
of the infectious period (T), which was estimated from the data. For round 2, R could not be 
calculated due to the small number of available data points.
To quantify the relative effect of transmission through direct contact with broilers 
compared to total transmission through direct contact and via the environment, a continuous 
explanatory variable was included in the model. This variable (pIP) was calculated as IPbroiler 
divided by IPtotal. Another explanatory variable (‘previnf’) was added describing whether or 
not broilers were infected (yes or no) during a previous time period. The full model is as 
follows:
 
cloglog (E C/S) = C0 + C1 (pIP) + C2 (previnf) + C3 (pIP * previnf) + log (IPtotal * Δt) (3)
where C0 is the intercept, and C1 and C2 are the regression coefficients for the two explanatory 
variables, and C3 for their interaction. It follows that the transmission rate parameters for 
the two routes (broiler or environment) and previous infection status (yes or no) can be 
calculated as follows:
β
environment,not previously infected
  = eC0 
β
broiler,not previously infected
         = eC0+C1
β
environment,previously infected
      = eC0+C2
β
broiler,previously infected
             = eC0+C1+C2+C3 (4)
First, the analysis was done without explanatory variables (intercept only model) to estimate 
the reproduction ratio for ESBL/AmpC-EC total, and for the A1, B1 and rest phylogenetic 
groups separately. Secondly, the analysis including explanatory variables was done. Variables 
with P>0.05 were removed from the model, and in case both variables remained in the model 
the interaction term was tested and considered significant at P<0.05.
Results
ESBL/AmpC-EC prevalence and ESBL/AmpC-genes
In round 1, the prevalence of ESBL/AmpC-EC was 28.8% (95% CI 19.2-40.0%) in broilers with 
tag, and 5.0% (95% CI 0.1-24.9%) in broilers without tag within two hours after arrival at 
the broiler farm (Table 1). At day 3 these percentages were 98.8% (95% CI 93.2-100.0%), 
and 100% (95% CI 83.2-100.0%) respectively. Prevalence at slaughter (day 70) was 39.4% 
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(95% CI 27.6-52.2%) in broilers with tag, and 25.0% (95% CI 8.7-49.1%) in broilers without 
tag. Except for one broiler with tag that was found positive at every sampling in round 1, 
broilers showed intermittent carriage. Upon arrival at the farm in round 2, ESBL/AmpC-EC 
was not detected in any broiler with tag (95% CI 0.0-4.5%), and in 5.0% (95% CI 0.1-24.9%) 
of broilers without tag (Table 2). Before tagging the prevalence was higher (5.0%) than after 
tagging (0.0%), but not significantly different (P=0.06), so the hypothesis that tagging results 
in higher prevalence of ESBL/AmpC-EC was rejected. On day 2, prevalences were 74.7 (95% 
CI 63.6-83.8%) in broilers with tag, and 65.0 (95% CI 40.8-84.6%) in broilers without tag. On 
day 3 these were 9l.1% (95% CI 82.6-96.4%) and 90.0% (95% CI 68.3-98.8%), respectively. At 
slaughter, the prevalence was 81.0% (95% CI 71.9-88.2%). 
Table 1. Types and numbers of collected samples, and prevalence of ESBL/AmpC-EC in production 
round 1.
Day Sample descriptiona Total collected Positive Prevalence (%)
1 Broiler without tag 20 1 5.0
Broiler with tag 80 23 28.8
Air broiler house 6 5 83.3
Feed, water, heating system broiler house 5 0 0.0
Broiler faeces 1 1 100.0
Transport box 3 3 100.0
Delivery van 2 2 100.0
Sample collector 3 1 33.3
Residence farmer 4 0 0.0
3 Broiler without tag 20 20 100.0
Broiler with tag 80 79 98.8
Air broiler house 6 6 100.0
Feed, water, heating system broiler house 5 5 100.0
Broiler faeces 2 2 100.0
4 Broiler without tag 20 20 100.0
Broiler with tag 78 76 97.4
Air broiler house 6 4 66.7
Feed, water, heating system broiler house 5 5 100.0
Broiler faeces 1 1 100.0
7 Broiler without tag 20 18 90.0
Broiler with tag 75 69 92.0
Air broiler house 6 4 66.7
Feed, water, heating broiler house 5 5 100.0
Broiler faeces 1 1 100.0
10 Broiler without tag 20 15 75.0
Broiler with tag 73 61 83.6
Air broiler house 6 4 66.7
Feed, water, heating system broiler house 5 5 100.0
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Day Sample descriptiona Total collected Positive Prevalence (%)
Broiler faeces 2 2 100.0
Sample collector 3 1 33.3
Residence farmer 4 0 0.0
42 Broiler without tag 20 3 15.0
Broiler with tag 68 13 19.1
Air broiler house 6 0 0.0
Feed, water, heating system broiler house 5 5 100.0
Broiler faeces 2 2 100.0
Soil free-range pasture 3 0 0.0
Sample collector 3 1 33.3
Residence farmer 4 0 0.0
70 Broiler without tag 20 5 25.0
Broiler with tag 66 26 39.4
Air broiler house 6 0 0.0
Feed, water, heating system broiler house 5 3 60.0
Broiler faeces 2 2 100.0
Soil free-range pasture 3 1 33.3
Sample collector 3 1 33.3
a Air: selective plates containing cefotaxime spread out over three locations, and left open for one hour in broiler 
house. Feed, water, heating system: environmental wipes taken from feeding system (front and back, three feeders 
per wipe), drinking water system (front and back, ten nipples per wipe), and heating system (top) in broiler house. 
Faeces: fresh, collected from floor of broiler house. Delivery van: environmental wipes from cargo area. Transport 
box: faeces from paper lining at bottom of box. Soil: free-range pasture in front of broiler house, halfway and back (9 
cores each location). Sample collector: faecal swab from individuals taking samples. Residence farmer: environmental 
wipes from dog, TV remote control, favourite armchair, and door handle inside and outside of residence.
The number of positive environmental wipes from feeding, drinking water, and heating 
systems and air samples from the broiler house varied between rounds and sampling times, 
from no positive samples to all samples positive. Prevalence of ESBL/AmpC-EC in broiler 
faeces, the delivery van, transport boxes, and soil from the outdoor pasture also varied 
between rounds and between sampling times (Tables 1 and 2). In round 2, samples collected 
from the heating system, and the floor of both the broiler house, and hygiene barrier were 
already positive before arrival of the broilers. ESBL/AmpC-EC were not detected at the farm 
residence in round 1. One sample collector was positive throughout round 1, and at the 
beginning of round 2.
Isolates that were positive for CTX-M-1 group genes were obtained from most broiler 
samples and samples from other sources in both round 1 and 2. In round 1, isolates from 
one broiler were all negative in the CIT and both multiplex PCR’s, and considered ESBL/
AmpC-positive, because the E. coli isolates expressed an ESBL-phenotype. In round 2, one 
broiler had CIT genes only, and isolates from two broilers and two broiler house samples 
Table 1. Continued
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were all negative in the CIT and both multiplex PCR’s. Isolates obtained from the latter PCR 
negative samples showed an AmpC-phenotype. These were excluded from analysis because 
chromosomal mutations might be involved, and the focus was on plasmid-located genes. 
Table 2. Types and numbers of collected samples, and prevalence of ESBL/AmpC-EC in production 
round 2.
Day Sample descriptiona Total collected Positive Prevalence (%)
1 Broiler without tag (before)b 20 1 5.0
Broiler without tag (after)b 20 0 0.0
Broiler with tag (before)c 80 0 0.0
Broiler with tag (after)c 80 0 0.0
Air broiler house (before)d 6 0 0.0
Air broiler house (after)d 6 0 0.0
Environmental wipes broiler housee 11 4 36.4
Feedf 1 0 0.0
Litterf 1 0 0.0
Transport box 2 1 50.0
Delivery van 2 2 100.0
Sample collector 3 1 33.3
2 Broiler without tag 20 13 65.0
Broiler with tag 79 59 74.7
Air broiler house 6 2 33.3
Feed, water, heating system broiler house 5 5 100.0
Broiler faeces 1 1 100.0
3 Broiler without tag 20 18 90.0
Broiler with tag 79 72 91.1
Air broiler house 6 4 66.7
Feed, water, heating system broiler house 5 5 100.0
Broiler faeces 1 1 100.0
70 Broiler without tag 100 81 81.0
Air broiler house 6 1 16.7
Feed, water, heating system broiler house 5 5 100.0
Broiler faeces 2 2 100.0
Soil free-range pasture 3 1 33.3
a Environmental wipes, transport box, delivery van, sample collector, soil and faeces samples taken as in round 1.
b Cloacal swabs taken before and after use of textile gun without nylon threads.
c  Cloacal swabs taken before and after use of textile gun for application of neck tags.
d Air samples taken before and after arrival of day-old chicks i.e. first set of selective plates containing cefotaxime 
opened for half an hour before arrival of chicks, and second set of selective plates opened for half an hour after 
arrival of chicks in broiler house.
e All day 1 environmental wipes taken in broiler house before arrival of chicks at following locations: feeding system, 
drinking water system, and heating system. Additional wipes taken from broiler house (i.e. floor, wall, separation 
curtain, inside of heating system), and from hygiene barrier attached to broiler house (i.e. floor, farmer’s boots).
f Feed and litter were taken from inside the broiler house before arrival of the chicks.
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E. coli phylogenetic groups and sequence types 
The predominant E. coli phylogenetic groups in broilers with and without tag, environmental 
wipes from feed, water and heating systems, and air samples taken inside the broiler house 
throughout round 1 and 2 were A1 and B1 (Table 3). The predominant E. coli sequence types in 
isolates further characterised by MLST were ST10 and ST88, belonging to the A1 phylogenetic 
group, and ST58 and ST155, belonging to the B1 phylogenetic group (Tables 4 and 5). E. coli 
with different phylogenetic groups could be isolated from the same sample on the same day. 
From day 3, there was a shift towards more different groups (Table 3). Furthermore, none of 
the 20 randomly selected broilers out of 80 with tag from round 1 were positive for the same 
E. coli sequence type at all sampling times (Table 5).
Table 3. E. coli phylogenetic groups per day in broiler and broiler house samples in round 1 and 2.
Round Day Samplea n
Prevalence (%)
Totalc A1 A0 B1 B2
3
D1 D2
1 1 Broiler 100b 24.0 24.0 0.0 2.0 1.0 0.0 0.0
House 11 45.5 45.5 0.0 0.0 0.0 0.0 0.0
3 Broiler 98 99.0 89.8 0.0 29.6 1.0 12.2 2.0
House 11 100.0 90.9 0.0 45.5 0.0 27.3 0.0
4 Broiler 95 97.9 84.2 0.0 34.7 0.0 9.5 2.1
House 11 81.8 63.6 0.0 27.3 0.0 18.2 0.0
7 Broiler 93 92.5 84.9 0.0 17.2 0.0 8.6 2.2
House 11 81.8 63.6 0.0 27.3 0.0 27.3 0.0
10 Broiler 87 81.6 63.2 0.0 13.8 0.0 6.9 8.0
House 11 81.8 81.8 0.0 9.1 0.0 0.0 0.0
42 Broiler 86 18.6 12.8 0.0 5.8 0.0 0.0 0.0
House 11 45.5 36.4 9.1 18.2 0.0 0.0 0.0
70 Broiler 86 36.0 10.5 0.0 5.8 0.0 0.0 23.3
House 11 27.3 9.1 0.0 27.3 0.0 0.0 0.0
2 1 Broiler 100 1.0 1.0 0.0 0.0 0.0 0.0 0.0
House 23 17.4 17.4 0.0 0.0 0.0 0.0 4.3
2 Broiler 99 71.7 69.7 1.0 14.1 2.0 1.0 1.0
House 11b 54.5 45.5 0.0 9.1 0.0 0.0 0.0
3 Broiler 99 89.9 79.8 1.0 35.4 1.0 0.0 3.0
House 11 72.7 72.7 0.0 54.5 0.0 0.0 0.0
70 Broiler 100b 81.0 75.0 3.0 18.0 1.0 0.0 0.0
House 13 61.5 53.8 0.0 15.4 7.7 0.0 0.0
a Broiler refers to cloacal swabs from broilers with and without tag. House refers to environmental wipes, and air 
samples taken inside the broiler house.
b One isolate with unknown phylogenetic group.
c Prevalences for individual phylogenetic groups do not add up to total because E. coli with different phylogenetic 
groups could be isolated from the same sample on the same day.
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In round 1, all tested samples from day 1 harboured at least one E. coli isolate that was 
identified as ST88 (Tables 4 and 5). The only exception was the sample collector, where only 
E. coli isolates with ST636 (B2
3
 phylogenetic group) were detected. In addition to being 
positive for ST88, broiler faeces, the paper lining at the bottom of the transport box, and 
environmental wipes from the delivery van were positive for ST155 (B1), ST106 (D2), and 
ST10 (A1) and ST58 (B1), respectively. While ST58 and ST155 were detected in broilers with 
and without tag on day 1, ST10 and ST106 were not detected in broilers with tag until day 
3. In round 2, all tested samples from day 1 also harboured at least one isolate with ST88. 
Environmental wipes from the heating system (new ST, A1; ST117, D2), and the floor of the 
hygiene barrier (ST43, A1) harboured sequence types that were not detected in round 1, 
however. 
Table 4. E. coli phylogenetic groups and sequence types in samples collected on day 1 in round 1 and 2.
Round Sample description
Phylogenetic 
group(s)
Sequence 
type(s)
1 Broiler without and with tag A1; B1; B2
3
88, 4358; 58, 155; 140
Air broiler house A1 88
Feed, water, heating system broiler house - -
Broiler faeces A1; B1 88; 155c
Transport box A1; D2 88; 106
Delivery van A1; B1 10, 88; 58
Sample collector B2
3 
636
Residence farmer - -
2a Broiler without tag A1 88
Air broiler house - -
Environmental wipes broiler houseb A1; D2 43, 88, new; 117
Transport box A1 88
Delivery van A1 88, nt
Sample collector B2
3
636
-, sample was ESBL/AmpC-negative; new, new sequence type; nt, non-typable.
a Due to the absence of fresh broiler faeces, none were collected.
b Heating system (ST88, ST117, new), floor broiler house (ST88), floor hygiene barrier (ST43). 
c Housekeeping gene adk 6 with one mutation, closest match is ST155.
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Table 5. E. coli sequence types per day from 20 broilers randomly selected from tagged broilers in round 
1.
Broiler ID
Day
1 3 4 7 10 42 70
K103a 88 10 10 10 10 - 155
K104a 88 10 106 10; 106 10; 155b - -
K105 88 10 10; 58 10; 106 10; 106 - 155
K106 - 155 nt 10 10 - -
K109 - 10; 3258 3258 10 3258 - 1551
K117 - 10 10 88 2485 - 88
K123 - 106 - 10 88 10 -
K128a - 10 10; 58 10; 155b - - 10
K133a 88; 4358 10; 58 10; 58 10 3258 - -
K140a - 10; 155 155 10; 155 155 - 1551
K142 - 10 10; 2001 10 3258 10 -
K147 88 10 10 10 - - -
K150 - 10; 155 88 10 10 - -
K155 - 10 88 - - - -
K157 - - 155 88; 155 155 155 155; 1551
K163 88 10; 58 58; 2001 88 58; 88 88 1551
K164 - 10; 58 10; 58 10 10 - -
K169 88 10; 155 10; 58 10 10 - 1551
K173 88; 155 10; 155 10 106 10 88 -
K179 - 88 10 - 10 - -
nt, non-typable; -, sample was ESBL/AmpC-negative.
a Randomly selected broilers where all collected isolates were typed to explore variation in ST within samples.
b Housekeeping gene adk 6 with one mutation, closest match is ST155.
Transmission quantification
Table 6 shows the model input summarised per interval for ESBL/AmpC-EC total, and for 
the A1, B1, and rest (i.e. A0, B2, D1, D2) phylogenetic groups separately, which was used for 
transmission quantification. The reproduction ratio for total ESBL/AmpC-EC, A1 group, B1 
group and rest group, respectively, was 1.70 (95% CI 0.55-5.25), 0.88 (95% CI 0.38-2.07), 0.51 
(95% CI 0.27-0.98), and 0.99 (95% CI 0.65-1.51) (Table 7).
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Table 6. Summarised model input used for estimation of transmission parameters for total ESBL/AmpC-
EC, and A1, B1 and rest phylogenetic groups.
ESBL/AmpC
Interval
(days)
Previously 
infected
Susceptible 
(S)
Cases
(C)a
Δt
(days)
IP
broiler
IP
environment
Total
1-3
No 57  56.5
2 0.24 0.45
Yes 0 0
3-4
No 1 1
1 0.99 1.00
Yes 0 0
4-7
No 0 0
3 0.98 0.82
Yes 2 2
7-10
No 0 0
3 0.92 0.82
Yes 5    3.5
10-42
No 0 0
32 0.82 0.82
Yes 11    1.5
42-70
No 0 0
 19.5
28 0.19 0.45
Yes 53
A1
1-3
No 57  52.5
2 0.24 0.45
Yes 0 0
3-4
No 5    2.5
1 0.90 0.91
Yes 1 1
4-7
No 3 3
3 0.84 0.64
Yes 10    9.5
7-10
No 0 0
3 0.85 0.64
Yes 11    6.5
10-42
No 0 0
32 0.63 0.82
Yes 20    2.5
42-70
No 0 0
28 0.13 0.36
Yes 57    4.5
B1
1-3
No 78  24.5
2 0.02 0.0
Yes 0 0
3-4
No 52  14.5
1 0.30 0.45
Yes 1 1
4-7
No 38    3.5
3 0.35 0.27
Yes 9    1.5
7-10
No 34    2.5
3 0.17 0.27
Yes 26    4.5
10-42
No 30    3.5
32 0.14 0.09
Yes 28    0.5
42-70
No 26    1.5
28 0.06 0.18
Yes 36    2.5
Rest
1-3
No 79  10.5
2 0.01 0.0
(A0, B2, D1 D2) Yes 0 0
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ESBL/AmpC
Interval
(days)
Previously 
infected
Susceptible 
(S)
Cases
(C)a
Δt
(days)
IP
broiler
IP
environment
3-4
No 67 7.5
1 0.15 0.27
Yes 1 0.5
4-7
No 57 5.5
3 0.12 0.18
Yes 9 1.5
7-10
No 50 5.5
3 0.11 0.27
Yes 15 2.5
10-42
No 41 0.5
32 0.15 0.0
Yes 17 0.5
42-70
No 40 8.5
28  0.006 0.09
Yes 26 9.5
Δt, time interval between samplings; IPbroiler, proportion of infected broilers; IP environment, proportion of positive 
environmental samples. 
a When C/S<1, 0.5 was added to the number of cases, and when I=0, 0.5 was added to the number of infected (I) 
animals.
Table 7. Transmission rate parameters (β) and reproduction ratios (R) with 95% confidence interval 
for total ESBL/AmpC-EC and A1, B1 and rest phylogenetic groups in round 1 from the ‘intercept only’ 
model.
ESBL/AmpC
Infectious
period (days)
β 
(day-1)
R 95% CI
Total 26.84 0.06 1.70 0.55-5.25
A1 18.44 0.05 0.88 0.38-2.07
B1   8.63 0.06 0.51 0.27-0.98
Rest (A0, B2, D1 and D2) 10.93 0.09 0.99 0.65-1.51
Effects of the relative effect of transmission through direct contact with broilers 
compared to total transmission through direct contact and via the environment (pIP), and 
previous infection status are shown in Table 8. For total ESBL/AmpC-EC, the effect of pIP 
was not significant (P=0.21), and the risk for an individual to become infected was lower if it 
was infected previously (β
previously infected 
=0.02 vs. β
not previously infected 
=3.41; P<0.0001). For the A1 
phylogenetic group there was significant interaction (P<0.0001) between pIP and previous 
infection status. The environmental route played a greater role when individuals were not 
previously infected (β
environment, not previously infected
=18.39 vs. β
broiler, not previously infected
=0.02), while the 
animal route played a relatively greater role when individuals were previously infected (βbroiler, 
previously infected
=982.50 vs. β
environment, previously infected
=2.73x10-6). For the B1 phylogenetic group there 
was also significant interaction (P<0.0001). In this case, however, the animal route played a 
relatively greater role when animals were not previously infected (β
broiler, not previously infected
=6.02 
vs. β
environment, not previously infected
=0.0004), and there was no effect of infection pressure from 
Table 6. Continued
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broilers when animals were previously infected (P=0.65). For the rest phylogenetic groups 
(i.e. A0, B2, D1, D2), the effect of previous infection was not significant (P=0.91). The relative 
proportion of infection pressure from broilers played a relatively smaller role than that from 
the environment (βbroiler=0.05 vs. βenvironment=0.16; P=0.001). 
Table 8. Estimates of transmission parameters and their 95% confidence for total ESBL/AmpC-EC and 
A1, B1 and rest phylogenetic groups in round 1.
ESBL/AmpC Transmission parameter Estimate (day-1)    95% CI P-values
Total β
not previously infected
3.41 1.91-6.11 <0.0001
β
previously infected
0.02 0.01-0.03 <0.0001
A1 β
environment, not previously infected
18.39 2.41-140.34   0.005
β
broiler, not previously infected
0.02 0.0007-0.69   0.015
β
environment, previously infected
2.73x10-6 1.63x10-7-4.56x10-5 <0.0001
β
broiler, previously infected
982.50 53.67-17985.64 <0.0001
B1 β
environment, not previously infected
0.0004 0.0001-0.001 <0.0001
β
broiler, not previously infected
6.02 3.71-9.77 <0.0001
β
environment, previously infected
0.03 0.006-0.14 <0.0001
β
broiler, previously infected
0.01 0.001-0.13   0.648
Rest β
environment
0.16 0.11-0.23 <0.0001
(A0, B2, D1, D2) βbroiler 0.05 0.03-0.08   0.001
Discussion
This is the first study to quantify transmission of ESBL/AmpC-EC in a broiler flock, and explore 
the effect of direct broiler contact relative to the environment on transmission. It is also 
the first longitudinal study on an organic broiler farm. A reproduction ratio of 1.70 for total 
ESBL/AmpC-EC indicates that it transmits and persists in the broiler flock. Interestingly, this 
does not hold true for individual phylogenetic groups as indicated by reproduction ratios 
less than one for groups separately. This might mean that total ESBL/AmpC-EC persistence 
is determined by repeated shifts from one phylogenetic group to another during the period 
between arrival at the farm and slaughter age. 
Although the prevalence in tagged broilers on day 1 in round 1 and 2 was considerably 
different (28.8% vs. 0.0%), the same general pattern in prevalence was seen in both 
production rounds, with a peak occurring around day 3, and a decrease towards slaughter 
age. Furthermore, the risk for an individual to become infected with ESBL/AmpC-EC was 
lower if it had been infected previously. An explanation for these results might be the 
acquisition of immunity to particular E. coli genotypes. Age dependent-susceptibility to E. 
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coli O157:H7 has been shown previously for broilers [24], but whether this also holds true 
for commensal E. coli populations has not been investigated to the authors’ knowledge. The 
genotypic data from the current study showed that the A1 phylogenetic group, or specifically 
ST88, predominated in broiler samples on day 1, and genotypes became more diverse from 
day 3 onwards. It can be speculated that this is a result of changes in the availability of niches 
for particular populations of E. coli, as the first weeks post-hatch are marked by changes 
in relative abundances of different bacterial species, and varies between compartments 
of the intestinal tract (i.e. duodenum, ileum, caecum; van der [25]). Horizontal transfer of 
CTX-M-1 group genes between E. coli of different phylogenetic groups and sequence types 
should also be considered as a potential explanation of the diversification of ESBL/Amp-
EC genotypes after day 3, as in situ experiments have shown that conjugation of plasmids 
still appeared without selective pressure from an antimicrobial agent [26]. The plasmids 
harbouring CTX-M-1 group genes were not investigated in the current study, but taking into 
account within-host dynamics of the bacterial population seems important in accurately 
describing the transmission dynamics of antibiotic resistant bacteria. Models combining this 
information with an epidemiological model representing the spread of resistance within the 
population could be a next step in understanding the apparent persistence of ESBL/AmpC-EC 
in the broiler production chain [27,28].
E. coli with ST88 were found at the end of production round 1 in broilers, and also in the 
broiler house at the beginning of round 2 before arrival of day-old chicks. This suggests that 
these particular E. coli can survive for prolonged periods of time outside their host, and might 
infect a new flock. In a survival experiment where bedding material and faeces from broilers 
were examined daily for concentrations of E. coli, it was shown that E. coli could survive for 
a minimum of 35 days (4.97x107 Colony Forming Units) under broiler house conditions and 
without addition of new faecal material [29], lending support to this idea. The MLST results 
are complemented by the results obtained from the model with explanatory variables, which 
show that the environment was relatively more important in the transmission of the A1 
phylogenetic group, to which ST88 belongs, and direct contact between broilers was relatively 
more important for the transmission of the B1 phylogenetic group, for those broilers that 
were not previously infected. ST58, belonging to the B1 phylogenetic group, was found in 
day-old chicks and the delivery van, but not in the broiler house environment on day 1 of 
round 1. Direct contact between broilers was relatively more important for transmission of 
the A1 phylogenetic group for broilers that were previously infected. This is also suggested 
by the MLST results which indicate a switch from ST88 on day 1 to ST10 on day 3. Due to the 
labour intensive nature of MLST only a small selection of isolates were typed, but using E. coli 
sequence types instead of phylogenetic groups will provide even more details on transmission 
dynamics. Together, these results suggest that the contaminated environment before the 
start of the production round and positive day-old chicks both play a role in the introduction 
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and transmission of ESBL/AmpC-EC in the new flock. Intervention strategies should focus on 
preventing the introduction of ESBL/AmpC-EC into the flock. Cleaning and disinfection of the 
broiler house and hygiene barrier between rounds reduces these bacteria in the environment 
[30], but in order to prevent their introduction by positive day-old chicks it is necessary to 
consider all previous steps in the broiler production chain, that is (great)grandparent and 
parent stock, and hatcheries. It is suggested that ESBL/AmpC-E. coli are introduced through 
breeding stock and that there is transmission through the production chain [3]. 
Following individual broilers in the current study provides a unique insight in ESBL/AmpC-
EC dynamics. Carriage of ESBL/AmpC-EC was intermittent in all broilers in the sense that 
no broiler was positive for ESBL/AmpC-EC with the same phylogenetic group or sequence 
type during the entire production round, which indicates how complex transmission of ESBL/
AmpC-EC actually is. Several factors should be taken into account when interpreting the 
results. Firstly, the length of the last two intervals in which measurements were taken, were 32 
and 28 days. This is long in comparison to the infectious period for total ESBL/AmpC-EC, and 
even more so in comparison to the infectious period for the individual phylogenetic groups, 
and perhaps also individual sequence types. Some cases (C), but also infected (I) individuals 
might have been missed during these intervals as individuals might have switched multiple 
times between susceptible and infected states. In a study modelling the epidemiology of 
Verocytotoxin-producing E. coli (VTEC) serogroups in young calves, it was shown that there 
is a difference in the rate at which different serogroups are lost from calves, with serogroups 
being divided into those with high and low recovery rate [31]. A higher recovery rate can 
reduce the total number of infections observed, and can have an impact on how often 
consecutive infections are observed [31]. Secondly, it should be taken into account that E. coli 
phylogenetic groups and sequence types were determined for a limited number of isolates 
(range 1-3) per positive sample. Analysis of multiple isolates from one tagged broiler showed 
two different sequence types (ST88 and ST4358) from the A1 phylogenetic group on the same 
day. This signifies that selection of a limited number of isolates might result in missing less 
dominant strains of ESBL/AmpC-EC, but perhaps also underestimating the number of ‘mixed’ 
infections. This was also observed in a study looking at VTEC in calves [31]. Lastly, from day 3 
onwards all oxidase negative isolates were included, instead of only those oxidase negative 
isolates that were also indole positive. It might be expected that this explains the increase 
in number of different phylogenetic groups from day 3, but the indole negative isolates 
belonged primarily to the A1 phylogenetic group (data not shown).
In conclusion, positive day-old chicks and the environment both play a role in the 
introduction and transmission of ESBL/AmpC-EC into the new flock. Furthermore, these 
resistant bacteria are able to transmit and persist in a broiler flock, even without selective 
pressure from antibiotics. The resulting endemic situation implies that contaminated broilers 
enter the slaughterhouse.
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Introduction
The aim of this thesis was to investigate the transmission of antibiotic resistant bacteria 
between animals and humans, and more specifically to investigate the transmission of ESBL-
producing Escherichia coli between broilers, and between broilers and humans in varying 
degrees of contact with broilers. This could help to elucidate the role of broilers in the 
transmission of antibiotic resistance to humans.
In this chapter the conclusions of the thesis are used to discuss the contribution of poultry 
to human carriage of ESBL-producing Enterobacteriaceae. Thereafter, transmission of ESBL-
producing Enterobacteriaceae between animals and humans, and between humans in the 
general population through other sources and pathways is examined. Finally, implications of 
the results, directions for future research, and the main conclusions of this thesis are given.
Contribution of poultry to human carriage of ESBL-producing Entero-
bacteriaceae
Clinically relevant antibiotic resistant (AMR) bacteria, that is ESBL-producing 
Enterobacteriaceae, methicillin-resistant Staphylococcus aureus, and vancomycin-resistant 
Enterococcus spp., are present in the natural environment, more specifically in soil, water, air 
and wildlife ([1]; Chapter 2). Examination of the vicinity of broiler farms showed that air 50 
m downwind and 100 m upwind of the broiler house, and soil surfaces 50 to 500 m from the 
broiler house are contaminated with ESBL-producing Enterobacteriaceae. Isolates originating 
from inside and outside the broiler house on the same farm showed 100% similarity by 
pulsed-field gel electrophoresis (PFGE; [2]). Furthermore, soil and flies on broiler farms, and 
surface water in the neighbourhood of these farms frequently contained ESBL-producing 
E. coli which were similar according to ESBL-gene, plasmid and sequence type to isolates 
obtained from broiler faeces on the same farm [3]. Individuals living close to broiler farms 
might, therefore, be exposed to ESBL-producing Enterobacteriaceae through the surrounding 
environment. Living in a municipality with high broiler density, however, did not increase the 
risk for carriage among humans in the general population. The overall high broiler density 
in the Netherlands (1301 broilers/km2) and mobility of individuals between municipalities 
and provinces may have disturbed a possible relationship between broiler density and ESBL-
carriage ([4]; Chapter 3). On the other hand, it is not known whether bacteria from poultry 
present in air, water, soil or wildlife can really infect humans.
All investigated Dutch broiler farms were positive for ESBL-producing E. coli, and these 
bacteria were highly prevalent on both conventional (85%, [5]; 100%, [6]; 96.4%, [7]; Chapter 
4) and organic (94.3%, [8]; Chapter 5) farms at 5 weeks of age, which is just before slaughter on 
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conventional farms. On organic farms, the sample level prevalence decreased to 39.4-81.0% 
at slaughter, which takes place at approximately 70 days of age ([8]; Chapter 5; Chapter 6). It 
should be noted that this decrease might also hold true for broilers on conventional farms if 
they would have a longer production round. Not only transmission via the environment, but 
close physical contact with broilers might, therefore, lead to increased risk for carriage of 
ESBL/AmpC-producing E. coli among humans. Prevalence of carriage among humans living 
or working on both conventional (33%, [5]; 19.1%, [7]; Chapter 4) and organic (18.5%; [8]; 
Chapter 5) broiler farms was higher compared to humans in the general population (5.1%; 
[4]; Chapter 3) and Dutch patients (4.9%; [9]). It was also shown that farmers and employees 
who spent more hours in the stable, had more physical contact with broilers, and performed 
more activities in the broiler house (e.g. weighing, vaccination, health checks) than their 
partners or family members, were more often positive (27.1% vs. 14.3%; OR=2.5; P=0.08). 
Furthermore, evidence for clonal transmission of ESBL-producing E. coli between humans 
and broilers on farms was found ([7]; Chapter 4). This suggests that there is an increased risk 
of exposure for humans on broiler farms, and that this is more pronounced for individuals in 
close contact with broilers. ESBL-producing E. coli are able to transmit and persist in a broiler 
flock, even without selection pressure from antibiotics, as indicated by a reproduction ratio 
of 1.70 for total ESBL/AmpC-producing E. coli on an organic broiler farm (Chapter 6). This 
suggests that broilers form a reservoir of antibiotic resistance genes for other flocks and 
humans living or working on these farms. 
The results from this thesis show that direct contact between humans, live broilers and 
the broiler farm environment, as experienced by people living or working on these farms, 
contributes to human carriage. To place this in perspective, however, there were 576 broiler 
farms in the Netherlands in 2014. Assuming that the average Dutch household size of 2.2 
individuals also applies to the farmers’ households, this means that 1267 individuals are 
living on broiler farms, which is only a very small percentage (0.009%; 1267/14875853) of 
the total Dutch population [10]. Therefore, the role of live broilers in the transmission of 
ESBL-producing E. coli to the general population is negligible. 
Transmission of ESBL-producing Enterobacteriaceae in the Dutch general 
population
Among the 99.99% of the Dutch general population without continuous exposure to broilers, 
5.1% are carriers of ESBL-producing Enterobacteriaceae (Chapter 3). The question is what 
other sources and pathways might play a role in the transmission of these resistant bacteria 
in the general population. Transmission between humans and other animal species, between 
humans, and to humans through travel abroad and consumption of food products will be 
discussed. 
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Transmission between humans and other animal species
Both occupational and domestic exposure to animals might play a role in transmission 
between humans and other animal species and will be discussed below.
Occupational exposure to animals
As with broilers, it can be speculated that transmission between and among humans, pigs, 
or cattle on farms might occur through direct contact or via the (farm) environment. Three 
studies have investigated carriage of ESBL-producing Enterobacteriaceae in humans living or 
working on pig farms. On two Danish pig farms, samples from three out of five people living 
or working on these farms were ESBL-positive. Human, animal, and environmental E. coli 
strains harboured indistinguishable or closely related IncN plasmids carrying bla
CTX-M-1
 [11]. On 
39 Danish pig farms, ESBL-producing E. coli were detected among 10% (19/195) of farmers, 
employees and residents on these farms. Overall, 70% (136/195) of individuals reported 
contact with pigs, and 18 out of 19 ESBL-positive individuals reported contact with pigs. For 
individuals having contact with pigs, the risk of being ESBL-positive was higher when ESBL-
producing E. coli were detected in the pigsties, compared to when they were not detected 
(15/72; 3/64; 21% vs. 5%; P=0.0056). ESBL-producing E. coli isolates with the same bla
CTX-M
, 
phylogenetic group, PFGE type and sequence type were detected in pigs and in humans in 
contact with pigs [12]. On 40 Dutch pig multiplier farms, overall prevalence of human ESBL-
carriage was 6% (8/142). Living or working on a farm with ESBL-positive pigs (13.5%; 7/52) 
compared to a farm with ESBL-negative pigs (1.1%; 1/90) was associated with an increased 
risk of carriage (OR=12.5; P=0.02). Human carriage increased with increasing number of 
working hours on the farm per week (OR=1.04 per working hour; P=0.0008). On one farm, 
two pig E. coli isolates and two human isolates were identical with respect to ESBL-gene, 
plasmid type and sequence type, and on another farm one pig E. coli isolate and one human 
isolate were identical. It is not clear whether the two isolates that came from the same farm 
were from separate individuals [13]. These studies suggest that, as seen for individuals living 
on broiler farms, contact with positive pigs is associated with an increased risk of carriage. A 
similar situation might be observed in individuals living or working on veal calf farms. It was 
shown that human carriage of methicillin-resistant Staphylococcus aureus (MRSA) on veal 
calf farms was associated with intensity of animal contact and number of positive animals 
on the farm [14], but this has not been investigated for EBSL-producing Enterobacteriaceae. 
Slaughterhouse employees or veterinarians might also be exposed to ESBL-positive animals, 
but there are no studies investigating transmission of ESBL-producing Enterobacteriaceae 
between humans and animals in these situations. For MRSA, however, contact with live 
pigs and broilers for individuals working at slaughterhouses has been shown a risk factor for 
carriage [15,16].
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Domestic exposure to animals
While living and working on a farm, working at a slaughterhouse or working as a veterinarian 
represents occupational exposure to animals, there are also opportunities where humans 
might come into contact with animals in a domestic situation such as at farm open house 
events, petting zoos or by owning companion animals. 
In the Netherlands, there are approximately 530 petting zoos (affiliated with the Dutch 
‘Vereniging Samenwerkende Kinderboerderijen Nederland’) which receive an estimated 29.3 
million visitors per year. Types of animals most commonly held are horse, donkey, cow, pig, 
sheep, goat, chicken, rabbit and Guinee pig [17]. There are reports of outbreaks of E. coli 
O157 infections associated with visits to farms and petting zoos [18,19], but there are no 
studies investigating prevalence of ESBL-producing Enterobacteriaceae or their transmission 
between humans and animals in these situations. 
It has been estimated that 18% of Dutch households owned at least one dog, and 24% of 
households owned at least one cat. The estimated numbers of cats and dogs in the Netherlands 
in 2012 were, 2.7 and 1.6 million respectively [20]. Close contact between companion 
animals and people within the same household offers favourable conditions for transmission 
by direct contact or indirectly through contamination of domestic environments. No studies 
exist, however, that investigate transmission of ESBL-producing Enterobacteriaceae between 
and among dogs, cats and humans within the household. With respect to horses, a study at 
a veterinary clinic in the Czech Republic showed that E. coli isolated from a horse, a drinking 
trough, and a human had the same PFGE type, implying clonal transmission between humans 
and horses. Furthermore, similar plasmids harbouring bla
CTX-M-1
 were found in isolates from 
horses, flies, and drinking troughs, suggesting horizontal gene transfer [21]. It was also shown 
that owning or having contact with a horse increased the risk for ESBL-carriage (15.6% vs. 
4.4%; OR=4.69) among individuals in the general Dutch population. This might not be solely 
attributable to owning or having contact with a horse, as prevalence increased from 4% in 
individuals without companion animals to 12% in individuals who owned more than four 
different species of companion animals ([4]; Chapter 3). Owning a pet was also associated 
with an increased risk for ESBL-carriage (OR=6.7) among volunteers recruited at an infection 
control conference (nurses and physicians from hospitals in Germany and Austria; [22]).
There are studies available showing E. coli strain sharing between and among dogs, 
cats and humans in the same household, suggesting that this might also hold true for ESBL-
producing Enterobacteriaceae. In a cross-sectional study that included 228 adults, children 
and pets from 63 households, strain sharing (i.e. highly related PFGE profile in isolates from 
two individuals) was more common among pet-pet pairs (22/38) than among human-human 
pairs (47/154) in the same household, and was more common among human-human pairs 
than among pet-human pairs (31/179; [23]). In a longitudinal study on 18 humans and 13 dogs 
living in 8 households, long-term carriage or intermittent shedding was demonstrated in most 
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humans and dogs; 10/18 humans studied were shown to share a clone least once with another 
person or with a dog in their household [24]. Although strain sharing does not necessarily 
indicate transmission, it is a likely explanation for these observations because of close physical 
contact between humans, and with their dogs or cats.
Transmission of ESBL-producing Enterobacteriaceae between humans and animals within 
the household is plausible, but might also occur outside the home (petting zoos and farm 
visits). What has not been considered so far, but is important to mention, is that households 
on livestock farms may also own one or more companion animals, and family members might 
visit petting zoos or other farms. It can be speculated that transmission between humans 
(within and between different households), livestock and companion animals also occurs and 
might be important in understanding the persistence of ESBL-producing Enterobacteriaceae. 
Transmission between humans 
So far studies on transmission between humans and animals resulting from professional 
or domestic exposure have been discussed, but in order to understand transmission in the 
general population human-to-human transmission should also be considered. Duration of 
carriage in humans will also be dealt with here because this has consequences for within 
and between household transmission, that is long-term carriers might form a reservoir of 
resistance genes for other household members leading to persistence of ESBL-producing 
Enterobacteriaceae within the household.
Transmission within and between households
Investigation of human-to-human transmission in the general population seems to focus 
mainly on the household, although there are other places such as child day-care centres 
[25] where human-human transmission of ESBL-producing Enterobacteriaceae might be 
important. Human-to-human transmission is also relevant for medical personnel in contact 
with patients who are carriers, but this is beyond the scope of this discussion. Available 
studies in the general population mainly concern household contacts of index patients with 
an infection caused by ESBL-producing Enterobacteriaceae. The prevalence of faecal carriage 
was significantly higher in household members, and non-household relatives of patients 
diagnosed with community-acquired urinary tract infections caused by ESBL-producing E. 
coli (23.8%; 25/105) than in unrelated individuals, not living in the same household (7.4%; 
4/54). Out of 19 families (household members and non-household relatives) with a least two 
carriers, eight families included carriers of isolates with the same PFGE pattern and ESBL-gene 
[26]. In another Spanish study, faecal carriage was 70% (28/40) among intensive care patients 
with community acquired infections with ESBL-producing bacteria, and was 16.7% (9/54) 
in household contacts of these patients. This is higher than the prevalence in the general 
Spanish population measured in the same geographic area (3.7%; [27]). Furthermore, up 
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to 66.7% (6/9) of intensive care patients and their corresponding household members had 
indistinguishable PFGE patterns [28]. In Norway, 20% (12/60) of household contacts of infants 
who became carriers of two unrelated bla
CTX-M-15
 carrying Klebsiella pneumoniae clones during 
a neonatal intensive care unit outbreak, were carriers of the same strain as the infants [29]. 
In Switzerland, ESBL-producing E. coli was found in 35.2% (31/88) of household contacts 
of patients presenting with carriage or infection with ESBL-producing Enterobacteriaceae, 
and based on E. coli phylogenetic group, sequence type and PFGE pattern, transmission was 
plausible for 22.7% (20/88) of contacts. Furthermore, evidence for transmission of ESBL-
producing K. pneumoniae was found in 25.0% (2/8) contacts [30]. 
Strain sharing among household members seems to occur regularly, especially if one of the 
members was infected with ESBL-producing Enterobacteriaceae. This suggests that patients 
returning home might be an important source of ESBL-producing Enterobacteriaceae for their 
household contacts, including both humans and pets. Furthermore, if patients are returning 
to their home on a livestock farm this might also have implications for transmission between 
household members, their pets and livestock. It can also be speculated that patients and 
individuals living or working on farms form a source of ESBL-producing Enterobacteriaceae 
for humans outside their own household [31].
Duration of carriage
Information about the duration of carriage of ESBL-producing Enterobacteriaceae in humans 
in the general population is lacking, however some information is available for specific sub-
groups such as patients and travellers. In infants who became carriers of bla
CTX-M-15
 carrying 
Klebsiella pneumoniae clones during a neonatal intensive care unit outbreak (n=51) and 
colonised parents (n=11) there was a significant difference in median length of carriage: for 
infants this was 12.5 (IQR (interquartile range) 9.0-17.5) months, and for parents 2.5 (IQR 1.0-
5.0) months [29]. In adult Swedish patients who were diagnosed with an infection caused by 
ESBL-producing Enterobacteriaceae, carriage was observed in 84% (51/61) of patients after 
one month, in 66% of patients (36/61) after 3 months, in 55% (31/61) after 6 months, and 
in 43% (26/61) after 12 months. In 28% (17/61) of patients, ESBL-production was found in a 
different bacterial strain or species during follow up than at the beginning of the study [32]. 
In Sweden, 24 out of 100 travellers who were initially ESBL-negative became positive after 
travel, and five out of 21 participants who completed the follow-up after 6 months were still 
colonised, but it was not reported whether this was with the same strain [33]. Of 113 Dutch 
travellers who had initially negative pre-travel samples and positive samples immediately 
after return, 16.8% (19/113) were still colonised after 6 months, and 7/19 participants had 
samples that were positive for E. coli with the same sequence type and CTX-M-group gene 
[34]. 
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These studies show that carriage in humans can be persistent and intermittent, but it is 
difficult to give an overall estimate of duration of carriage due to, for example, differences 
in definition of persistence and clearance, lack of molecular information, and the fact that 
information is limited to specific groups of individuals (not a random sample).
Travel abroad
In 2014, 12.5 million Dutch people went on vacations: 4.6 million went abroad only, 3.1 went 
on vacations in the Netherlands only, and 4.8 went on vacations abroad as well as in the 
Netherlands [10]. Prevalences of ESBL-producing Enterobacteriaceae among humans in the 
general population, as well as distributions of ESBL-genes, vary across geographic regions 
[35]. Individuals might face an increased level of exposure when travelling to countries 
where prevalences are higher than in the Netherlands. Multiple studies have identified travel 
abroad as a risk factor for carriage of ESBL-producing Enterobacteriaceae in humans in the 
general population, with increased rates of colonisation after travel. In Canadian patients 
with community-onset infections caused by ESBL-producing E. coli 43.6% (71/163) reported 
overseas travel, and this was associated with increased risk of infection (RR=5.7; P=<0.0001; 
[36]). Of 100 ESBL-negative Swedish travellers planning a trip outside of Northern Europe, 
24 had acquired ESBL-producing Enterobacteriaceae during travel. Travellers visiting India 
showed the highest rate of acquisition of ESBL-producing Enterobacteriaceae with 88% (7/8) 
colonised upon return, compared to 0% (0/1), 0% (0/2), 0% (0/6), 4% (1/25), 13% (2/16), 29% 
(4/14), and 32% (10/31) colonised for travellers to South America, North America, Central 
America, Africa, Southern Europe, Middle East and Asia (excluding India), respectively (three 
participants visited more than one continent; [33]). In Dutch travellers (n=370), 8.6% were 
colonised with ESBL-producing Enterobacteriaceae before travel, and 30.5% acquired these 
bacteria during travel. Travel to South and East Asia were associated with an increased risk, 
while travel to Southeast Asia, Central Asia, Africa, the Middle East, South America, and 
Central America and the Caribbean were not [34]. 
These studies indicate that travellers returning to their home country might be an 
important source of ESBL-producing Enterobacteriaceae for the general population, also in 
light of the evidence given for within and between household transmission.
Food products
ESBL- and AmpC-producing Enterobacteriaceae have been isolated from various types 
of retail meat, including chicken, turkey, pork, and beef, and in vegetables meant for raw 
consumption, such as celery, carrots and lettuce. 
Resistance to cefotaxime, an indicator for ESBL, in randomly selected E. coli isolates 
recovered from raw chicken, pork and beef was 9.1%, 3.6%, and 1.2%, respectively, in Europe 
[37]. In the Netherlands, this was 2.3%, 1.9%, 1.9%, and 0.9% from turkey, chicken, beef 
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and pork, respectively. No positive isolates were found in veal and lamb [38]. With selective 
enrichment, prevalences in raw fresh meat were 67.0% in chicken, 50.9% in turkey, 3.1% 
in veal, 2.7% in pork and 2.2% in beef. Again no positive isolates were found in lamb [38]. 
It should be noted that an unknown portion of samples originated from imported meat, 
therefore this does not necessarily correspond with what is present in faecal samples from 
animals in the Netherlands. Concentrations of ESBL-producing bacteria on meat are not 
included in the European and Dutch monitoring programmes, however some data for chicken 
meat is available. Median loads of ESBL-producing microorganisms were 80 CFU/25g (range 
<20-1360) in conventional poultry meat samples versus <20 CFU/25g (range 0-260) in organic 
samples [39], but these are not available for other types of meat. 
Vegetables are also not included in the European and Dutch monitoring programmes, but 
two Dutch studies investigated samples from for example blanched celery, bunched carrots, 
butterhead lettuce, endive, iceberg lettuce, bean sprouts, spring onion, radish and parsnip. 
A 5% (63/1216) prevalence of third-generation cephalosporin resistant Enterobacteriaceae 
in vegetables after selective enrichment was shown, but only 0.8% of all samples were ESBL-
producing faecal Enterobacteriaceae [40]. Another study showed a 6% (7/119) prevalence 
of ESBL-producing faecal Enterobacteriaceae in vegetables after selective enrichment [41]. 
Thorough cooking destroys bacteria, but there may be cross contamination in the kitchen 
between meat and vegetables meant for raw consumption through handling of the food or 
via implements [42]. ESBL-producing E. coli were detected on cutting boards after poultry 
meat preparation and before cleaning in both the hospital kitchen and private homes. ESBL-
producing E. coli were not detected on cutting boards after preparation of beef, pork, lamb, 
game and vegetables. The meat and vegetables themselves were not sampled in this study, 
however [43]. Undercooking of meat preparations such as minced meat, burger or sausage 
might also lead to ingestion of ESBL-producing Enterobacteriaceae as these bacteria might be 
found in the meat, and not just on the surface [42]. Vegetables can become contaminated 
with ESBL-producing Enterobacteriaceae by growth in contaminated soil, and irrigation with 
contaminated water, but also during processing [44]. When consumed raw, ESBL-producing 
Enterobacteriaceae may be transferred to humans.
In Chapter 3 of this thesis consumption of meat, chicken meat and vegetables from the 
garden were investigated, but not found to be a risk factor for carriage among humans in the 
general Dutch population ([4]; Chapter 3). Other studies investigating meat and/or vegetable 
consumption, reached a similar conclusion [26,45]. Circumstantial evidence for transmission 
of ESBL-producing Enterobacteriaceae to humans is available from other studies, however. 
For example, a foodborne outbreak of ESBL-producing Enterobacteriaceae has been 
reported, namely the German outbreak of E. coli O104:H4 harbouring bla
CTX-M-15
 associated 
with fenugreek sprouts [46]. Case-control and cohort studies implicated a certain producer 
of sprouts as the source of the outbreak, but these bacteria were not detected in the sprouts 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
General Discussion
127
themselves or in environmental samples [47]. Similar genes, plasmids and E. coli sequence 
types (based on multi-locus sequence typing; MLST) have been found in isolates from meat 
and humans, suggesting transfer of ESBL-producing E. coli to humans [48]. Whole-genome 
sequencing (WGS) of isolates from the aforementioned study collected from humans and 
broiler meat showed that there was a difference of 1263 Single-Nucleotide Polymorphisms 
(SNPs) per Mbp core genome between them, while for spatiotemporally-related isolates 
from human and pigs that were expected to be clonally related this was only 1.8 SNPs per 
Mbp core genome [49]. Drawing conclusions about transmission based on gene, plasmid and 
sequence type can therefore be highly speculative in isolates that are not spatiotemporally 
related. 
It is clear that humans are exposed to ESBL-producing Enterobacteriaceae via food 
products, but present knowledge is insufficient to determine the consequences of ingestion 
for carriage. Factors that need to be considered are the ability of bacteria of livestock origin 
to survive and multiply in the human gastrointestinal tract, and the role of horizontal gene 
transfer between bacteria of livestock and human origin. It has been shown that inoculation 
of mice with ESBL-producing E. coli of avian origin leads to short-term colonisation, and 
conjugation of plasmids was not observed [50]. However, an in situ continuous flow culture 
system simulating the human caecum and ascending colon showed that conjugation of 
plasmids from avian to human E. coli is possible, even without selective pressure from 
antibiotics [51]. It can be speculated that the role of chicken meat in human carriage is limited, 
but data are lacking to be able to suggest the same for other types of meat and vegetables.
Implications of results and directions for future research
A number of sources and pathways that might be relevant for the transmission of ESBL-
producing Enterobacteriaceae between humans, and between animals and humans have 
been given in the sections above. The relative contribution of each of these to carriage 
among humans remains to be elucidated, however. Attribution is the process of determining 
how much of a given infection is due to particular sources and pathways [52]. Attribution is 
also a useful tool to prioritise intervention strategies, but in order to determine the impact of 
these measures it is necessary to understand transmission dynamics and ultimately quantify 
transmission in human and animal populations. In this section, approaches that might be used 
to attribute ESBL/AmpC-producing Enterobacteriaceae to different sources and routes, and 
factors that might hamper the development of these approaches are given. This is followed 
by a discussion of the importance of understanding dynamics of transmission in livestock and 
other animal populations, and potential strategies for control. Finally, the main conclusions 
of this thesis are given. 
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Relative contribution of different sources and routes to carriage among humans in the general 
population
Two different approaches might be used to attribute ESBL/AmpC-producing Entero-
bacteriaceae to different sources and routes. First, to estimate the relative exposure to 
resistance determinants through various transmission routes (e.g. direct contact, via the 
environment, travel abroad, consumption of food) a comparative exposure assessment might 
be used. To estimate the exposure dose for each transmission route, information on the 
prevalence and dose of the resistance determinant in the source, the changes in prevalence and 
quantity of the resistance determinant throughout the transmission chain, and the frequency 
at which humans are exposed by that route is required. The exposure doses are compared, 
and the human disease burden caused by particular resistance determinants is partitioned to 
each of the various transmission routes, proportionally to the size of the exposure dose [52]. 
Second, to estimate the relative importance of different sources (e.g. livestock, companion 
animals, environment) for exposure to the resistance determinant in humans, a source 
attribution model based on microbial subtyping data might be used. The principle behind 
this method is to compare bacterial genetic profiles found in the various sources with the 
ones found in humans based on for example, DNA sequence data. Information that would be 
required for a source attribution model based on microbial subtyping includes a collection 
of isolates from humans and different sources, subtyping methods that can provide detailed 
knowledge of all types in relevant sources, and a model to infer sources of human infection 
based on the subtype distributions obtained within each investigated source [53].
Models have been developed that attribute foodborne infections to their sources and 
pathways using microbial subtyping [54,55] and comparative exposure assessment [56]. 
Perhaps these models could be adapted for ESBL-producing Enterobacteriaceae. Several 
factors can be identified that might hamper the adaptation of these models for ESBL-
producing Enterobacteriaceae, and indicate directions for future research. First, selection of 
typing methods that are discriminatory enough to enable recognition of correlation between 
human isolates and their sources, but not too discriminatory so that there is a risk that 
correlated isolates may not be recognised as related [53]. It has been shown that similarity 
between isolates cannot be based on sequence type, plasmid family and ESBL-gene alone 
in case isolates are not spatiotemporally related [49]. Whole-genome sequencing might 
provide a suitable alternative, but then the question still remains whether it is more accurate 
to look at virulence and resistance gene content, the genetic backbone of the host strain or a 
combination of these. Furthermore, transfer of resistance genes between chromosome and 
plasmid, between plasmids, and between bacteria makes it difficult to establish correlations 
between isolates from humans and those from possible sources. Second, detailed molecular 
typing data is not available from all putative sources. Isolates from patients, livestock and 
meat have been systematically collected in the Dutch and European monitoring programmes, 
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but this is not the case for companion animals, humans in the general population, and the 
natural environment for example. Studies quantifying ESBL-producing Enterobacteriaceae 
in putative sources and changes in concentration along various transmission pathways to 
sites for human exposure are available for broilers, but is lacking for other sources. For 
example, quantitative data is available on ESBL-producing E. coli shed by broilers [57], on 
reduction through processing in the slaughterhouse [58], and on concentration in retail meat 
[39]. Approaches to determine the relative contribution of different sources to carriage of 
ESBL-producing Enterobacteriaceae are considered here but it is important to keep in mind 
that the relationship between exposure, infection, carriage and disease is unclear, making it 
difficult to determine the implications of different sources and pathways for human health. 
Dynamics of transmission in livestock and other animal populations
Equally important to future research into sources and pathways that contribute to human 
carriage, is the continued elucidation of transmission dynamics in livestock, but also other 
animal populations and more specifically companion animals as these are in close contact to 
humans. 
In order to understand transmission dynamics on livestock farms, longitudinal studies 
have been conducted examining the prevalence of ESBL-producing Enterobacteriaceae in 
different livestock species ([6,59,60]; Chapter 6). On two pig farms all investigated age groups 
were positive for CTX-M positive coliforms: sows in the last week of gestation (35-71%), 
piglets during the first week after birth (56-91%) and just before weaning (71-97%), weaners 
6 weeks after weaning (21-56%) and finishers just before slaughter (16-17%). Prevalence of 
carriage increased until weaning, while a decrease was observed in weaning and finishing 
sections, with the lowest prevalence being found before slaughter. Mean faecal counts of 
CTX-M positive coliforms decreased from piglets (107 CFU/g) to weaners (105 CFU/g) and from 
weaners to finishers (103 CFU/g). On a third farm, which applied all-in/all-out management 
in the farrowing and finishing sections and continuous production in the weaning section 
compared to continuous production in all sections on the other two farms, only weaners 
tested positive (10%). On one farm bla
CTX-M-9
 were found while on the other two farms this 
was bla
CTX-M-1 
, and no shift in genotypes was reported. Data on individual animals were 
unfortunately not presented and environmental samples of the different sections were not 
taken [59]. On three veal calf farms, prevalence was comparable upon arrival of the animals 
at the farm (18-26%) and a similar distribution of primarily bla
CTX-M-1
 genes was shown. In the 
following ten weeks of the study, each farm showed a different pattern of prevalence: on one 
farm ESBL/AmpC-producing E. coli were not detected after the first sampling, on another 
farm prevalence increased to 37% at week 3 and then decreased below detection level at 
week 10, and on the third farm prevalence decreased to 1.4% at week 10. Between arrival 
and the next sampling moment at week 3 a shift in the predominant gene group occurred 
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from bla
CTX-M-1
 to bla
CTX-M-9 
, which according to the authors might be explained by presence 
below detection level at arrival, presence and acquisition through the stable environment 
or as a result of antibiotic treatment. Although calves were housed individually until week 6, 
no data on individual animals was reported and no samples of the farm environment were 
taken [60]. On three conventional broiler farms, environmental samples from the broiler 
house were positive for EBSL/AmpC-producing E. coli before arrival of chicks, and in day-
old chicks the prevalence ranged from 0-20% upon arrival at the farm. After one week the 
prevalence on these farms was 96-100% and it was 100% on all farms until the end of the 
study at 5 weeks of age. ESBL-genes, plasmids and sequence types were not determined 
so shifts in genotypes during the study period were not observed [6]. In a longitudinal 
study on an organic farm, broilers were followed individually from arrival till slaughter age 
(Chapter 6). This is the first study to quantify transmission of ESBL/AmpC-producing E. coli 
in an animal population and explore the effect of direct contact, relative to the environment 
in transmission. Total ESBL/AmpC-producing E. coli are able to transmit and persist in an 
organic broiler flock, but this was not the case for individual phylogenetic groups as indicated 
by reproduction ratios less than one for groups separately. Persistence of total ESBL/AmpC-
producing E. coli might therefore be determined by repeated shifts from one phylogenetic 
group to another between arrival on the farm and slaughter age. Furthermore, the risk for 
an individual to become infected with ESBL/AmpC-producing E. coli was lower if it had been 
infected previously, which might be explained by the acquisition of immunity to particular E. 
coli genotypes. The environment was relatively more important in the transmission of the A1 
phylogenetic group, and direct contact between broilers was relatively more important for 
the transmission of the B1 phylogenetic group, for those broilers that were not previously 
infected. These results suggest that the contaminated environment before the start of 
the production round and positive day-old chicks both play a role in the introduction and 
transmission of ESBL/AmpC-EC in the new flock. 
A decrease in prevalence of ESBL-producing Enterobacteriaceae was seen on all types of 
farms towards slaughter except on conventional broiler farms ([6,59,60]; Chapter 6), but as 
mentioned previously this might be related to the length of production round. Furthermore, 
there appears to be a shift in genotypes on both veal calf and organic broiler farms, but 
unfortunately data is lacking to determine if this is also the case on pig and conventional 
broiler farms. It would be useful to apply the methods from Chapter 6 on other livestock 
farms to estimate duration of carriage, quantify transmission parameters, and elucidate the 
role of direct contact, relative to the environment in transmission. Also, it is important to 
confirm present findings for organic broiler farms and compare this to conventional broiler 
farms. Information on transmission dynamics will provide starting points for intervention on 
livestock farms, which will lead to fewer contaminated animals. Fewer contaminated animals 
both on farms and entering the slaughterhouse could affect carriage in humans exposed to 
these animals. 
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For companion animals only one longitudinal study has been published, which included 
38 dogs from 24 owners that were sampled once per month for a period of 6 months. Dogs 
showed a monthly, and in some cases even a weekly, shift in shedding of ESBL-producing 
Enterobacteriaceae. It was also shown that when dogs were positive this was not with the 
same ESBL-gene throughout the study period. Unfortunately, E. coli genotypes and plasmids 
were not determined [61]. In Chapter 6 it was speculated that persistence of ESBL/AmpC-
producing E. coli during a production round was determined by shifts in genotypes. This might 
also be an explanation for persistence in dogs, but the factors driving these shifts remain to 
be elucidated.
Control strategies on livestock farms
ESBL-producing Enterobacteriaceae from livestock might represent a reservoir of resistance 
genes, and reasons for maintenance of this reservoir are needed to inform control 
strategies. In the Netherlands, the total use of antimicrobials in farm animals was reduced 
by 56% between 2007 and 2012, and the aim is to accomplish a 70% reduction in 2015 
[62]. Cefotaxime-resistant E. coli decreased in farm animals from 2008-2013, but has levelled 
off in 2014 [38]. Prudent use of antimicrobials and efforts to reduce antibiotic use should 
be continued, however it is has been suggested that while reducing antibiotic use will have 
an impact on resistance, it will not eliminate it. Resistance is often associated with reduced 
bacterial fitness, and it is proposed that a reduction in antibiotic use would benefit the fitter 
susceptible bacteria, allowing them to outcompete resistant strains over time. Compensatory 
evolution and co-selection of resistance to more than one antibiotic limit the reversibility of 
resistance, however [63]. In an in vitro experiment fitness cost resulting in a lower bacterial 
growth rate or lower maximum density due to presence of the plasmid IncI1 carrying the 
bla
CTX-M-1
 gene, frequently identified in humans and animals, were not observed [64], lending 
support to this idea. This suggests that reduction of antibiotic use alone will not be enough to 
eliminate the reservoir of resistance genes in livestock. 
Maintenance of resistance genes in livestock might also be explained by the presence 
of other potential reservoirs of resistance genes (e.g. on the same farm), that is humans, 
companion animals, and vermin (i.e. flies, rats). Although it has been indicated that reducing 
antibiotic use will not reverse resistance, also prudent use of antimicrobials in humans and 
companion animals should be pursued. The Netherlands had an antibiotic consumption 
rate of 10.4 defined daily doses (DDD) per 1000 inhabitants per day in humans in 2013, 
which is the lowest in Europe. In comparison, the highest consumption rate was shown in 
Greece and was 32.2 DDD/1000 inhabitants/day [65]. It can, therefore, be speculated that 
antimicrobial use in humans in the Netherlands is currently prudent. Also the occurrence 
of cefotaxime-resistance among human clinical isolates, and indicator for ESBL-production, 
is one of the lowest in Europe [66]. Systematic reporting on antimicrobial consumption and 
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antimicrobial resistance in companion animals is currently lacking, which is an important 
data gap. Besides reduction of antibiotic use, control strategies on livestock farms that limit 
interactions between livestock, companion animals, wildlife, vermin and humans should be 
considered. Examples include, preventing companion animals from entering animal housing, 
active control of vermin and strict hygiene protocols for veterinarians or other personnel 
entering the animal houses. In the case of organic broilers, it was shown that a contaminated 
environment before the start of the production round and positive day-old chicks both play 
a role in the introduction and transmission of ESBL/AmpC-producing E. coli in the new flock 
(Chapter 6). To prevent introduction through day-old chicks it is necessary to consider all 
previous steps in the broiler production chain, that is (great)grandparent and parent stock, 
and hatcheries [6]. Veal calves were also positive upon arrival on the farm [60], which 
suggests that here previous steps in the production chain also need to be taken into account 
for control. Future studies should quantify the effectiveness of intervention measures on 
farms that take into account all different reservoirs of resistance genes, but also at previous 
points in the animal production chain.
Main conclusions of this thesis
To summarise, all investigated conventional and organic broiler farms were positive for ESBL/
AmpC-producing Enterobacteriaceae, and these bacteria were able to persist and transmit 
in a flock without antibiotic pressure. Prevalence in humans living or working on farms was 
higher than in the general population. Also, individuals living or working on farms with a high 
degree of contact with broilers were at an increased risk for carriage compared to those 
individuals with a low degree of contact. Furthermore, evidence for clonal transmission 
of ESBL/AmpC-producing E. coli between humans and broilers on farms was found. These 
results suggest that direct contact with broilers contributes to carriage of individuals on 
farms. As only a very small percentage of the general population is exposed to live broilers, 
compared to the percentage of individuals owning pets, visiting petting zoos and travelling 
abroad, direct contact with broilers does not appear to be important for carriage in the 
general human population. Putative sources and pathways include companion animals, 
other humans, travel abroad and food products. Their relative contribution to carriage of 
ESBL-producing Enterobacteriaceae among humans in the general population remains to be 
elucidated, and more insight in dynamics of transmission in both livestock and other animal 
populations in close contact with humans is needed.
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The emergence of antibiotic resistance both in humans and in animals requires urgent 
attention. Antibiotic resistance in animals becomes a public health issue when there is 
transmission of antibiotic resistant bacteria, or their resistance genes, from animals to 
humans. β-lactam antibiotics are critically important for the treatment of human bacterial 
infections, and resistance to this class of antibiotics mediated by extended-spectrum 
β-lactamases (ESBL) and AmpC β-lactamases has emerged in Gram-negative bacteria. Poultry, 
in particular broilers, might play a role in the transmission of resistance genes to humans due 
to the high prevalence of ESBL/AmpC-producing Enterobacteriaceae among their intestinal 
biome, compared to other livestock species, companion animals, and wildlife. Poultry meat 
has been identified as a possible source for human infections, and transmission to humans 
via the food chain was hypothesised. This is only one possible route, however, by which 
ESBL-producing Enterobacteriaceae might be exchanged between broilers and humans. 
Transmission by close physical contact and via the environment should also be considered as 
broiler farms, their immediate surroundings, but also the wider natural environment could be 
contaminated with ESBL-producing Enterobacteriaceae, potentially leading to transmission 
at sites relevant for human exposure. 
The aim of this thesis was to investigate transmission of antibiotic resistant bacteria 
between animals and humans, and more specifically the transmission of ESBL-producing 
E. coli between broilers, and between broilers and humans in varying degrees of contact 
with these animals. In order to gain insight into transmission routes, studies were conducted 
answering key questions on (1) the role of the natural environment in the transmission of 
clinically relevant antimicrobial resistant (AMR) bacteria to humans; (2) prevalence of, and risk 
factors for, carriage of ESBL-producing Enterobacteriaceae in the general human population 
living in areas with high and low broiler densities, and humans on conventional and organic 
broiler farms; and (3) prevalence of carriage, and transmission dynamics among broilers on a 
broiler farm under field conditions.
Systematically collected and categorised evidence from literature showed that clinically 
relevant AMR bacteria are present in the natural environment, more specifically in soil, 
water, air, and wildlife. No direct evidence was found showing transmission of AMR bacteria 
to humans, although one study did find genetically related isolates from humans, animals 
and the surrounding environment suggesting transmission is plausible. Quantitative data 
and epidemiological studies further suggest this (Chapter 2). The occurrence of clinically 
relevant AMR bacteria in the environment leads to the hypothesis that individuals in areas 
with high broiler densities might have an increased risk for carriage of ESBL-producing 
Enterobacteriaceae. This hypothesis was rejected, however, as the risk was lower (3.6% vs. 
6.7%; OR=0.45; P=0.009) for these individuals (Chapter 3). Mean distance to the nearest 
broiler farm was smaller for individuals in municipalities with high broiler densities (2.2 km), 
compared with low broiler densities (6.2 km; P≤0.0001). The overall high broiler density in 
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the Netherlands (1301 broilers/km2) and mobility of individuals between municipalities and 
provinces, may have disturbed a possible relationship between broiler density and ESBL-
carriage, however. Owning a horse increased the risk for ESBL-carriage (15.6% vs. 4.4%; 
OR=4.69; P≤0.0001). This might not be solely attributable to owning or having contact 
with a horse, as prevalence increased from 4% in individuals without companion animals 
to almost 12% in individuals who owned more than four different species of companion 
animals (Chapter 3). Contact with multiple species of companion animals might play a role in 
transmission, but information on the mutual exchange of ESBL-producing Enterobacteriaceae 
between companion animals and their owners is needed.
Not only transmission via the environment, but close physical contact with broilers might 
lead to increased risk for carriage of ESBL/AmpC-producing E. coli among humans. Compared 
to humans in the general population (5.1%; Chapter 3) and Dutch patients (4.9%), prevalence 
of carriage among farmers, their family members and employees on both conventional 
(19.1%; Chapter 4) and organic (18.5%; Chapter 5) broiler farms was higher. Evidence for 
clonal transmission of ESBL/AmpC-producing E. coli between humans and broilers was found 
on conventional farms (Chapter 4), and horizontal gene transfer was suspected on both 
conventional and organic farms (Chapters 4 and 5). An increased risk of carriage was shown 
among farmers and employees compared to partners and family members (27.1% vs. 14.3%; 
OR=2.5; P=0.08), suggesting an increased risk of exposure for humans on broiler farms and 
that this risk is larger for individuals in close contact with broilers. Transmission through direct 
contact with broilers and via the farm environment therefore results in human carriage. 
Due to differences in management practices between conventional and organic farms, 
especially antibiotic use, the prevalence of ESBL/AmpC-producing E. coli carriage among 
broilers, and humans living and/or working on organic broiler farms were compared to 
results from conventional farms. All investigated broiler farms were positive for ESBL/AmpC-
producing E. coli, and there appeared to be no difference in sample-level prevalence between 
conventional (96.4%; Chapter 4) and organic (94.3%; Chapter 5) farms at five weeks of age, 
which was just before slaughter on conventional farms. On organic farms, the sample level 
prevalence decreased to 80.0% at slaughter age, which is approximately 70 days (Chapter 
5). The decrease might also be the case for broilers on conventional farms if the production 
round would be longer. 
ESBL/AmpC-producing E. coli are able to transmit and persist on organic farms, even 
without selective pressure from antibiotics, as indicated by a reproduction ratio of 1.70 for total 
ESBL/AmpC-producing E. coli (Chapter 6). This does not hold true for individual phylogenetic 
groups as indicated by reproduction ratios less than one for groups separately, however. This 
might mean that persistence of total ESBL/AmpC-producing E. coli is determined by repeated 
shifts from one phylogenetic group to another during the period between arrival at the 
farm and slaughter age. Furthermore, the environment was relatively more important in the 
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transmission of the A1 phylogenetic group and direct contact between broilers was relatively 
more important for the transmission of the B1 phylogenetic group, for those broilers that 
were not previously infected. This suggests that the contaminated environment before the 
start of the production round and positive day-old chicks both play a role in the introduction 
and transmission of ESBL/AmpC-producing E. coli in the new flock.
The results of this thesis show that direct contact between humans, broilers and the broiler 
farm environment, as experienced by people living or working on these farms, contributes 
to human carriage. In the general population, not living on broiler farms, different sources 
and pathways might contribute to carriage among humans such as occupational or domestic 
exposure to animals, human-human transmission, travel abroad and consumption of food 
products, although the contribution of each remains to be elucidated.
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